data_1c7m_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1c7m _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.573 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 . . . . . 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 . . . . . 0 CA--C 1.564 1.492 0 CA-C-O 120.508 0.194 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . . . . . . 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 . . . . . 0 CA--C 1.568 1.648 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.673 -0.68 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 . . . . . 0 CA--C 1.572 1.814 0 CA-C-O 121.443 0.639 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 CA--C 1.579 2.062 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 CA--C 1.566 1.567 0 CA-C-O 120.786 0.327 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.575 1.939 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.569 1.706 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.574 1.876 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 CA--C 1.57 1.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.477 HD12 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 121.332 0.587 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.568 1.642 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 CA--C 1.566 1.587 0 CA-C-O 120.62 0.248 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 . . . . . 0 CA--C 1.565 1.544 0 CA-C-O 121.226 0.536 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 . . . . . 0 CA--C 1.568 1.645 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.573 1.853 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . . . . . . 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.572 1.825 0 CA-C-O 121.512 0.672 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 CA--C 1.57 1.732 0 CA-C-O 121.317 0.58 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.574 1.895 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 120.905 0.384 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 CA--C 1.566 1.59 0 CA-C-O 120.774 0.321 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.568 1.673 0 CA-C-O 121.912 0.863 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 CA--C 1.57 1.734 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . . . . . . 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 121.32 0.581 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.54 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.53 79.3 1.89 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.601 0.76 . . . . 0.0 110.49 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.32 104.66 45.69 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.66 64.66 0.77 Allowed 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.68 46.57 1.07 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -172.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.54 106.93 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -72.9 100.49 2.94 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.294 0.638 . . . . 0.0 111.357 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.96 -47.69 0.82 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -76.82 139.5 40.35 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 118.431 1.115 . . . . 0.0 113.122 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.19 -55.74 22.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.85 -43.85 8.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 118.433 2.133 . . . . 0.0 118.433 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -87.86 101.41 13.7 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 118.309 1.054 . . . . 0.0 110.505 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 C--O 1.254 1.338 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.349 -167.342 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.3 71.35 1.42 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 112.037 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -111.48 99.99 46.19 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 68.32 79.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 87.73 0.07 OUTLIER Glycine 0 N--CA 1.483 1.822 0 O-C-N 121.547 -0.721 . . . . 0.0 113.616 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.22 142.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 117.283 0.542 . . . . 0.0 110.265 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.323 6.8 t0 60.81 -154.43 0.37 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 168.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.71 39.59 3.1 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.188 -0.945 . . . . 0.0 115.451 155.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -92.0 118.22 30.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.488 1.144 . . . . 0.0 110.69 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.58 -47.86 68.55 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.84 -44.12 6.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.45 -52.83 34.75 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.468 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 119.057 2.984 . . . . 0.0 119.057 169.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.403 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.44 77.19 1.61 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.382 -0.823 . . . . 0.0 112.933 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.71 96.64 50.21 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 71.03 75.21 0.19 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.7 64.51 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.96 133.6 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.83 115.17 2.42 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.74 -30.8 9.62 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 118.129 2.012 . . . . 0.0 118.129 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.63 129.75 34.75 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.624 1.712 . . . . 0.0 112.126 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.62 -38.63 91.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.92 48.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 118.176 2.031 . . . . 0.0 118.176 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.04 117.03 18.21 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 118.937 1.369 . . . . 0.0 112.623 174.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.219 -172.58 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.443 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mmm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 72.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -112.73 101.31 52.7 Favored Pre-proline 0 CA--C 1.571 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.72 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . 70.6 62.6 0.2 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.27 5.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 119.209 2.443 . . . . 0.0 119.209 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.0 t -81.14 96.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 119.165 1.482 . . . . 0.0 110.381 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.45 103.63 2.51 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.475 0.655 . . . . 0.0 110.906 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.78 -51.58 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.884 -154.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.47 135.83 39.37 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 118.213 1.006 . . . . 0.0 111.675 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -49.34 62.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.82 -58.91 3.62 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -87.96 100.8 13.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.207 -178.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 96.73 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.31 110.31 59.54 Favored Pre-proline 0 CA--C 1.579 2.062 0 C-N-CA 123.823 0.849 . . . . 0.0 111.014 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 67.87 22.26 8.76 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.6 51.41 2.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t -133.8 105.1 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.18 123.18 20.99 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.075 0.55 . . . . 0.0 111.785 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.09 -53.74 0.73 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -163.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 129.38 34.82 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 117.784 0.792 . . . . 0.0 111.847 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.78 -50.43 62.7 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.92 -31.53 3.59 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.69 84.49 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 120.164 1.982 . . . . 0.0 109.739 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.012 -166.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtp . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.01 76.55 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.365 0.984 . . . . 0.0 113.455 -173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -104.04 109.42 62.36 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . 71.75 26.37 3.06 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 58.76 4.13 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.66 111.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 160.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.96 100.05 2.37 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 111.379 169.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.71 -51.1 0.68 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -162.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -80.57 134.26 35.9 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 118.277 1.038 . . . . 0.0 111.829 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -66.45 -51.31 58.21 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.73 -51.81 2.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -79.68 86.95 5.23 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.845 0.858 . . . . 0.0 110.754 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 . . . . . 0 C--O 1.253 1.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.583 -170.973 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.31 72.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.629 1.104 . . . . 0.0 112.891 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -104.08 106.81 54.98 Favored Pre-proline 0 CA--C 1.574 1.876 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 73.03 88.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.67 71.47 0.11 Allowed Glycine 0 N--CA 1.487 2.088 0 O-C-N 121.552 -0.717 . . . . 0.0 114.511 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.16 115.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.65 95.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.05 -41.85 1.31 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 -165.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -86.49 133.35 33.76 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 119.324 1.562 . . . . 0.0 113.296 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.477 HD12 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.47 -47.69 75.7 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.14 14.94 12.47 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 165.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -139.45 76.6 1.57 Allowed 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 120.003 1.901 . . . . 0.0 109.119 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.771 0.828 . . . . 0.0 113.02 -168.052 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.272 . . 53.39 49.2 20.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.388 2.736 . . . . 0.0 118.388 -171.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -108.85 98.06 27.55 Favored Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 65.2 29.77 11.67 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 48.77 2.38 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.94 102.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.76 105.72 3.86 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.181 0.592 . . . . 0.0 110.801 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.29 -51.65 0.77 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-O 119.6 -0.555 . . . . 0.0 114.139 -158.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -79.5 134.58 36.52 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.179 0.99 . . . . 0.0 111.899 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.07 -50.69 69.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.34 -37.08 92.51 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 118.862 2.305 . . . . 0.0 118.862 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -89.87 91.75 8.74 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.016 0.908 . . . . 0.0 109.318 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.152 0.981 . . . . 0.0 111.166 -171.023 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mmm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.094 0.474 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.33 74.54 0.93 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.441 0.638 . . . . 0.0 111.421 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -107.15 101.71 39.63 Favored Pre-proline 0 CA--C 1.568 1.642 0 O-C-N 121.452 -0.78 . . . . 0.0 109.244 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . 66.74 76.3 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.25 58.56 0.4 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 117.336 1.695 . . . . 0.0 117.336 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.23 115.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.75 107.08 3.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.513 -0.742 . . . . 0.0 111.511 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.51 -42.56 1.19 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 -165.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -91.79 143.61 26.34 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 118.816 1.308 . . . . 0.0 113.898 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.0 -54.07 46.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.82 -48.6 6.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.87 100.92 13.64 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.385 1.092 . . . . 0.0 110.927 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.887 -167.802 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.481 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.213 0.53 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 68.21 10.42 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.33 89.5 52.11 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . 72.14 15.65 5.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.37 82.78 0.44 Allowed Glycine 0 N--CA 1.489 2.198 0 O-C-N 120.84 -1.162 . . . . 0.0 114.237 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.7 t -135.13 114.19 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 168.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -74.41 96.73 2.93 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.487 0.661 . . . . 0.0 110.355 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.61 -50.6 0.62 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.59 -158.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -104.22 125.88 50.86 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 118.239 1.02 . . . . 0.0 110.881 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.475 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.35 -47.94 77.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.61 -58.65 2.65 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 116.689 1.435 . . . . 0.0 116.689 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -82.32 93.87 7.24 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.926 -173.318 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.475 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 82.37 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.785 . . . . 0.0 112.405 -172.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 100.22 53.1 Favored Pre-proline 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 -175.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 77.75 98.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.43 83.12 0.04 OUTLIER Glycine 0 N--CA 1.486 2.006 0 CA-C-O 119.311 -0.716 . . . . 0.0 112.97 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.58 141.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.191 0.996 . . . . 0.0 109.873 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.332 2.4 t70 60.88 -150.84 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 167.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.24 41.37 2.6 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.197 -0.939 . . . . 0.0 114.875 151.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -86.73 121.5 29.33 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.833 1.316 . . . . 0.0 111.433 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.55 -51.51 59.29 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.04 -58.57 3.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.46 115.74 24.16 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.408 0.683 . . . . 0.0 110.717 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.532 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.3 76.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.027 0.83 . . . . 0.0 111.638 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -106.94 103.61 48.25 Favored Pre-proline 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.64 90.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.65 70.81 0.1 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -142.81 115.44 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.21 101.59 1.91 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.145 0.578 . . . . 0.0 111.533 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.18 -51.15 0.8 Allowed Glycine 0 N--CA 1.489 2.192 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.893 -162.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -88.05 129.78 35.18 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.601 1.2 . . . . 0.0 112.472 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.73 -39.66 66.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.99 -61.9 3.13 Favored Glycine 0 N--CA 1.49 2.291 0 CA-C-N 119.857 1.208 . . . . 0.0 115.909 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.5 96.13 10.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -164.194 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.0 83.38 2.21 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -121.15 99.01 46.67 Favored Pre-proline 0 CA--C 1.573 1.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.21 33.14 5.65 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.4 -35.88 21.98 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.08 97.07 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 119.426 1.613 . . . . 0.0 108.996 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.62 129.13 37.32 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.576 0.703 . . . . 0.0 112.113 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.82 -54.15 0.76 Allowed Glycine 0 N--CA 1.491 2.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.087 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.46 141.9 52.0 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.44 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -67.4 -50.64 58.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.84 -55.29 7.43 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.63 112.34 23.55 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 117.718 0.759 . . . . 0.0 110.591 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -172.613 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.44 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.184 0.902 . . . . 0.0 111.985 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.75 105.63 56.6 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . 70.09 29.58 3.77 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 58.42 2.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 118.049 1.98 . . . . 0.0 118.049 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -140.47 100.96 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 164.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.04 103.04 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.715 -0.616 . . . . 0.0 110.921 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.78 -47.92 0.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -158.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -77.72 139.87 39.45 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 118.402 1.101 . . . . 0.0 112.716 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.68 -50.62 66.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.88 -26.89 73.83 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 119.461 2.545 . . . . 0.0 119.461 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -89.23 104.98 17.48 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.584 1.192 . . . . 0.0 109.622 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 123.427 0.691 . . . . 0.0 110.787 -166.217 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.93 95.85 8.91 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 119.546 1.066 . . . . 0.0 111.759 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -128.53 106.56 19.04 Favored Pre-proline 0 CA--C 1.572 1.805 0 O-C-N 120.442 -1.411 . . . . 0.0 109.113 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . 66.47 30.84 8.46 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.81 52.81 1.7 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.17 102.81 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 166.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.25 108.94 5.66 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.182 0.593 . . . . 0.0 110.922 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.83 -49.07 0.91 Allowed Glycine 0 N--CA 1.49 2.296 0 CA-C-O 119.509 -0.606 . . . . 0.0 114.592 -159.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -80.69 135.84 36.09 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 118.224 1.012 . . . . 0.0 112.249 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' MET . . . . . 0.45 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.53 -52.96 18.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.53 -52.53 5.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 117.584 1.793 . . . . 0.0 117.584 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.1 104.39 16.97 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.194 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.253 1.284 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.698 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . 0.45 ' C1A' ' SD ' ' A' ' 78' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.91 72.55 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.51 107.8 57.24 Favored Pre-proline 0 CA--C 1.574 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . 64.28 33.09 11.82 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.55 51.59 1.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -170.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.28 106.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.94 108.19 5.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.736 -0.602 . . . . 0.0 110.644 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.92 -53.05 0.75 Allowed Glycine 0 N--CA 1.49 2.269 0 CA-C-O 119.665 -0.519 . . . . 0.0 113.895 -159.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.63 129.78 35.01 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 117.887 0.843 . . . . 0.0 111.42 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.41 -52.89 41.82 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.16 -54.02 5.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 117.735 1.854 . . . . 0.0 117.735 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -90.26 94.03 9.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.045 0.926 . . . . 0.0 109.564 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 C--O 1.254 1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.729 -169.378 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.31 80.62 1.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.743 0.817 . . . . 0.0 111.763 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.19 103.55 55.41 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . 68.24 18.18 9.26 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.14 66.72 1.81 Allowed Glycine 0 N--CA 1.488 2.109 0 O-C-N 120.234 -1.541 . . . . 0.0 116.312 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.7 t -140.31 107.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 168.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.67 104.55 4.64 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.82 -50.57 0.77 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 -162.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -87.24 128.14 35.16 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 118.106 0.953 . . . . 0.0 111.671 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.46 -49.71 68.09 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.11 -47.11 7.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 118.963 2.345 . . . . 0.0 118.963 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -96.48 94.48 7.42 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.066 0.946 . . . . 0.0 110.017 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.579 -169.38 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.74 73.54 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 120.199 1.363 . . . . 0.0 112.092 172.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.72 103.64 52.17 Favored Pre-proline 0 CA--C 1.57 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 109.71 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.18 30.18 5.83 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.21 58.59 2.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 -171.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.1 t -141.66 109.53 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.53 94.54 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.02 -46.89 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 -163.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.33 138.0 36.66 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 118.441 1.12 . . . . 0.0 112.806 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.7 -50.75 63.73 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.88 -58.57 4.02 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 117.194 1.637 . . . . 0.0 117.194 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -86.48 116.95 24.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.614 0.707 . . . . 0.0 110.855 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -173.339 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.75 72.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.773 1.624 . . . . 0.0 113.146 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -104.65 107.79 59.09 Favored Pre-proline 0 CA--C 1.574 1.903 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . 73.51 62.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.59 52.57 0.76 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.48 108.44 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.84 100.87 3.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.752 . . . . 0.0 110.953 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.17 -48.35 0.74 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -163.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -79.76 141.84 35.94 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-N 118.422 1.111 . . . . 0.0 113.254 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.56 -53.9 44.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.13 65.75 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.2 87.75 7.48 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 118.544 1.172 . . . . 0.0 111.204 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.911 0.884 . . . . 0.0 111.25 -169.385 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.562 1.437 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.85 69.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 113.286 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -107.25 105.04 54.69 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 63.49 37.69 10.38 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.68 53.6 1.71 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 118.88 2.312 . . . . 0.0 118.88 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.7 t -141.46 104.77 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 162.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.24 100.48 3.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.626 -0.671 . . . . 0.0 110.675 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.63 -50.79 0.67 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-O 119.52 -0.6 . . . . 0.0 114.452 -158.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -78.76 136.27 37.34 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.314 1.057 . . . . 0.0 112.127 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -66.58 -50.45 63.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.66 -46.47 18.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -88.32 89.08 7.85 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.128 0.964 . . . . 0.0 111.391 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 117.896 -1.05 . . . . 0.0 112.568 -172.953 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.573 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 . . . . . 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 . . . . . 0 CA--C 1.564 1.492 0 CA-C-O 120.508 0.194 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . . . . . . 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 . . . . . 0 CA--C 1.568 1.648 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.673 -0.68 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 . . . . . 0 CA--C 1.572 1.814 0 CA-C-O 121.443 0.639 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 CA--C 1.579 2.062 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 CA--C 1.566 1.567 0 CA-C-O 120.786 0.327 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.418 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.575 1.939 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.569 1.706 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.574 1.876 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 96' ' ' LEU . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 CA--C 1.57 1.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.41 HD11 HG23 ' A' ' 34' ' ' VAL 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 121.332 0.587 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.568 1.642 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 CA--C 1.566 1.587 0 CA-C-O 120.62 0.248 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 . . . . . 0 CA--C 1.565 1.544 0 CA-C-O 121.226 0.536 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 57' ' ' TRP . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 . . . . . 0 CA--C 1.568 1.645 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.426 ' CE2' HG22 ' A' ' 38' ' ' VAL . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.573 1.853 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.537 ' N ' HD21 ' A' ' 91' ' ' ASN . 18.7 m-20 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 92' ' ' LEU . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . . . . . . 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.572 1.825 0 CA-C-O 121.512 0.672 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.537 HD21 ' N ' ' A' ' 3' ' ' ASP . 9.6 m120 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.4 HD11 ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 CA--C 1.57 1.732 0 CA-C-O 121.317 0.58 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.404 ' CE2' HG22 ' A' ' 38' ' ' VAL . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.574 1.895 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG22 ' CE2' ' A' ' 57' ' ' TRP . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 120.905 0.384 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.406 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.434 ' N ' HD21 ' A' ' 91' ' ' ASN . 7.2 m-20 . . . . . 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 CA--C 1.566 1.59 0 CA-C-O 120.774 0.321 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.434 HD21 ' N ' ' A' ' 3' ' ' ASP . 9.7 m120 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 57' ' ' TRP . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.568 1.673 0 CA-C-O 121.912 0.863 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.403 ' CE2' HG22 ' A' ' 38' ' ' VAL . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 CA--C 1.57 1.734 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 57' ' ' TRP . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . . . . . . 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 121.32 0.581 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG22 ' A' ' 38' ' ' VAL . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.54 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.53 79.3 1.89 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.601 0.76 . . . . 0.0 110.49 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.32 104.66 45.69 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.66 64.66 0.77 Allowed 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.68 46.57 1.07 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -172.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.54 106.93 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -72.9 100.49 2.94 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.294 0.638 . . . . 0.0 111.357 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.96 -47.69 0.82 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -76.82 139.5 40.35 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 118.431 1.115 . . . . 0.0 113.122 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.19 -55.74 22.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.85 -43.85 8.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 118.433 2.133 . . . . 0.0 118.433 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -87.86 101.41 13.7 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 118.309 1.054 . . . . 0.0 110.505 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 C--O 1.254 1.338 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.349 -167.342 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.676 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.3 71.35 1.42 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 112.037 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -111.48 99.99 46.19 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG21 HMA3 ' A' ' 101' ' ' HEC . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 68.32 79.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 87.73 0.07 OUTLIER Glycine 0 N--CA 1.483 1.822 0 O-C-N 121.547 -0.721 . . . . 0.0 113.616 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.22 142.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 117.283 0.542 . . . . 0.0 110.265 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.323 6.8 t0 60.81 -154.43 0.37 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 168.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.71 39.59 3.1 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.188 -0.945 . . . . 0.0 115.451 155.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -92.0 118.22 30.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.488 1.144 . . . . 0.0 110.69 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.58 -47.86 68.55 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.84 -44.12 6.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.45 -52.83 34.75 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.468 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 119.057 2.984 . . . . 0.0 119.057 169.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.615 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.44 77.19 1.61 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.382 -0.823 . . . . 0.0 112.933 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.71 96.64 50.21 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 71.03 75.21 0.19 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.7 64.51 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.96 133.6 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.83 115.17 2.42 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.74 -30.8 9.62 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 118.129 2.012 . . . . 0.0 118.129 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.63 129.75 34.75 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.624 1.712 . . . . 0.0 112.126 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.62 -38.63 91.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.92 48.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 118.176 2.031 . . . . 0.0 118.176 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.04 117.03 18.21 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 118.937 1.369 . . . . 0.0 112.623 174.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.219 -172.58 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.675 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mmm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 72.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -112.73 101.31 52.7 Favored Pre-proline 0 CA--C 1.571 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.72 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . 70.6 62.6 0.2 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.27 5.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 119.209 2.443 . . . . 0.0 119.209 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.0 t -81.14 96.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 119.165 1.482 . . . . 0.0 110.381 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.45 103.63 2.51 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.475 0.655 . . . . 0.0 110.906 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.78 -51.58 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.884 -154.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.47 135.83 39.37 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 118.213 1.006 . . . . 0.0 111.675 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -49.34 62.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.82 -58.91 3.62 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -87.96 100.8 13.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.207 -178.544 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.62 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 96.73 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.31 110.31 59.54 Favored Pre-proline 0 CA--C 1.579 2.062 0 C-N-CA 123.823 0.849 . . . . 0.0 111.014 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 67.87 22.26 8.76 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.6 51.41 2.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t -133.8 105.1 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.18 123.18 20.99 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.075 0.55 . . . . 0.0 111.785 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.09 -53.74 0.73 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -163.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 129.38 34.82 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 117.784 0.792 . . . . 0.0 111.847 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.418 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.78 -50.43 62.7 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.92 -31.53 3.59 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.69 84.49 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 120.164 1.982 . . . . 0.0 109.739 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.012 -166.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.705 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtp . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.01 76.55 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.365 0.984 . . . . 0.0 113.455 -173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -104.04 109.42 62.36 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . 71.75 26.37 3.06 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 58.76 4.13 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.66 111.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 160.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.96 100.05 2.37 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 111.379 169.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.71 -51.1 0.68 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -162.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -80.57 134.26 35.9 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 118.277 1.038 . . . . 0.0 111.829 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.525 HD21 HMB1 ' A' ' 101' ' ' HEC . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -66.45 -51.31 58.21 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.73 -51.81 2.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -79.68 86.95 5.23 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.845 0.858 . . . . 0.0 110.754 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 . . . . . 0 C--O 1.253 1.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.583 -170.973 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.65 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.31 72.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.629 1.104 . . . . 0.0 112.891 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -104.08 106.81 54.98 Favored Pre-proline 0 CA--C 1.574 1.876 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 96' ' ' LEU . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 73.03 88.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.67 71.47 0.11 Allowed Glycine 0 N--CA 1.487 2.088 0 O-C-N 121.552 -0.717 . . . . 0.0 114.511 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.16 115.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.65 95.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.05 -41.85 1.31 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 -165.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -86.49 133.35 33.76 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 119.324 1.562 . . . . 0.0 113.296 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.41 HD11 HG23 ' A' ' 34' ' ' VAL 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.47 -47.69 75.7 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.14 14.94 12.47 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 165.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -139.45 76.6 1.57 Allowed 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 120.003 1.901 . . . . 0.0 109.119 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.771 0.828 . . . . 0.0 113.02 -168.052 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.682 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.272 . . 53.39 49.2 20.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.388 2.736 . . . . 0.0 118.388 -171.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -108.85 98.06 27.55 Favored Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 65.2 29.77 11.67 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 48.77 2.38 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.94 102.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.76 105.72 3.86 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.181 0.592 . . . . 0.0 110.801 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.29 -51.65 0.77 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-O 119.6 -0.555 . . . . 0.0 114.139 -158.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -79.5 134.58 36.52 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.179 0.99 . . . . 0.0 111.899 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.07 -50.69 69.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.34 -37.08 92.51 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 118.862 2.305 . . . . 0.0 118.862 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -89.87 91.75 8.74 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.016 0.908 . . . . 0.0 109.318 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.152 0.981 . . . . 0.0 111.166 -171.023 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.661 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mmm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.094 0.474 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.33 74.54 0.93 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.441 0.638 . . . . 0.0 111.421 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -107.15 101.71 39.63 Favored Pre-proline 0 CA--C 1.568 1.642 0 O-C-N 121.452 -0.78 . . . . 0.0 109.244 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . 66.74 76.3 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.25 58.56 0.4 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 117.336 1.695 . . . . 0.0 117.336 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.23 115.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.75 107.08 3.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.513 -0.742 . . . . 0.0 111.511 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.51 -42.56 1.19 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 -165.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -91.79 143.61 26.34 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 118.816 1.308 . . . . 0.0 113.898 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.0 -54.07 46.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.82 -48.6 6.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.87 100.92 13.64 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.385 1.092 . . . . 0.0 110.927 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.887 -167.802 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.714 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.213 0.53 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 68.21 10.42 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.33 89.5 52.11 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . 72.14 15.65 5.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.37 82.78 0.44 Allowed Glycine 0 N--CA 1.489 2.198 0 O-C-N 120.84 -1.162 . . . . 0.0 114.237 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.7 t -135.13 114.19 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 168.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -74.41 96.73 2.93 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.487 0.661 . . . . 0.0 110.355 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.61 -50.6 0.62 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.59 -158.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -104.22 125.88 50.86 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 118.239 1.02 . . . . 0.0 110.881 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.475 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.35 -47.94 77.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.61 -58.65 2.65 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 116.689 1.435 . . . . 0.0 116.689 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -82.32 93.87 7.24 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.926 -173.318 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.689 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 82.37 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.785 . . . . 0.0 112.405 -172.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 100.22 53.1 Favored Pre-proline 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 -175.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 77.75 98.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.43 83.12 0.04 OUTLIER Glycine 0 N--CA 1.486 2.006 0 CA-C-O 119.311 -0.716 . . . . 0.0 112.97 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.58 141.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.191 0.996 . . . . 0.0 109.873 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.332 2.4 t70 60.88 -150.84 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 167.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.24 41.37 2.6 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.197 -0.939 . . . . 0.0 114.875 151.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -86.73 121.5 29.33 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.833 1.316 . . . . 0.0 111.433 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.55 -51.51 59.29 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.04 -58.57 3.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.46 115.74 24.16 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.408 0.683 . . . . 0.0 110.717 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.532 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.662 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.3 76.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.027 0.83 . . . . 0.0 111.638 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -106.94 103.61 48.25 Favored Pre-proline 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 57' ' ' TRP . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.64 90.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.65 70.81 0.1 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -142.81 115.44 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.21 101.59 1.91 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.145 0.578 . . . . 0.0 111.533 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.18 -51.15 0.8 Allowed Glycine 0 N--CA 1.489 2.192 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.893 -162.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -88.05 129.78 35.18 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.601 1.2 . . . . 0.0 112.472 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.426 ' CE2' HG22 ' A' ' 38' ' ' VAL . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD21 HMB1 ' A' ' 101' ' ' HEC . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.73 -39.66 66.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.99 -61.9 3.13 Favored Glycine 0 N--CA 1.49 2.291 0 CA-C-N 119.857 1.208 . . . . 0.0 115.909 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.5 96.13 10.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -164.194 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.655 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.0 83.38 2.21 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -121.15 99.01 46.67 Favored Pre-proline 0 CA--C 1.573 1.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.21 33.14 5.65 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.4 -35.88 21.98 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.08 97.07 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 119.426 1.613 . . . . 0.0 108.996 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.62 129.13 37.32 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.576 0.703 . . . . 0.0 112.113 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.82 -54.15 0.76 Allowed Glycine 0 N--CA 1.491 2.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.087 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.46 141.9 52.0 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.44 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CZ ' HBB2 ' A' ' 101' ' ' HEC . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD21 HMB1 ' A' ' 101' ' ' HEC . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -67.4 -50.64 58.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.84 -55.29 7.43 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.63 112.34 23.55 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 117.718 0.759 . . . . 0.0 110.591 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -172.613 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.621 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.184 0.902 . . . . 0.0 111.985 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.75 105.63 56.6 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 92' ' ' LEU . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . 70.09 29.58 3.77 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 58.42 2.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 118.049 1.98 . . . . 0.0 118.049 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -140.47 100.96 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 164.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.04 103.04 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.715 -0.616 . . . . 0.0 110.921 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.78 -47.92 0.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -158.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -77.72 139.87 39.45 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 118.402 1.101 . . . . 0.0 112.716 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.4 HD11 ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.68 -50.62 66.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.88 -26.89 73.83 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 119.461 2.545 . . . . 0.0 119.461 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -89.23 104.98 17.48 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.584 1.192 . . . . 0.0 109.622 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 123.427 0.691 . . . . 0.0 110.787 -166.217 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.659 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.93 95.85 8.91 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 119.546 1.066 . . . . 0.0 111.759 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -128.53 106.56 19.04 Favored Pre-proline 0 CA--C 1.572 1.805 0 O-C-N 120.442 -1.411 . . . . 0.0 109.113 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . 66.47 30.84 8.46 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.81 52.81 1.7 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.17 102.81 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 166.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.25 108.94 5.66 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.182 0.593 . . . . 0.0 110.922 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.83 -49.07 0.91 Allowed Glycine 0 N--CA 1.49 2.296 0 CA-C-O 119.509 -0.606 . . . . 0.0 114.592 -159.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -80.69 135.84 36.09 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 118.224 1.012 . . . . 0.0 112.249 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.404 ' CE2' HG22 ' A' ' 38' ' ' VAL . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' MET . . . . . 0.45 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.53 -52.96 18.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.53 -52.53 5.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 117.584 1.793 . . . . 0.0 117.584 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.1 104.39 16.97 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.194 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.253 1.284 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.698 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.689 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.91 72.55 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.51 107.8 57.24 Favored Pre-proline 0 CA--C 1.574 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG22 ' CE2' ' A' ' 57' ' ' TRP . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . 64.28 33.09 11.82 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.55 51.59 1.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -170.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.28 106.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.94 108.19 5.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.736 -0.602 . . . . 0.0 110.644 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.92 -53.05 0.75 Allowed Glycine 0 N--CA 1.49 2.269 0 CA-C-O 119.665 -0.519 . . . . 0.0 113.895 -159.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.63 129.78 35.01 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 117.887 0.843 . . . . 0.0 111.42 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.406 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.466 HD21 HMB1 ' A' ' 101' ' ' HEC . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.41 -52.89 41.82 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.16 -54.02 5.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 117.735 1.854 . . . . 0.0 117.735 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -90.26 94.03 9.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.045 0.926 . . . . 0.0 109.564 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 C--O 1.254 1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.729 -169.378 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.601 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.31 80.62 1.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.743 0.817 . . . . 0.0 111.763 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.19 103.55 55.41 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . 68.24 18.18 9.26 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.14 66.72 1.81 Allowed Glycine 0 N--CA 1.488 2.109 0 O-C-N 120.234 -1.541 . . . . 0.0 116.312 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.7 t -140.31 107.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 168.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.67 104.55 4.64 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.82 -50.57 0.77 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 -162.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -87.24 128.14 35.16 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 118.106 0.953 . . . . 0.0 111.671 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.46 -49.71 68.09 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.11 -47.11 7.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 118.963 2.345 . . . . 0.0 118.963 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -96.48 94.48 7.42 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.066 0.946 . . . . 0.0 110.017 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.579 -169.38 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.642 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.74 73.54 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 120.199 1.363 . . . . 0.0 112.092 172.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.72 103.64 52.17 Favored Pre-proline 0 CA--C 1.57 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 109.71 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 57' ' ' TRP . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.18 30.18 5.83 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.21 58.59 2.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 -171.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.1 t -141.66 109.53 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.53 94.54 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.02 -46.89 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 -163.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.33 138.0 36.66 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 118.441 1.12 . . . . 0.0 112.806 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.403 ' CE2' HG22 ' A' ' 38' ' ' VAL . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.7 -50.75 63.73 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.88 -58.57 4.02 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 117.194 1.637 . . . . 0.0 117.194 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -86.48 116.95 24.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.614 0.707 . . . . 0.0 110.855 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -173.339 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.635 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.75 72.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.773 1.624 . . . . 0.0 113.146 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -104.65 107.79 59.09 Favored Pre-proline 0 CA--C 1.574 1.903 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . 73.51 62.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.59 52.57 0.76 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.48 108.44 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.84 100.87 3.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.752 . . . . 0.0 110.953 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.17 -48.35 0.74 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -163.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -79.76 141.84 35.94 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-N 118.422 1.111 . . . . 0.0 113.254 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.56 -53.9 44.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.13 65.75 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.2 87.75 7.48 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 118.544 1.172 . . . . 0.0 111.204 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.911 0.884 . . . . 0.0 111.25 -169.385 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.682 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.562 1.437 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.85 69.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 113.286 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -107.25 105.04 54.69 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 57' ' ' TRP . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 63.49 37.69 10.38 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.68 53.6 1.71 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 118.88 2.312 . . . . 0.0 118.88 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.7 t -141.46 104.77 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 162.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.24 100.48 3.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.626 -0.671 . . . . 0.0 110.675 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.63 -50.79 0.67 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-O 119.52 -0.6 . . . . 0.0 114.452 -158.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -78.76 136.27 37.34 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.314 1.057 . . . . 0.0 112.127 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG22 ' A' ' 38' ' ' VAL . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -66.58 -50.45 63.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.66 -46.47 18.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -88.32 89.08 7.85 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.128 0.964 . . . . 0.0 111.391 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 117.896 -1.05 . . . . 0.0 112.568 -172.953 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HEC . . . . . 0.648 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 . . . . . 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . . . . . . 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 CA--C 1.573 1.832 0 N-CA-C 113.122 0.786 . . . . 0.0 113.122 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 . . . . . 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 . . . . . 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 . . . . . 0 CA--C 1.564 1.492 0 CA-C-O 120.508 0.194 . . . . 0.0 110.69 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 . . . . . 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . . . . . . 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 . . . . . 0 CA--C 1.568 1.648 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 . . . . . 0 CA--C 1.571 1.776 0 CA-C-O 118.673 -0.68 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . . . . . . 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 . . . . . 0 CA--C 1.572 1.814 0 CA-C-O 121.443 0.639 . . . . 0.0 111.675 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 . . . . . 0 CA--C 1.579 2.062 0 CA-C-O 118.354 -0.831 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . . . . . . 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 . . . . . 0 CA--C 1.566 1.567 0 CA-C-O 120.786 0.327 . . . . 0.0 111.847 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.418 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 CA--C 1.575 1.939 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . . . . . . 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 . . . . . 0 CA--C 1.569 1.706 0 CA-C-O 121.62 0.724 . . . . 0.0 111.829 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 . . . . . 0 CA--C 1.574 1.876 0 CA-C-O 118.262 -0.875 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 96' ' ' LEU . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 CA--C 1.57 1.722 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.41 HD11 HG23 ' A' ' 34' ' ' VAL 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 . . . . . 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 . . . . . 0 CA--C 1.57 1.722 0 CA-C-O 121.332 0.587 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 . . . . . 0 CA--C 1.568 1.642 0 CA-C-O 118.489 -0.767 . . . . 0.0 109.244 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.57 1.721 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . . . . . . 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 . . . . . 0 CA--C 1.566 1.587 0 CA-C-O 120.62 0.248 . . . . 0.0 110.881 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 . . . . . 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . . . . . . 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 . . . . . 0 CA--C 1.565 1.544 0 CA-C-O 121.226 0.536 . . . . 0.0 111.433 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 . . . . . 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 57' ' ' TRP . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 . . . . . 0 CA--C 1.568 1.645 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.426 ' CE2' HG22 ' A' ' 38' ' ' VAL . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 . . . . . 0 CA--C 1.573 1.853 0 CA-C-O 118.57 -0.728 . . . . 0.0 110.187 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . . . . . . 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 . . . . . 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 92' ' ' LEU . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . . . . . . 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 CA--C 1.572 1.825 0 CA-C-O 121.512 0.672 . . . . 0.0 112.716 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.4 HD11 ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 . . . . . 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 . . . . . 0 CA--C 1.572 1.805 0 CA-C-O 118.332 -0.842 . . . . 0.0 109.113 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . . . . . . 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 . . . . . 0 CA--C 1.57 1.732 0 CA-C-O 121.317 0.58 . . . . 0.0 112.249 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.404 ' CE2' HG22 ' A' ' 38' ' ' VAL . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 . . . . . 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 . . . . . 0 CA--C 1.574 1.895 0 CA-C-O 118.288 -0.863 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.406 HG22 ' CE2' ' A' ' 57' ' ' TRP . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . . . . . . 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 . . . . . 0 CA--C 1.567 1.622 0 CA-C-O 120.905 0.384 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.406 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 . . . . . 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . . . . . . 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 . . . . . 0 CA--C 1.566 1.59 0 CA-C-O 120.774 0.321 . . . . 0.0 111.671 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 . . . . . 0 CA--C 1.57 1.728 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 57' ' ' TRP . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . . . . . . 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 . . . . . 0 CA--C 1.568 1.673 0 CA-C-O 121.912 0.863 . . . . 0.0 112.806 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.403 ' CE2' HG22 ' A' ' 38' ' ' VAL . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 . . . . . 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 . . . . . 0 CA--C 1.574 1.903 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . . . . . . 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 . . . . . 0 CA--C 1.57 1.734 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 . . . . . 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 57' ' ' TRP . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . . . . . . 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 . . . . . 0 CA--C 1.569 1.675 0 CA-C-O 121.32 0.581 . . . . 0.0 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG22 ' A' ' 38' ' ' VAL . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 . . . . . 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . 0.265 0.0 OUTLIER . . . . . 0 CA--C 1.565 1.54 0 N-CA-C 114.06 1.133 . . . . 0.0 114.06 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -130.53 79.3 1.89 Allowed 'General case' 0 CA--C 1.563 1.464 0 C-N-CA 123.601 0.76 . . . . 0.0 110.49 173.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -104.32 104.66 45.69 Favored Pre-proline 0 CA--C 1.569 1.7 0 CA-C-O 118.459 -0.782 . . . . 0.0 109.868 -175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -71.3 -29.98 16.3 Favored 'Trans proline' 0 CA--C 1.565 2.066 0 C-N-CA 122.527 2.151 . . . . 0.0 117.363 -175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.27 -41.87 99.06 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 167.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.23 -36.32 81.62 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.322 1.971 . . . . 0.0 116.322 165.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.39 -20.13 58.42 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 119.224 2.45 . . . . 0.0 119.224 166.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -67.99 -47.4 68.66 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.114 1.457 . . . . 0.0 113.875 168.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -66.15 -36.66 83.69 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.784 1.772 . . . . 0.0 115.784 170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 18.9 t -62.61 -43.68 98.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 119.464 1.029 . . . . 0.0 112.946 164.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.71 -22.91 58.63 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 117.302 2.334 . . . . 0.0 117.302 168.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.32 -29.77 38.64 Favored Glycine 0 CA--C 1.559 2.841 0 N-CA-C 119.169 2.428 . . . . 0.0 119.169 162.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -63.14 -38.87 92.9 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 163.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -76.72 -37.24 56.4 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 173.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.301 16.1 ptmt -74.81 -10.02 59.1 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 -156.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.66 -38.37 90.04 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 115.428 1.64 . . . . 0.0 115.428 156.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 55.6 m -85.62 -46.33 10.88 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.886 1.809 . . . . 0.0 115.886 170.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -115.22 130.2 56.85 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 119.858 1.208 . . . . 0.0 112.647 -171.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -99.77 -37.52 9.05 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -171.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.313 13.7 mt 85.13 -51.11 0.09 Allowed 'General case' 0 N--CA 1.505 2.313 0 CA-C-N 119.885 1.221 . . . . 0.0 112.478 -164.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -87.34 64.8 8.43 Favored 'General case' 0 CA--C 1.567 1.599 0 O-C-N 121.563 -0.711 . . . . 0.0 112.626 -172.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.65 -30.4 0.28 Allowed Glycine 0 N--CA 1.5 2.961 0 N-CA-C 121.301 3.28 . . . . 0.0 121.301 171.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -55.92 -39.18 71.28 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 -173.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . 0.287 4.6 m-20 69.77 -95.74 0.03 OUTLIER 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.998 1.719 . . . . 0.0 111.799 -175.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.24 -102.93 2.92 Favored Glycine 0 N--CA 1.489 2.196 0 CA-C-N 119.219 0.918 . . . . 0.0 114.043 175.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.1 t -89.18 -60.79 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.196 0 CA-C-N 117.524 0.662 . . . . 0.0 109.848 171.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.48 167.67 27.52 Favored Glycine 0 CA--C 1.553 2.433 0 CA-C-N 118.819 0.736 . . . . 0.0 114.842 168.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -68.18 169.32 16.96 Favored 'Trans proline' 0 CA--C 1.565 2.06 0 CA-C-N 121.408 2.604 . . . . 0.0 115.937 178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -68.21 125.83 27.64 Favored 'General case' 0 CA--C 1.571 1.755 0 O-C-N 120.335 -1.478 . . . . 0.0 112.377 167.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.9 mt -97.07 28.5 3.54 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -71.0 85.85 0.71 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.64 53.51 6.5 Favored Glycine 0 CA--C 1.547 2.05 0 O-C-N 121.273 -0.892 . . . . 0.0 115.259 -159.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.4 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.9 p -70.81 -27.49 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 165.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.21 106.81 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 CA-C-N 119.379 0.99 . . . . 0.0 109.207 176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.23 8.04 66.96 Favored Glycine 0 N--CA 1.497 2.754 0 N-CA-C 119.467 2.547 . . . . 0.0 119.467 -164.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.1 ttm-85 -93.54 152.41 19.06 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 119.544 1.672 . . . . 0.0 110.84 170.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -54.43 153.11 5.82 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 120.714 -1.242 . . . . 0.0 113.991 167.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.1 t -77.23 127.52 38.14 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.701 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 166.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.261 . . 63.66 64.66 0.77 Allowed 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -157.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -126.68 46.57 1.07 Allowed Glycine 0 N--CA 1.493 2.48 0 N-CA-C 118.291 2.076 . . . . 0.0 118.291 -172.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 58.6 t -134.54 106.93 8.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 170.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -72.9 100.49 2.94 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 123.294 0.638 . . . . 0.0 111.357 -177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.96 -47.69 0.82 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 114.99 0.756 . . . . 0.0 114.99 -161.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -76.82 139.5 40.35 Favored 'General case' 0 CA--C 1.573 1.832 0 CA-C-N 118.431 1.115 . . . . 0.0 113.122 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -82.25 99.39 9.28 Favored 'General case' 0 CA--C 1.568 1.656 0 CA-C-O 121.54 0.686 . . . . 0.0 111.641 175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -87.11 158.89 19.08 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 114.293 1.22 . . . . 0.0 114.293 -177.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 85.9 p -72.56 156.35 39.1 Favored 'General case' 0 CA--C 1.567 1.613 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 172.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.91 -51.54 78.45 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 116.456 2.021 . . . . 0.0 116.456 176.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -68.17 -25.33 37.28 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 CA-C-N 123.919 2.435 . . . . 0.0 117.036 174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.6 tpp -65.18 -49.35 70.12 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 165.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 25.4 mmtp -60.71 -45.41 94.33 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.6 -21.77 66.8 Favored 'General case' 0 CA--C 1.57 1.735 0 N-CA-C 118.261 2.689 . . . . 0.0 118.261 172.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -65.6 -62.07 1.73 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-N 119.944 1.247 . . . . 0.0 113.171 168.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.38 -127.6 23.82 Favored Glycine 0 N--CA 1.489 2.218 0 CA-C-N 119.529 1.059 . . . . 0.0 114.259 -176.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.18 -122.61 30.75 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 116.156 1.223 . . . . 0.0 116.156 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -154.67 151.84 29.25 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-O 122.293 1.045 . . . . 0.0 113.737 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 14.3 m95 -81.13 87.28 6.07 Favored 'General case' 0 CA--C 1.562 1.434 0 CA-C-O 122.158 0.98 . . . . 0.0 112.574 162.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 75.5 p -72.68 157.91 88.15 Favored Pre-proline 0 CA--C 1.577 1.981 0 N-CA-C 113.444 0.905 . . . . 0.0 113.444 172.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.6 54.87 2.02 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 122.785 2.323 . . . . 0.0 115.794 169.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -169.56 -59.95 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.657 0 C-N-CA 126.192 1.797 . . . . 0.0 107.238 -165.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.27 -46.83 79.52 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 160.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.7 mt -57.32 -36.89 71.69 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.8 mm-40 -60.35 -34.32 73.68 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -94.73 -32.65 13.24 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.579 1.326 . . . . 0.0 114.579 169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.1 t80 -57.98 -42.32 84.86 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.494 1.665 . . . . 0.0 115.494 164.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 55.9 mt -67.26 -11.6 57.92 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.955 2.576 . . . . 0.0 117.955 170.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 27.2 m -103.07 -37.21 7.85 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -131.51 82.58 61.19 Favored Pre-proline 0 CA--C 1.576 1.943 0 CA-C-N 120.501 1.5 . . . . 0.0 107.693 171.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -52.8 -44.75 45.64 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 123.681 2.921 . . . . 0.0 117.01 175.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -70.48 -15.94 62.86 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 117.649 2.463 . . . . 0.0 117.649 171.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.1 -43.98 55.65 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 166.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.83 -50.87 17.19 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.945 0 CA-C-N 118.99 0.814 . . . . 0.0 111.957 175.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.24 91.38 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.013 0 CA-C-N 120.124 1.329 . . . . 0.0 107.438 173.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 109.54 4.61 Favored 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 -178.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 85.87 40.84 7.43 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 117.339 1.696 . . . . 0.0 117.339 -165.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.4 t -71.82 142.73 49.64 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 119.376 1.588 . . . . 0.0 112.43 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -72.42 7.53 1.77 Allowed 'General case' 0 CA--C 1.578 2.037 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 161.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -80.58 105.02 11.51 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.415 1.461 . . . . 0.0 109.876 172.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.72 71.41 6.36 Favored 'General case' 0 CA--C 1.568 1.639 0 CA-C-O 122.537 1.161 . . . . 0.0 113.005 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -136.85 129.45 30.29 Favored 'General case' 0 CA--C 1.562 1.404 0 C-N-CA 123.901 0.88 . . . . 0.0 109.312 -174.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.71 -32.45 57.84 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 116.89 2.181 . . . . 0.0 116.89 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 131.15 146.32 5.81 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 117.025 1.57 . . . . 0.0 117.025 -176.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 76.9 mt -82.98 137.24 43.45 Favored Pre-proline 0 CA--C 1.573 1.857 0 CA-C-O 118.294 -0.86 . . . . 0.0 112.974 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.91 -53.4 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.297 1.998 . . . . 0.0 116.097 -173.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.83 148.1 25.98 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-N 119.543 1.065 . . . . 0.0 111.754 -176.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.4 tp -58.45 -35.24 53.39 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 167.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -57.19 -36.76 71.23 Favored 'General case' 0 CA--C 1.563 1.464 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 166.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -61.84 -55.79 26.14 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.226 1.376 . . . . 0.0 113.641 177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.272 0.0 OUTLIER -65.26 -44.96 86.4 Favored 'General case' 0 CA--C 1.566 1.593 0 N-CA-C 116.312 1.967 . . . . 0.0 116.312 170.744 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.39 -44.03 84.17 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 117.554 2.427 . . . . 0.0 117.554 170.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -62.33 -44.51 96.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 169.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 7.9 tt -60.47 -46.5 89.85 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.4 mt -56.13 -46.4 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.078 0 C-N-CA 124.226 1.01 . . . . 0.0 112.946 170.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.11 -42.34 72.81 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 117.449 2.388 . . . . 0.0 117.449 165.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -57.09 -65.93 0.54 Allowed 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 168.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.332 0.6 OUTLIER -80.41 5.88 13.79 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 118.791 2.885 . . . . 0.0 118.791 -176.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -63.19 -55.74 22.54 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.487 -1.383 . . . . 0.0 113.68 145.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -81.85 -43.85 8.06 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 118.433 2.133 . . . . 0.0 118.433 176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -87.86 101.41 13.7 Favored 'General case' 0 CA--C 1.56 1.352 0 CA-C-N 118.309 1.054 . . . . 0.0 110.505 -178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 . . . . . 0 C--O 1.254 1.338 0 CA-C-O 118.028 -0.987 . . . . 0.0 111.349 -167.342 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.676 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtm . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 121.202 0.525 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.3 71.35 1.42 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.338 -0.851 . . . . 0.0 112.037 -179.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 25.4 m-20 -111.48 99.99 46.19 Favored Pre-proline 0 CA--C 1.568 1.652 0 CA-C-O 118.533 -0.746 . . . . 0.0 109.568 -177.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -70.02 -23.67 29.33 Favored 'Trans proline' 0 CA--C 1.569 2.271 0 C-N-CA 122.644 2.229 . . . . 0.0 117.312 -179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.2 -28.31 69.3 Favored 'General case' 0 CA--C 1.572 1.789 0 N-CA-C 116.996 2.221 . . . . 0.0 116.996 162.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.39 -34.59 48.02 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 160.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.98 -23.38 74.39 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 119.031 2.372 . . . . 0.0 119.031 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -65.43 -41.96 92.94 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 173.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -71.51 -34.1 69.81 Favored 'General case' 0 CA--C 1.568 1.67 0 N-CA-C 115.292 1.59 . . . . 0.0 115.292 169.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.5 t -60.59 -43.41 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 119.636 1.107 . . . . 0.0 113.238 161.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 38.9 t80 -59.44 -22.15 61.06 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 167.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.72 -30.1 27.4 Favored Glycine 0 CA--C 1.561 2.907 0 N-CA-C 119.064 2.386 . . . . 0.0 119.064 162.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -66.24 -41.42 90.03 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 114.83 1.418 . . . . 0.0 114.83 164.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.1 m -75.36 -40.52 58.08 Favored 'General case' 0 CA--C 1.567 1.605 0 N-CA-C 116.064 1.876 . . . . 0.0 116.064 177.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -61.93 -21.48 64.8 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 119.643 3.201 . . . . 0.0 119.643 -170.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.29 -34.75 77.19 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 166.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.8 m -94.08 -48.18 6.34 Favored 'General case' 0 CA--C 1.57 1.72 0 N-CA-C 115.373 1.619 . . . . 0.0 115.373 168.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -100.54 140.55 34.64 Favored 'General case' 0 N--CA 1.492 1.638 0 C-N-CA 123.96 0.904 . . . . 0.0 113.071 -171.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -100.82 164.95 11.6 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-O 122.889 1.328 . . . . 0.0 111.237 163.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 36.0 mt -95.57 -31.52 13.26 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.313 -1.492 . . . . 0.0 114.264 160.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -90.44 68.07 6.72 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 120.129 1.331 . . . . 0.0 113.05 -167.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.32 -47.69 3.24 Favored Glycine 0 N--CA 1.495 2.604 0 N-CA-C 119.563 2.585 . . . . 0.0 119.563 165.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.7 m-80 -84.56 162.29 19.88 Favored 'General case' 0 N--CA 1.494 1.747 0 CA-C-N 118.409 1.104 . . . . 0.0 111.893 173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -102.71 -81.87 0.49 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.292 -0.88 . . . . 0.0 111.821 -166.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.24 -109.99 2.65 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 118.554 0.616 . . . . 0.0 111.867 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 93.6 t -90.18 -59.78 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 162.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.14 146.18 20.2 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.498 0.959 . . . . 0.0 115.498 177.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -69.67 143.14 50.33 Favored 'Trans proline' 0 CA--C 1.561 1.842 0 C-N-CA 123.355 2.703 . . . . 0.0 114.608 175.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.7 p-80 -64.66 135.3 55.76 Favored 'General case' 0 CA--C 1.569 1.677 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -165.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 98.7 mt -101.21 16.78 24.37 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 -163.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -62.47 97.75 0.1 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 178.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 68.34 39.54 87.6 Favored Glycine 0 CA--C 1.547 2.073 0 N-CA-C 117.427 1.731 . . . . 0.0 117.427 -166.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG21 HMA3 ' A' ' 101' ' ' HEC . 8.2 p -60.83 -31.93 50.8 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.23 0 N-CA-C 115.189 1.551 . . . . 0.0 115.189 168.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.1 t -69.34 103.08 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.814 0 C-N-CA 124.456 1.102 . . . . 0.0 109.045 172.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 94.62 -1.34 66.1 Favored Glycine 0 N--CA 1.496 2.69 0 N-CA-C 119.416 2.526 . . . . 0.0 119.416 -162.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -83.95 154.38 23.39 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.08 1.94 . . . . 0.0 110.505 168.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.6 t -54.9 154.75 4.94 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.498 -1.376 . . . . 0.0 114.125 168.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -77.29 121.18 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.644 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 160.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 68.32 79.08 0.22 Allowed 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -171.241 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.78 87.73 0.07 OUTLIER Glycine 0 N--CA 1.483 1.822 0 O-C-N 121.547 -0.721 . . . . 0.0 113.616 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -157.22 142.9 9.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 117.283 0.542 . . . . 0.0 110.265 167.441 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.323 6.8 t0 60.81 -154.43 0.37 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.053 1.501 . . . . 0.0 115.053 168.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -89.71 39.59 3.1 Favored Glycine 0 N--CA 1.49 2.272 0 O-C-N 121.188 -0.945 . . . . 0.0 115.451 155.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -92.0 118.22 30.57 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-N 118.488 1.144 . . . . 0.0 110.69 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.1 t30 -85.53 124.31 31.94 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 121.796 0.807 . . . . 0.0 110.826 169.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -95.54 176.91 5.99 Favored 'General case' 0 CA--C 1.574 1.897 0 C-N-CA 123.734 0.814 . . . . 0.0 111.546 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 53.0 p -70.76 160.72 32.17 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.012 -1.68 . . . . 0.0 114.744 174.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -57.03 -46.1 99.9 Favored Pre-proline 0 CA--C 1.575 1.913 0 N-CA-C 116.839 2.162 . . . . 0.0 116.839 175.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.4 -22.7 21.29 Favored 'Trans proline' 0 CA--C 1.57 2.296 0 CA-C-N 124.215 2.541 . . . . 0.0 116.729 170.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -56.04 24.79 Favored 'General case' 0 CA--C 1.572 1.82 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 155.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -69.63 -37.34 76.78 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.98 -19.57 66.05 Favored 'General case' 0 CA--C 1.571 1.781 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 165.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.7 t-80 -68.81 -64.92 0.77 Allowed 'General case' 0 CA--C 1.57 1.747 0 CA-C-N 120.565 1.529 . . . . 0.0 112.517 168.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.49 -131.44 26.8 Favored Glycine 0 N--CA 1.489 2.173 0 CA-C-N 119.53 1.059 . . . . 0.0 114.593 -177.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.86 -115.93 8.27 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 116.238 1.255 . . . . 0.0 116.238 167.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -153.67 151.73 30.01 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 172.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 17.7 m95 -81.81 89.65 6.34 Favored 'General case' 0 CA--C 1.56 1.33 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.98 157.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 79.3 p -74.54 156.01 87.14 Favored Pre-proline 0 CA--C 1.576 1.981 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 173.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -64.32 9.98 0.13 Allowed 'Trans proline' 0 CA--C 1.579 2.757 0 N-CA-C 119.669 2.911 . . . . 0.0 119.669 172.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -119.71 -44.8 2.52 Favored 'General case' 0 N--CA 1.494 1.759 0 C-N-CA 125.434 1.493 . . . . 0.0 111.677 170.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.94 -41.23 74.34 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 164.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.8 mt -58.18 -33.99 69.85 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 116.568 2.062 . . . . 0.0 116.568 161.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -65.74 -42.71 90.64 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 121.594 1.997 . . . . 0.0 114.786 172.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.24 -47.53 73.47 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 167.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -62.0 -48.45 80.25 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 173.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 97.2 mt -62.65 -26.64 68.74 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 116.385 1.995 . . . . 0.0 116.385 169.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.4 m -68.71 -44.14 74.52 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 121.334 1.879 . . . . 0.0 115.122 165.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -148.38 85.39 6.3 Favored Pre-proline 0 CA--C 1.576 1.968 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -57.55 -45.16 35.78 Favored 'Trans proline' 0 C--N 1.372 1.781 0 C-N-CA 123.446 2.764 . . . . 0.0 117.209 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -69.02 -16.11 63.63 Favored 'General case' 0 CA--C 1.573 1.85 0 N-CA-C 117.316 2.339 . . . . 0.0 117.316 170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.45 -43.03 58.0 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 115.475 1.657 . . . . 0.0 115.475 168.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 68.2 t -77.25 -53.07 15.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 CA-C-N 119.497 1.044 . . . . 0.0 111.863 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 55.2 t -107.57 93.81 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 120.204 1.366 . . . . 0.0 107.506 173.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.52 107.03 4.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.901 . . . . 0.0 112.264 176.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.14 40.38 4.87 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 117.355 1.702 . . . . 0.0 117.355 -161.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 10.2 t -81.02 135.2 35.81 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.705 1.253 . . . . 0.0 110.053 163.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -67.56 8.91 0.29 Allowed 'General case' 0 CA--C 1.579 2.08 0 N-CA-C 116.513 2.042 . . . . 0.0 116.513 164.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.403 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.7 ttt -83.32 105.82 14.59 Favored 'General case' 0 CA--C 1.56 1.348 0 O-C-N 120.789 -1.194 . . . . 0.0 110.084 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.55 69.98 4.83 Favored 'General case' 0 CA--C 1.569 1.687 0 CA-C-O 122.812 1.292 . . . . 0.0 113.159 174.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.3 t80 -136.98 129.72 30.43 Favored 'General case' 0 CA--C 1.56 1.362 0 C-N-CA 124.431 1.092 . . . . 0.0 108.176 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.64 -38.27 48.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 116.343 1.979 . . . . 0.0 116.343 -178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.63 139.54 3.17 Favored Glycine 0 CA--C 1.543 1.829 0 N-CA-C 116.818 1.487 . . . . 0.0 116.818 -171.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.2 mt -82.78 120.61 76.7 Favored Pre-proline 0 CA--C 1.568 1.665 0 CA-C-O 118.04 -0.981 . . . . 0.0 111.433 164.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -83.24 -40.96 0.1 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.513 2.142 . . . . 0.0 117.309 -165.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.4 mtpm? -87.25 145.4 26.39 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 119.99 1.268 . . . . 0.0 110.861 177.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 11.2 tp -55.09 -36.49 39.28 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 166.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.8 mp0 -62.15 -34.31 76.14 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.38 -56.28 15.4 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.589 1.541 . . . . 0.0 113.508 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.252 0.0 OUTLIER -64.65 -43.98 91.89 Favored 'General case' 0 CA--C 1.566 1.558 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 171.739 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.37 -48.19 81.4 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.05 2.241 . . . . 0.0 117.05 171.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -62.54 -43.17 99.48 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.645 1.72 . . . . 0.0 115.645 170.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.71 -45.29 81.94 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 115.618 1.71 . . . . 0.0 115.618 166.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.3 mt -60.19 -42.24 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 CA-C-N 119.7 1.136 . . . . 0.0 113.443 171.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.74 -44.56 81.82 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 116.85 2.167 . . . . 0.0 116.85 165.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -53.7 -51.87 61.87 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 162.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 90.0 mt -61.32 -32.34 72.2 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 174.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -67.58 -47.86 68.55 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -83.84 -44.12 6.92 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 118.579 2.191 . . . . 0.0 118.579 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -67.45 -52.83 34.75 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.508 1.669 . . . . 0.0 115.508 176.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . 0.468 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 119.057 2.984 . . . . 0.0 119.057 169.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.615 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mpp? . . . . . 0 N--CA 1.487 1.38 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -102.44 77.19 1.61 Allowed 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.382 -0.823 . . . . 0.0 112.933 -175.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -118.71 96.64 50.21 Favored Pre-proline 0 CA--C 1.569 1.696 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -176.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -71.8 -32.67 11.22 Favored 'Trans proline' 0 CA--C 1.566 2.082 0 C-N-CA 122.515 2.143 . . . . 0.0 117.073 -172.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.75 -33.78 76.42 Favored 'General case' 0 CA--C 1.569 1.673 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 167.609 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.24 -25.07 63.21 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 162.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.17 -19.61 79.78 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 119.008 2.363 . . . . 0.0 119.008 168.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -44.68 82.08 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 119.655 1.728 . . . . 0.0 115.43 175.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.1 pttp -62.95 -37.05 85.53 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 166.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.2 t -61.64 -41.56 90.8 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 CA-C-N 119.278 0.944 . . . . 0.0 113.435 165.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -59.67 -26.7 65.76 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 116.642 2.09 . . . . 0.0 116.642 165.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.13 -26.68 28.89 Favored Glycine 0 CA--C 1.559 2.783 0 N-CA-C 119.394 2.517 . . . . 0.0 119.394 163.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -67.03 -37.31 83.89 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 163.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -81.07 -33.31 33.5 Favored 'General case' 0 CA--C 1.573 1.852 0 N-CA-C 116.725 2.12 . . . . 0.0 116.725 175.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -60.13 -27.8 67.35 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 120.089 3.366 . . . . 0.0 120.089 -161.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.94 -35.68 80.91 Favored 'General case' 0 CA--C 1.567 1.63 0 N-CA-C 116.137 1.903 . . . . 0.0 116.137 168.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 56.6 m -86.65 -45.44 11.01 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 169.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -111.47 134.56 52.96 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 119.454 1.025 . . . . 0.0 111.332 -172.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -97.51 -41.77 8.02 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 -176.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.48 2.4 pp 54.72 17.22 1.64 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 120.184 3.401 . . . . 0.0 120.184 -173.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -104.78 56.59 0.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.492 -0.755 . . . . 0.0 110.397 163.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 57.48 14.37 13.55 Favored Glycine 0 CA--C 1.557 2.677 0 N-CA-C 120.721 3.048 . . . . 0.0 120.721 -170.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -136.55 160.3 39.19 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 123.165 1.459 . . . . 0.0 110.66 -177.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -92.1 -85.84 0.24 Allowed 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.951 -164.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 110.86 -116.41 4.28 Favored Glycine 0 N--CA 1.49 2.277 0 CA-C-N 118.925 0.784 . . . . 0.0 112.306 -174.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -91.87 -50.7 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.402 165.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -92.32 176.07 38.31 Favored Glycine 0 CA--C 1.558 2.746 0 N-CA-C 115.593 0.997 . . . . 0.0 115.593 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.56 170.7 16.91 Favored 'Trans proline' 0 CA--C 1.569 2.241 0 CA-C-N 121.086 2.443 . . . . 0.0 116.62 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -66.66 127.49 32.59 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.162 -1.586 . . . . 0.0 112.787 171.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 94.8 mt -99.48 11.65 38.56 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 6.1 p-10 -68.05 112.23 4.91 Favored 'General case' 0 CA--C 1.565 1.542 0 O-C-N 120.883 -1.136 . . . . 0.0 111.044 169.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.49 40.55 39.07 Favored Glycine 0 N--CA 1.484 1.896 0 N-CA-C 116.171 1.229 . . . . 0.0 116.171 -171.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.6 p -84.17 -28.0 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.077 0 N-CA-C 115.714 1.746 . . . . 0.0 115.714 173.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 34.0 t -74.54 106.15 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-N 119.739 1.154 . . . . 0.0 108.835 178.19 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.64 9.59 61.19 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.267 2.467 . . . . 0.0 119.267 -162.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 55.4 ttm-85 -95.92 148.89 22.16 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 119.809 1.805 . . . . 0.0 111.235 173.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.289 0.6 OUTLIER -60.9 149.96 34.65 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 114.192 1.182 . . . . 0.0 114.192 174.247 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 42.0 t -77.39 116.82 21.38 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.621 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 175.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.278 . . 71.03 75.21 0.19 Allowed 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 113.917 1.081 . . . . 0.0 113.917 -155.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.7 64.51 0.28 Allowed Glycine 0 N--CA 1.489 2.202 0 N-CA-C 116.102 1.201 . . . . 0.0 116.102 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 69.6 t -134.96 133.6 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 172.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -56.83 115.17 2.42 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 177.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 101.74 -30.8 9.62 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 118.129 2.012 . . . . 0.0 118.129 -176.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -86.63 129.75 34.75 Favored 'General case' 0 CA--C 1.568 1.648 0 CA-C-N 119.624 1.712 . . . . 0.0 112.126 -177.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -83.61 -23.14 32.03 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 118.256 2.687 . . . . 0.0 118.256 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 64.47 162.09 0.12 Allowed 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 48.7 p -81.29 158.51 24.74 Favored 'General case' 0 CA--C 1.568 1.639 0 O-C-N 120.381 -1.45 . . . . 0.0 113.585 170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -59.05 -48.46 96.61 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.925 -1.988 . . . . 0.0 116.007 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -68.11 -24.09 39.01 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 124.901 2.786 . . . . 0.0 117.183 170.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -61.62 -51.43 68.55 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 162.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -61.59 -36.08 79.66 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 168.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.98 -21.49 66.51 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.171 2.656 . . . . 0.0 118.171 167.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.96 -66.89 0.5 Allowed 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 120.329 1.422 . . . . 0.0 112.49 167.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.79 -127.24 25.12 Favored Glycine 0 N--CA 1.489 2.172 0 CA-C-N 119.5 1.045 . . . . 0.0 113.742 -172.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.82 -127.84 45.2 Favored Glycine 0 N--CA 1.493 2.499 0 CA-C-N 118.675 1.237 . . . . 0.0 115.042 171.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 -150.62 150.69 31.49 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.441 1.274 . . . . 0.0 114.441 168.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.3 m95 -77.39 83.34 3.83 Favored 'General case' 0 CA--C 1.562 1.408 0 CA-C-O 122.434 1.111 . . . . 0.0 112.399 161.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.9 p -72.21 160.18 83.43 Favored Pre-proline 0 CA--C 1.576 1.972 0 C-N-CA 123.94 0.896 . . . . 0.0 113.302 175.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -66.6 24.12 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.875 0 N-CA-C 118.838 2.592 . . . . 0.0 118.838 168.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -132.29 -45.69 0.92 Allowed 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 126.331 1.852 . . . . 0.0 110.929 170.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.61 -43.86 76.47 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 116.118 1.895 . . . . 0.0 116.118 165.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.1 mt -59.01 -33.0 70.22 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 163.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -62.94 -35.34 79.81 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 116.207 1.929 . . . . 0.0 116.207 177.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.32 -33.56 16.05 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -61.44 -41.57 97.4 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 121.71 2.05 . . . . 0.0 114.847 169.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 59.0 mt -67.38 -9.85 45.47 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 118.149 2.648 . . . . 0.0 118.149 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 41.9 m -102.6 -37.11 8.09 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 167.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -135.43 80.81 44.55 Favored Pre-proline 0 CA--C 1.575 1.924 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 175.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -54.28 -48.24 22.58 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 123.737 2.958 . . . . 0.0 116.82 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -69.26 -18.92 63.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 117.299 2.333 . . . . 0.0 117.299 173.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.06 -43.99 64.01 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 167.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.35 -48.24 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 119.123 0.874 . . . . 0.0 112.305 174.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 87.0 t -111.69 98.12 6.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 CA-C-N 120.177 1.353 . . . . 0.0 107.388 171.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 9.6 mtmp? -72.26 110.47 6.72 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 111.463 176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 87.38 39.45 7.27 Favored Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -163.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.9 t -77.14 135.57 38.55 Favored 'General case' 0 CA--C 1.561 1.375 0 CA-C-N 118.556 1.178 . . . . 0.0 109.92 161.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.3 mttp -68.8 11.64 0.18 Allowed 'General case' 0 CA--C 1.58 2.111 0 N-CA-C 116.36 1.985 . . . . 0.0 116.36 166.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.443 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -86.58 102.81 14.5 Favored 'General case' 0 CA--C 1.558 1.281 0 O-C-N 120.761 -1.212 . . . . 0.0 110.028 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.39 68.38 6.55 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-O 122.211 1.005 . . . . 0.0 113.037 175.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 54.5 t80 -124.46 127.37 47.39 Favored 'General case' 0 CA--C 1.56 1.331 0 C-N-CA 123.701 0.801 . . . . 0.0 109.787 -174.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.09 -9.61 58.84 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 117.811 2.523 . . . . 0.0 117.811 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 104.96 147.82 16.87 Favored Glycine 0 N--CA 1.484 1.891 0 N-CA-C 117.234 1.654 . . . . 0.0 117.234 174.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 80.4 mt -84.7 132.54 46.17 Favored Pre-proline 0 CA--C 1.572 1.792 0 C-N-CA 123.626 0.77 . . . . 0.0 112.715 170.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.89 -50.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.021 0 C-N-CA 122.504 2.136 . . . . 0.0 116.29 -173.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -81.11 145.35 31.12 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-N 119.592 1.087 . . . . 0.0 111.436 -179.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.8 tp -59.93 -33.02 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.186 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 166.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -58.63 -37.32 75.66 Favored 'General case' 0 CA--C 1.566 1.565 0 N-CA-C 115.132 1.531 . . . . 0.0 115.132 167.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -64.3 -56.53 13.88 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.544 1.065 . . . . 0.0 113.611 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.271 0.0 OUTLIER -62.89 -43.12 99.66 Favored 'General case' 0 CA--C 1.566 1.569 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 170.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.6 -48.36 75.0 Favored 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 117.327 2.343 . . . . 0.0 117.327 169.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.38 -43.05 99.73 Favored 'General case' 0 CA--C 1.571 1.786 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 171.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.4 -50.04 72.76 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 165.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.6 mt -58.09 -46.66 88.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 124.221 1.009 . . . . 0.0 112.598 174.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.17 -41.07 83.06 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.654 2.464 . . . . 0.0 117.654 166.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -54.46 -60.17 3.7 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 167.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.367 0.8 OUTLIER -91.21 15.05 12.64 Favored 'General case' 0 N--CA 1.498 1.937 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -64.62 -38.63 91.67 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.307 -1.496 . . . . 0.0 114.779 138.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -67.33 -49.92 48.43 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 118.176 2.031 . . . . 0.0 118.176 175.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.04 117.03 18.21 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 118.937 1.369 . . . . 0.0 112.623 174.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 77.4 mt-30 . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.219 -172.58 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.675 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.7 mmm . . . . . 0 N--CA 1.486 1.369 0 N-CA-C 110.558 -0.164 . . . . 0.0 110.558 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -109.94 72.7 0.81 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -112.73 101.31 52.7 Favored Pre-proline 0 CA--C 1.571 1.776 0 O-C-N 121.305 -0.872 . . . . 0.0 109.72 -178.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -70.85 -28.05 20.49 Favored 'Trans proline' 0 CA--C 1.568 2.206 0 C-N-CA 122.723 2.282 . . . . 0.0 117.441 -179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.95 -33.33 75.47 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 166.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.03 -37.23 75.54 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 160.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -67.54 -21.45 72.63 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 119.515 2.566 . . . . 0.0 119.515 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.0 pp20? -63.84 -33.79 76.47 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 163.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.3 mtmp? -64.98 -47.37 77.81 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 167.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 t -64.18 -38.88 83.62 Favored 'Isoleucine or valine' 0 CA--C 1.581 2.141 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 172.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -59.17 -24.82 63.4 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.744 2.127 . . . . 0.0 116.744 162.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -51.27 -28.48 19.54 Favored Glycine 0 CA--C 1.559 2.842 0 N-CA-C 119.305 2.482 . . . . 0.0 119.305 160.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.1 mmtt -67.93 -36.85 80.84 Favored 'General case' 0 CA--C 1.577 2.006 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 164.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.5 m -80.34 -36.42 34.19 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -61.09 -21.15 63.42 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.902 3.297 . . . . 0.0 119.902 -169.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -35.57 79.34 Favored 'General case' 0 CA--C 1.569 1.691 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 165.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 68.7 m -93.06 -44.26 8.48 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 169.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -109.99 135.52 50.7 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 119.668 1.122 . . . . 0.0 112.587 -170.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -100.14 -36.0 9.47 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 -175.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.513 3.5 pp 53.14 1.59 0.02 OUTLIER 'General case' 0 N--CA 1.51 2.526 0 N-CA-C 120.197 3.406 . . . . 0.0 120.197 -166.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -109.06 60.35 0.6 Allowed 'General case' 0 CA--C 1.567 1.604 0 C-N-CA 124.291 1.036 . . . . 0.0 110.95 -177.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.62 -58.81 3.38 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 117.307 1.683 . . . . 0.0 117.307 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 63.0 m-80 -78.79 166.56 22.31 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-O 122.393 1.092 . . . . 0.0 112.737 174.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -98.38 -77.6 0.51 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.505 -0.747 . . . . 0.0 112.27 -168.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.19 -122.52 5.48 Favored Glycine 0 N--CA 1.489 2.224 0 C-N-CA 123.584 0.611 . . . . 0.0 112.337 -177.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.15 -52.02 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 CA-C-N 117.151 0.475 . . . . 0.0 110.16 163.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.9 170.75 35.08 Favored Glycine 0 CA--C 1.558 2.777 0 N-CA-C 115.873 1.109 . . . . 0.0 115.873 166.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -67.98 164.8 30.42 Favored 'Trans proline' 0 CA--C 1.563 1.928 0 C-N-CA 122.853 2.369 . . . . 0.0 115.447 175.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -63.66 125.82 25.55 Favored 'General case' 0 CA--C 1.57 1.749 0 O-C-N 120.623 -1.298 . . . . 0.0 112.943 172.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.7 mt -92.48 16.84 11.01 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -65.76 114.24 4.88 Favored 'General case' 0 CA--C 1.566 1.578 0 CA-C-O 122.077 0.941 . . . . 0.0 113.199 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.7 27.35 69.37 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 118.262 2.065 . . . . 0.0 118.262 -172.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.274 5.5 p -69.11 -29.73 43.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 -175.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.2 t -73.48 104.94 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 CA-C-N 119.482 1.037 . . . . 0.0 108.931 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.07 16.14 54.65 Favored Glycine 0 CA--C 1.556 2.628 0 N-CA-C 119.115 2.406 . . . . 0.0 119.115 -162.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.0 ttp180 -110.02 149.85 29.38 Favored 'General case' 0 N--CA 1.494 1.751 0 CA-C-N 119.891 1.846 . . . . 0.0 110.829 176.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.305 0.6 OUTLIER -60.33 149.85 32.35 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.022 1.489 . . . . 0.0 115.022 -176.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.3 t -79.03 121.11 31.52 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.693 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 174.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.308 . . 70.6 62.6 0.2 Allowed 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -151.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -90.19 -40.27 5.84 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 119.209 2.443 . . . . 0.0 119.209 -176.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 79.0 t -81.14 96.46 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 119.165 1.482 . . . . 0.0 110.381 -175.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -70.45 103.63 2.51 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.475 0.655 . . . . 0.0 110.906 177.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.78 -51.58 0.73 Allowed Glycine 0 N--CA 1.491 2.306 0 CA-C-O 119.598 -0.557 . . . . 0.0 113.884 -154.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -76.47 135.83 39.37 Favored 'General case' 0 CA--C 1.572 1.814 0 CA-C-N 118.213 1.006 . . . . 0.0 111.675 170.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -81.08 91.74 6.15 Favored 'General case' 0 CA--C 1.569 1.684 0 O-C-N 121.571 -0.706 . . . . 0.0 111.813 176.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -77.7 162.46 26.97 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 113.623 0.972 . . . . 0.0 113.623 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 42.9 p -74.71 162.36 28.79 Favored 'General case' 0 CA--C 1.569 1.701 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 175.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -57.73 -52.45 74.28 Favored Pre-proline 0 CA--C 1.576 1.967 0 N-CA-C 115.966 1.839 . . . . 0.0 115.966 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.24 -18.78 39.31 Favored 'Trans proline' 0 CA--C 1.569 2.243 0 CA-C-N 123.864 2.416 . . . . 0.0 116.993 171.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -66.1 -51.96 53.19 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 162.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -62.22 -43.2 99.37 Favored 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 170.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.83 -11.57 58.83 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 118.519 2.785 . . . . 0.0 118.519 169.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.1 t-80 -69.52 -64.76 0.82 Allowed 'General case' 0 N--CA 1.493 1.724 0 CA-C-N 120.671 1.578 . . . . 0.0 111.988 163.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.86 -129.74 30.13 Favored Glycine 0 N--CA 1.488 2.165 0 CA-C-N 119.403 1.002 . . . . 0.0 114.07 -174.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.78 -125.9 40.42 Favored Glycine 0 N--CA 1.493 2.475 0 O-C-N 121.348 -1.089 . . . . 0.0 115.012 170.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -150.73 152.83 34.47 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 168.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.9 m95 -77.27 86.51 3.7 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-O 122.032 0.92 . . . . 0.0 112.652 163.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.6 p -72.46 155.36 91.29 Favored Pre-proline 0 CA--C 1.577 1.985 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 176.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -66.23 16.09 0.1 Allowed 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 119.647 2.903 . . . . 0.0 119.647 175.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -127.99 -39.75 1.74 Allowed 'General case' 0 CA--C 1.572 1.818 0 C-N-CA 124.889 1.275 . . . . 0.0 112.092 168.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.13 -40.84 70.98 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 84.2 mt -58.48 -34.23 70.66 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 116.353 1.982 . . . . 0.0 116.353 161.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.51 -32.23 72.9 Favored 'General case' 0 N--CA 1.499 2.008 0 N-CA-C 116.279 1.955 . . . . 0.0 116.279 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -74.75 -50.36 17.66 Favored 'General case' 0 CA--C 1.57 1.734 0 C-N-CA 123.575 0.75 . . . . 0.0 112.548 164.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -61.09 -43.83 98.28 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 116.034 1.864 . . . . 0.0 116.034 176.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 82.0 mt -67.43 -5.51 15.09 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 171.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.5 m -108.19 -34.61 6.79 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 120.328 1.422 . . . . 0.0 114.624 166.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -133.25 80.82 57.75 Favored Pre-proline 0 CA--C 1.578 2.048 0 CA-C-N 120.633 1.56 . . . . 0.0 108.193 171.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -55.45 -46.07 35.07 Favored 'Trans proline' 0 C--N 1.375 1.969 0 C-N-CA 123.689 2.926 . . . . 0.0 117.148 179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -82.01 10.32 6.79 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 117.757 2.503 . . . . 0.0 117.757 171.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.33 -46.49 8.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.56 -1.337 . . . . 0.0 113.421 158.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.2 t -72.33 -49.93 39.25 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.895 0 CA-C-N 119.03 0.832 . . . . 0.0 112.218 175.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.7 t -110.11 86.41 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 168.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -72.84 105.1 4.24 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.131 -0.981 . . . . 0.0 111.262 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.19 37.42 4.35 Favored Glycine 0 CA--C 1.554 2.529 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -158.688 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -80.17 140.43 36.34 Favored 'General case' 0 CA--C 1.56 1.353 0 CA-C-N 118.84 1.32 . . . . 0.0 110.742 165.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 49.0 mttm -66.42 3.02 1.03 Allowed 'General case' 0 CA--C 1.58 2.097 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 161.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -82.32 101.78 10.78 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 119.94 1.245 . . . . 0.0 110.321 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.38 70.51 5.83 Favored 'General case' 0 CA--C 1.567 1.602 0 CA-C-O 122.416 1.103 . . . . 0.0 112.923 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -130.71 127.29 38.53 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.778 0.831 . . . . 0.0 109.436 -174.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.7 -19.55 57.57 Favored 'General case' 0 CA--C 1.565 1.544 0 N-CA-C 117.634 2.457 . . . . 0.0 117.634 -179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.33 145.33 8.57 Favored Glycine 0 N--CA 1.486 1.973 0 N-CA-C 116.972 1.549 . . . . 0.0 116.972 177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.4 mt -81.88 137.53 46.95 Favored Pre-proline 0 CA--C 1.573 1.835 0 CA-C-O 118.367 -0.825 . . . . 0.0 113.077 170.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.61 -54.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.426 2.084 . . . . 0.0 116.025 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -80.64 149.32 29.88 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-N 119.547 1.067 . . . . 0.0 111.964 -177.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -58.38 -38.78 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.281 0 O-C-N 121.102 -0.999 . . . . 0.0 113.585 165.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 54.0 mp0 -60.18 -31.89 70.55 Favored 'General case' 0 CA--C 1.562 1.432 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 171.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 71.9 m-20 -62.42 -57.28 11.82 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 120.295 1.407 . . . . 0.0 113.292 174.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.34 -42.01 88.76 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -55.33 -45.93 76.35 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 122.209 2.277 . . . . 0.0 117.027 168.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -64.13 -43.91 93.83 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.33 -43.9 95.99 Favored 'General case' 0 CA--C 1.575 1.929 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 168.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.82 -45.41 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 120.688 -1.257 . . . . 0.0 112.911 169.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.47 -42.51 78.36 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 165.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -53.7 -55.32 27.23 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.711 1.374 . . . . 0.0 114.711 162.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 68.9 mt -61.16 -28.57 69.22 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 176.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -67.96 -49.34 62.27 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.754 1.39 . . . . 0.0 114.754 165.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.82 -58.91 3.62 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 116.993 1.557 . . . . 0.0 116.993 176.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -87.96 100.8 13.17 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 173.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.6 mt-30 . . . . . 0 C--O 1.253 1.283 0 CA-C-O 118.027 -0.987 . . . . 0.0 109.207 -178.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.62 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.569 1.682 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.85 96.73 3.48 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.237 -0.915 . . . . 0.0 111.273 -177.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -100.31 110.31 59.54 Favored Pre-proline 0 CA--C 1.579 2.062 0 C-N-CA 123.823 0.849 . . . . 0.0 111.014 -177.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.76 -11.82 28.16 Favored 'Trans proline' 0 CA--C 1.573 2.456 0 C-N-CA 122.931 2.421 . . . . 0.0 118.323 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.37 -42.57 71.61 Favored 'General case' 0 N--CA 1.495 1.805 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 161.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.87 -32.92 72.92 Favored 'General case' 0 CA--C 1.566 1.568 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 164.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.73 -28.49 71.71 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 118.707 2.243 . . . . 0.0 118.707 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -57.91 -46.34 85.12 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.612 1.338 . . . . 0.0 114.612 162.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 28.9 mtmm -67.65 -46.55 72.12 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 174.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 62.1 t -58.74 -43.49 87.98 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -59.71 -26.72 65.84 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.825 2.157 . . . . 0.0 116.825 167.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -32.54 41.82 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.138 2.415 . . . . 0.0 119.138 168.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -63.91 -36.76 85.0 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 115.898 1.814 . . . . 0.0 115.898 162.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.31 -33.88 67.71 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 116.386 1.995 . . . . 0.0 116.386 168.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -52.44 -28.57 20.58 Favored 'General case' 0 N--CA 1.502 2.158 0 N-CA-C 119.129 3.011 . . . . 0.0 119.129 -174.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.21 -29.15 67.28 Favored 'General case' 0 CA--C 1.569 1.702 0 N-CA-C 116.69 2.107 . . . . 0.0 116.69 167.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 31.8 m -105.93 -47.98 3.73 Favored 'General case' 0 CA--C 1.572 1.79 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 169.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -102.14 137.2 40.73 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 120.267 1.394 . . . . 0.0 112.899 -170.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 50.9 mttp -112.65 -35.14 5.6 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 -168.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.289 24.9 mt 81.63 -39.61 0.13 Allowed 'General case' 0 N--CA 1.506 2.329 0 N-CA-C 114.795 1.405 . . . . 0.0 114.795 -173.02 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 -86.54 48.63 1.66 Allowed 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -163.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.62 -20.3 0.37 Allowed Glycine 0 CA--C 1.559 2.801 0 N-CA-C 119.546 2.578 . . . . 0.0 119.546 -166.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -86.82 157.79 19.49 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 118.881 1.34 . . . . 0.0 112.035 -179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -128.29 -86.78 0.56 Allowed 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.486 -166.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 82.06 -105.25 2.54 Favored Glycine 0 N--CA 1.489 2.223 0 CA-C-N 119.842 1.201 . . . . 0.0 114.25 178.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.6 t -84.61 -62.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.101 0 CA-C-O 119.03 -0.509 . . . . 0.0 110.156 172.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -100.38 136.16 12.54 Favored Glycine 0 CA--C 1.551 2.32 0 CA-C-O 118.382 -1.232 . . . . 0.0 113.088 176.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -67.76 161.03 45.59 Favored 'Trans proline' 0 CA--C 1.559 1.736 0 CA-C-N 121.905 2.853 . . . . 0.0 116.244 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.9 p-80 -61.85 120.64 11.13 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.3 mt -93.76 27.93 2.54 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 49.6 p30 -72.76 87.26 1.27 Allowed 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -169.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.546 1.974 0 O-C-N 121.217 -0.927 . . . . 0.0 114.676 -159.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 9.3 p -77.55 -27.02 15.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.128 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 164.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.0 t -71.47 103.55 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 CA-C-N 119.35 0.977 . . . . 0.0 108.648 173.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.25 14.95 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 118.48 2.152 . . . . 0.0 118.48 -162.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.3 ttm-85 -117.52 154.19 31.9 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 124.759 1.224 . . . . 0.0 109.82 171.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 t -56.58 152.97 10.95 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 120.133 -1.604 . . . . 0.0 113.912 166.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.418 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.9 t -74.24 135.35 27.62 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.642 0 O-C-N 121.777 -0.577 . . . . 0.0 109.829 165.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.301 . . 67.87 22.26 8.76 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -160.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.6 51.41 2.66 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 118.758 2.263 . . . . 0.0 118.758 -171.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 87.5 t -133.8 105.1 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -70.18 123.18 20.99 Favored 'General case' 0 CA--C 1.569 1.673 0 C-N-CA 123.075 0.55 . . . . 0.0 111.785 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.09 -53.74 0.73 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 114.266 0.467 . . . . 0.0 114.266 -163.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -84.83 129.38 34.82 Favored 'General case' 0 CA--C 1.566 1.567 0 CA-C-N 117.784 0.792 . . . . 0.0 111.847 175.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 26.5 t30 -86.29 117.6 25.2 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-O 121.511 0.672 . . . . 0.0 110.824 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -86.43 -177.89 6.3 Favored 'General case' 0 CA--C 1.575 1.908 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -177.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 24.9 p -80.64 162.89 24.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 119.626 -1.921 . . . . 0.0 113.449 173.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -58.73 -50.95 85.24 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 116.119 -1.896 . . . . 0.0 115.659 176.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.37 -24.6 42.99 Favored 'Trans proline' 0 CA--C 1.571 2.334 0 CA-C-N 124.752 2.733 . . . . 0.0 116.998 169.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.67 -51.45 62.48 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.032 1.494 . . . . 0.0 115.032 165.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -59.44 -42.22 91.43 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.049 1.5 . . . . 0.0 115.049 168.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.69 -17.78 64.85 Favored 'General case' 0 CA--C 1.571 1.759 0 N-CA-C 118.649 2.833 . . . . 0.0 118.649 170.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -64.61 -62.09 1.8 Allowed 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 120.733 1.606 . . . . 0.0 112.961 169.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.86 -123.47 24.35 Favored Glycine 0 N--CA 1.488 2.16 0 CA-C-N 119.176 0.898 . . . . 0.0 113.765 -175.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.6 -113.09 5.17 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 116.275 1.27 . . . . 0.0 116.275 162.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -165.3 151.99 10.29 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.418 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.2 m95 -89.51 84.75 6.4 Favored 'General case' 0 CA--C 1.561 1.389 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.593 159.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -77.55 161.78 70.86 Favored Pre-proline 0 CA--C 1.586 2.345 0 CA-C-O 118.151 -0.928 . . . . 0.0 112.291 174.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -66.21 22.37 0.09 OUTLIER 'Trans proline' 0 CA--C 1.585 3.036 0 N-CA-C 119.589 2.881 . . . . 0.0 119.589 173.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -131.99 -47.61 0.94 Allowed 'General case' 0 CA--C 1.571 1.763 0 C-N-CA 126.926 2.091 . . . . 0.0 109.649 174.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.03 -42.84 73.11 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 116.023 1.861 . . . . 0.0 116.023 167.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 72.3 mt -59.0 -34.26 71.66 Favored 'General case' 0 N--CA 1.497 1.902 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -70.67 -26.1 63.28 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 117.144 2.276 . . . . 0.0 117.144 173.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -80.01 -48.63 13.02 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-N 119.148 0.885 . . . . 0.0 112.605 163.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -60.08 -47.19 86.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 176.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.79 -24.65 66.99 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.326 2.343 . . . . 0.0 117.326 174.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 57.5 m -84.5 -38.0 20.63 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 169.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -135.25 82.96 39.84 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-N 120.58 1.536 . . . . 0.0 107.971 172.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -56.47 -44.92 41.3 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 123.548 2.832 . . . . 0.0 117.075 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 4.3 ptpp? -79.5 5.65 12.35 Favored 'General case' 0 CA--C 1.577 2.01 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 171.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -91.56 -46.7 7.82 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 120.267 1.394 . . . . 0.0 113.541 161.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 89.3 t -69.98 -48.42 63.2 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-N 119.351 0.978 . . . . 0.0 112.268 171.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.0 t -113.2 85.39 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 170.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.57 110.25 3.1 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.916 -1.115 . . . . 0.0 112.359 175.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.49 39.67 6.66 Favored Glycine 0 CA--C 1.553 2.439 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -160.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.8 t -75.73 142.52 42.39 Favored 'General case' 0 CA--C 1.563 1.459 0 CA-C-N 118.9 1.35 . . . . 0.0 110.706 161.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -66.43 -2.12 4.24 Favored 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 116.105 1.891 . . . . 0.0 116.105 161.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -78.48 104.06 8.84 Favored 'General case' 0 CA--C 1.561 1.397 0 CA-C-N 120.362 1.437 . . . . 0.0 111.172 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 69.9 4.97 Favored 'General case' 0 CA--C 1.568 1.669 0 CA-C-O 122.534 1.159 . . . . 0.0 113.283 175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -132.69 131.21 41.04 Favored 'General case' 0 CA--C 1.56 1.354 0 C-N-CA 124.169 0.988 . . . . 0.0 109.128 -175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.18 -33.08 50.36 Favored 'General case' 0 CA--C 1.562 1.43 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -176.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 139.72 133.63 3.03 Favored Glycine 0 CA--C 1.545 1.959 0 N-CA-C 116.548 1.379 . . . . 0.0 116.548 -175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.6 mt -76.4 129.85 78.8 Favored Pre-proline 0 CA--C 1.575 1.936 0 CA-C-O 118.254 -0.879 . . . . 0.0 112.629 163.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -82.57 -50.24 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.989 0 C-N-CA 122.473 2.116 . . . . 0.0 116.627 -172.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.1 mttp -86.69 145.77 26.56 Favored 'General case' 0 N--CA 1.487 1.408 0 CA-C-N 119.242 0.928 . . . . 0.0 110.96 -173.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.86 -39.38 56.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 N-CA-C 114.109 1.151 . . . . 0.0 114.109 167.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -61.29 -36.0 78.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 115.892 1.812 . . . . 0.0 115.892 167.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -61.79 -53.26 58.32 Favored 'General case' 0 N--CA 1.499 2.013 0 CA-C-N 121.46 1.937 . . . . 0.0 113.787 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.274 0.0 OUTLIER -63.58 -44.31 94.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 167.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.1 -46.63 82.42 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 170.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -56.4 -50.82 70.52 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 114.864 1.431 . . . . 0.0 114.864 170.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -52.1 -42.61 63.4 Favored 'General case' 0 CA--C 1.574 1.887 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 164.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.266 48.9 mt -67.33 -34.15 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.049 0 O-C-N 120.76 -1.212 . . . . 0.0 114.24 175.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.02 93.66 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.994 1.85 . . . . 0.0 115.994 160.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -54.06 -57.25 11.77 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 166.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.1 mt -64.13 -20.76 66.21 Favored 'General case' 0 N--CA 1.502 2.143 0 N-CA-C 117.221 2.304 . . . . 0.0 117.221 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.78 -50.43 62.7 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 164.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -107.92 -31.53 3.59 Favored Glycine 0 N--CA 1.493 2.497 0 N-CA-C 119.266 2.467 . . . . 0.0 119.266 -176.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -87.69 84.49 7.07 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 120.164 1.982 . . . . 0.0 109.739 173.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.347 0 CA-C-N 115.391 -0.822 . . . . 0.0 112.012 -166.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.705 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.8 mtp . . . . . 0 N--CA 1.488 1.462 0 CA-C-O 118.657 -0.687 . . . . 0.0 112.43 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -111.01 76.55 0.98 Allowed 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 119.365 0.984 . . . . 0.0 113.455 -173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -104.04 109.42 62.36 Favored Pre-proline 0 CA--C 1.575 1.939 0 O-C-N 121.222 -0.924 . . . . 0.0 109.893 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -70.35 -28.24 22.65 Favored 'Trans proline' 0 CA--C 1.567 2.15 0 C-N-CA 122.655 2.236 . . . . 0.0 117.489 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.05 -46.37 78.03 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 171.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.39 -30.4 71.18 Favored 'General case' 0 CA--C 1.57 1.726 0 N-CA-C 116.461 2.023 . . . . 0.0 116.461 164.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.56 -20.86 61.96 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 165.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -68.75 -42.41 77.55 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 168.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -67.79 -35.66 79.05 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 167.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 10.9 t -64.86 -37.75 81.0 Favored 'Isoleucine or valine' 0 CA--C 1.583 2.22 0 CA-C-N 119.619 1.099 . . . . 0.0 113.5 165.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -57.19 -28.09 62.52 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 161.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.31 -26.64 30.06 Favored Glycine 0 CA--C 1.558 2.764 0 N-CA-C 119.572 2.589 . . . . 0.0 119.572 163.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 66.4 mmtt -67.07 -39.27 86.82 Favored 'General case' 0 CA--C 1.577 2.004 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 162.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -78.35 -33.82 48.83 Favored 'General case' 0 CA--C 1.572 1.813 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 175.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -58.64 -30.63 67.45 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 119.687 3.217 . . . . 0.0 119.687 -165.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.26 -35.89 78.52 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 170.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.7 m -89.39 -43.18 11.07 Favored 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 168.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -112.55 131.75 55.45 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 120.118 1.326 . . . . 0.0 111.934 -171.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 99.9 mttt -101.6 -36.99 8.57 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 115.708 1.744 . . . . 0.0 115.708 -174.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.55 3.0 pp 60.65 -7.41 0.08 Allowed 'General case' 0 N--CA 1.503 2.2 0 N-CA-C 120.141 3.385 . . . . 0.0 120.141 -171.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -92.47 53.49 2.1 Favored 'General case' 0 CA--C 1.571 1.786 0 O-C-N 120.929 -1.107 . . . . 0.0 112.914 178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.96 -59.09 2.66 Favored Glycine 0 N--CA 1.497 2.713 0 O-C-N 120.521 -1.362 . . . . 0.0 115.893 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -58.85 155.41 13.16 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 116.348 1.981 . . . . 0.0 116.348 167.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -99.08 -77.19 0.52 Allowed 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 113.794 -1.548 . . . . 0.0 111.026 -168.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.41 -123.44 5.71 Favored Glycine 0 N--CA 1.488 2.104 0 C-N-CA 123.898 0.761 . . . . 0.0 112.45 -179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 43.1 t -87.78 -51.02 13.2 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.207 0 C-N-CA 122.912 0.485 . . . . 0.0 110.282 163.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -87.31 176.42 46.77 Favored Glycine 0 CA--C 1.557 2.661 0 N-CA-C 115.818 1.087 . . . . 0.0 115.818 164.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -68.3 170.58 14.41 Favored 'Trans proline' 0 CA--C 1.564 2.003 0 C-N-CA 122.759 2.306 . . . . 0.0 115.888 173.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.7 p-80 -67.05 128.0 34.72 Favored 'General case' 0 CA--C 1.571 1.756 0 O-C-N 120.615 -1.303 . . . . 0.0 112.46 169.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 87.1 mt -94.15 16.58 14.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p30 -64.89 112.6 3.35 Favored 'General case' 0 CA--C 1.567 1.613 0 O-C-N 121.216 -0.928 . . . . 0.0 113.115 176.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.95 34.56 65.24 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.902 1.921 . . . . 0.0 117.902 -173.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.264 9.7 p -72.0 -29.84 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.048 0 N-CA-C 116.952 2.204 . . . . 0.0 116.952 -177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.8 t -74.02 107.36 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 CA-C-N 119.825 1.193 . . . . 0.0 109.212 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.63 6.47 65.8 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 -162.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.8 ttp180 -98.74 151.44 20.76 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 120.084 1.942 . . . . 0.0 110.943 175.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.297 0.6 OUTLIER -61.03 153.04 26.39 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 -177.677 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 38.3 t -78.39 126.33 38.47 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.731 0 CA-C-O 121.582 0.706 . . . . 0.0 109.172 172.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.318 . . 71.75 26.37 3.06 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 117.583 2.438 . . . . 0.0 117.583 -152.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -88.45 58.76 4.13 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 118.313 2.085 . . . . 0.0 118.313 -174.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 55.7 t -140.66 111.18 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 106.479 -1.674 . . . . 0.0 106.479 160.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -71.96 100.05 2.37 Favored 'General case' 0 CA--C 1.569 1.703 0 O-C-N 121.619 -0.676 . . . . 0.0 111.379 169.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.71 -51.1 0.68 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 115.002 0.761 . . . . 0.0 115.002 -162.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -80.57 134.26 35.9 Favored 'General case' 0 CA--C 1.569 1.706 0 CA-C-N 118.277 1.038 . . . . 0.0 111.829 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -81.34 95.05 6.89 Favored 'General case' 0 CA--C 1.568 1.665 0 O-C-N 121.696 -0.627 . . . . 0.0 111.338 174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -81.77 164.23 21.84 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.7 p -71.35 158.71 35.86 Favored 'General case' 0 CA--C 1.569 1.71 0 O-C-N 120.583 -1.323 . . . . 0.0 114.263 174.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -58.28 -48.36 97.14 Favored Pre-proline 0 CA--C 1.578 2.043 0 CA-C-O 115.964 -1.97 . . . . 0.0 116.101 176.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.54 -24.03 36.44 Favored 'Trans proline' 0 CA--C 1.571 2.367 0 CA-C-N 125.007 2.824 . . . . 0.0 117.118 170.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.5 tpt -62.37 -51.42 67.66 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 162.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -62.88 -40.14 96.62 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 171.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.95 -18.44 65.25 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 118.378 2.733 . . . . 0.0 118.378 169.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.1 t-80 -66.1 -65.8 0.63 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 120.491 1.496 . . . . 0.0 112.467 167.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.17 -130.2 29.58 Favored Glycine 0 N--CA 1.488 2.166 0 CA-C-N 119.426 1.012 . . . . 0.0 114.072 -173.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.88 -125.55 39.36 Favored Glycine 0 N--CA 1.494 2.52 0 O-C-N 121.115 -1.226 . . . . 0.0 115.027 171.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -150.56 151.73 33.06 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 171.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.0 m95 -79.28 85.39 5.13 Favored 'General case' 0 CA--C 1.561 1.395 0 CA-C-O 122.1 0.952 . . . . 0.0 112.699 162.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.0 p -72.96 158.82 86.62 Favored Pre-proline 0 CA--C 1.578 2.046 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -71.5 53.77 1.8 Allowed 'Trans proline' 0 CA--C 1.578 2.719 0 C-N-CA 122.883 2.389 . . . . 0.0 116.215 171.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -172.11 -62.24 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.635 0 C-N-CA 125.801 1.64 . . . . 0.0 107.178 -162.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.64 -44.28 76.99 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.716 1.747 . . . . 0.0 115.716 162.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -57.8 -34.95 70.18 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 162.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 62.0 mt-30 -68.05 -27.83 66.86 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 116.926 2.195 . . . . 0.0 116.926 175.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -82.29 -47.77 11.99 Favored 'General case' 0 CA--C 1.571 1.774 0 CA-C-N 119.079 0.854 . . . . 0.0 113.302 162.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -59.37 -41.26 88.92 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.17 -1.06 6.89 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 117.61 2.448 . . . . 0.0 117.61 169.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 49.2 m -113.02 -38.18 4.57 Favored 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 120.297 1.408 . . . . 0.0 114.008 167.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -131.83 83.13 58.17 Favored Pre-proline 0 CA--C 1.576 1.977 0 CA-C-N 120.485 1.493 . . . . 0.0 107.744 169.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -53.19 -46.39 34.2 Favored 'Trans proline' 0 C--N 1.376 1.991 0 C-N-CA 123.734 2.956 . . . . 0.0 117.184 177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.39 -15.96 62.91 Favored 'General case' 0 CA--C 1.572 1.806 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 173.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.19 -43.14 58.4 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 81.5 t -76.84 -52.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 CA-C-N 119.105 0.866 . . . . 0.0 111.856 173.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 64.5 t -109.0 92.89 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 172.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 109.63 6.04 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.347 -0.846 . . . . 0.0 112.24 176.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.59 38.17 6.7 Favored Glycine 0 CA--C 1.552 2.375 0 N-CA-C 117.458 1.743 . . . . 0.0 117.458 -160.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.8 t -78.76 135.65 37.17 Favored 'General case' 0 CA--C 1.56 1.338 0 CA-C-N 118.915 1.358 . . . . 0.0 110.038 162.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -70.34 11.41 0.34 Allowed 'General case' 0 CA--C 1.58 2.104 0 N-CA-C 116.099 1.889 . . . . 0.0 116.099 163.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -84.05 100.67 11.24 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.66 -1.275 . . . . 0.0 109.521 175.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.78 70.09 6.24 Favored 'General case' 0 CA--C 1.566 1.564 0 CA-C-O 122.362 1.077 . . . . 0.0 112.934 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -127.26 127.65 44.74 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 123.733 0.813 . . . . 0.0 109.68 -173.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.57 -16.03 58.88 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 110.31 148.39 11.86 Favored Glycine 0 CA--C 1.545 1.932 0 N-CA-C 117.461 1.744 . . . . 0.0 117.461 176.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 89.7 mt -86.46 136.4 35.27 Favored Pre-proline 0 CA--C 1.572 1.812 0 C-N-CA 123.908 0.883 . . . . 0.0 112.566 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.53 -51.78 0.04 OUTLIER 'Trans proline' 0 CA--C 1.565 2.04 0 C-N-CA 122.402 2.068 . . . . 0.0 116.283 -173.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 36.0 mtmm -85.67 148.37 25.92 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 119.505 1.048 . . . . 0.0 111.54 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -56.39 -39.12 59.09 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 166.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -60.79 -31.83 71.18 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -61.8 -56.49 18.88 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.569 1.986 . . . . 0.0 113.742 176.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.56 -45.21 91.53 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 116.463 2.023 . . . . 0.0 116.463 168.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.22 -39.19 81.93 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 117.692 2.478 . . . . 0.0 117.692 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -61.07 -49.04 78.97 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 167.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.525 HD21 HMB1 ' A' ' 101' ' ' HEC . 28.6 tp -59.5 -45.11 92.66 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 170.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 64.9 mt -57.61 -46.78 86.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 C-N-CA 124.084 0.954 . . . . 0.0 112.62 169.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.16 72.92 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.462 2.394 . . . . 0.0 117.462 165.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -56.39 -67.72 0.28 Allowed 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 117.691 -1.147 . . . . 0.0 113.2 166.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.378 0.8 OUTLIER -81.3 8.44 9.09 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 118.555 2.798 . . . . 0.0 118.555 -175.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -66.45 -51.31 58.21 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.356 -1.465 . . . . 0.0 114.316 144.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.73 -51.81 2.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -79.68 86.95 5.23 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 123.845 0.858 . . . . 0.0 110.754 174.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 . . . . . 0 C--O 1.253 1.287 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.583 -170.973 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.65 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.2 mtp . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.31 72.69 1.0 Allowed 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 119.629 1.104 . . . . 0.0 112.891 178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -104.08 106.81 54.98 Favored Pre-proline 0 CA--C 1.574 1.876 0 O-C-N 121.255 -0.903 . . . . 0.0 109.896 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.09 -30.53 13.33 Favored 'Trans proline' 0 CA--C 1.568 2.211 0 C-N-CA 122.567 2.178 . . . . 0.0 117.371 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.14 -34.43 78.05 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 168.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.88 -33.13 70.28 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 116.068 1.877 . . . . 0.0 116.068 160.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.54 -32.5 84.4 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 118.842 2.297 . . . . 0.0 118.842 175.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -62.55 -34.3 76.67 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 163.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 7.5 mmpt? -67.33 -48.03 68.73 Favored 'General case' 0 CA--C 1.568 1.665 0 C-N-CA 123.782 0.833 . . . . 0.0 112.999 170.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 t -59.0 -43.36 88.72 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 168.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -56.28 -21.87 26.6 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.375 2.361 . . . . 0.0 117.375 169.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.4 -27.74 41.63 Favored Glycine 0 CA--C 1.559 2.809 0 N-CA-C 119.276 2.47 . . . . 0.0 119.276 167.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.8 mtmt -69.78 -34.27 73.54 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 162.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.448 ' SG ' HD11 ' A' ' 92' ' ' LEU . 2.8 m -75.26 -37.76 60.81 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 116.302 1.964 . . . . 0.0 116.302 170.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -60.6 -27.04 67.42 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -165.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.61 -35.95 81.18 Favored 'General case' 0 CA--C 1.568 1.658 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 167.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 60.9 m -89.18 -40.98 12.51 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.5 m-70 -117.58 141.89 47.84 Favored 'General case' 0 N--CA 1.494 1.775 0 CA-C-N 120.237 1.381 . . . . 0.0 113.49 -169.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -106.45 144.61 32.88 Favored 'General case' 0 CA--C 1.567 1.609 0 CA-C-O 122.284 1.04 . . . . 0.0 111.929 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 18.9 mt -98.67 23.83 8.22 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 167.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -133.73 69.54 1.47 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 119.218 -2.176 . . . . 0.0 110.843 172.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 78.64 -54.85 4.12 Favored Glycine 0 N--CA 1.493 2.495 0 N-CA-C 118.604 2.202 . . . . 0.0 118.604 168.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 65.4 m-80 -78.34 172.72 13.19 Favored 'General case' 0 CA--C 1.572 1.792 0 CA-C-O 122.221 1.01 . . . . 0.0 113.307 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -95.34 -83.22 0.36 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.051 -1.031 . . . . 0.0 112.735 -167.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 114.14 -123.84 6.23 Favored Glycine 0 N--CA 1.49 2.234 0 CA-C-N 118.539 0.609 . . . . 0.0 112.296 -170.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 38.9 t -89.88 -49.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.286 0 C-N-CA 123.221 0.609 . . . . 0.0 110.702 166.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.56 175.69 40.85 Favored Glycine 0 CA--C 1.558 2.742 0 CA-C-N 119.302 0.956 . . . . 0.0 115.437 163.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -70.65 173.32 11.94 Favored 'Trans proline' 0 CA--C 1.566 2.112 0 CA-C-N 121.099 2.45 . . . . 0.0 115.324 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -63.9 132.99 52.44 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.566 -1.334 . . . . 0.0 113.379 175.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 89.6 mt -101.56 1.66 38.16 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 177.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -72.89 101.02 3.06 Favored 'General case' 0 CA--C 1.565 1.557 0 CA-C-N 120.418 1.463 . . . . 0.0 110.306 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.89 53.33 4.0 Favored Glycine 0 CA--C 1.547 2.068 0 N-CA-C 116.792 1.477 . . . . 0.0 116.792 -162.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.279 5.4 p -93.87 -32.8 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 161.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.41 HG23 HD11 ' A' ' 96' ' ' LEU . 85.8 t -66.81 108.55 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 120.326 1.421 . . . . 0.0 109.615 175.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.53 9.59 71.96 Favored Glycine 0 CA--C 1.554 2.492 0 N-CA-C 119.308 2.483 . . . . 0.0 119.308 -166.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 50.2 ttp180 -98.08 152.75 18.98 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.067 1.934 . . . . 0.0 110.597 169.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.7 t -51.82 153.39 2.51 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 114.633 1.345 . . . . 0.0 114.633 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.8 t -79.95 115.19 21.96 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.655 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 165.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.251 . . 73.03 88.2 0.1 Allowed 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.281 1.215 . . . . 0.0 114.281 -166.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -171.67 71.47 0.11 Allowed Glycine 0 N--CA 1.487 2.088 0 O-C-N 121.552 -0.717 . . . . 0.0 114.511 177.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 97.3 t -143.16 115.22 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 175.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -66.65 95.77 0.36 Allowed 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.05 -41.85 1.31 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 116.016 1.166 . . . . 0.0 116.016 -165.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -86.49 133.35 33.76 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 119.324 1.562 . . . . 0.0 113.296 -176.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -84.88 105.7 15.85 Favored 'General case' 0 CA--C 1.569 1.7 0 C-N-CA 123.307 0.643 . . . . 0.0 111.435 173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -86.69 158.85 19.35 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.213 1.19 . . . . 0.0 114.213 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 9.4 p -70.2 157.5 37.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.743 -1.223 . . . . 0.0 113.858 173.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.27 -51.2 81.76 Favored Pre-proline 0 CA--C 1.578 2.042 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -72.86 -21.12 21.61 Favored 'Trans proline' 0 CA--C 1.568 2.201 0 CA-C-N 123.975 2.455 . . . . 0.0 117.254 172.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 30.9 ttm -67.68 -48.54 66.32 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 120.767 1.621 . . . . 0.0 113.994 161.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -65.11 -38.4 90.58 Favored 'General case' 0 CA--C 1.567 1.619 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 174.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.85 -14.02 62.78 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 118.404 2.742 . . . . 0.0 118.404 165.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 7.2 t-80 -68.21 -64.5 0.85 Allowed 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 120.897 1.681 . . . . 0.0 112.992 172.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.71 -127.68 16.4 Favored Glycine 0 N--CA 1.488 2.161 0 CA-C-N 119.326 0.966 . . . . 0.0 114.043 -174.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.6 -124.18 35.55 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 115.841 1.096 . . . . 0.0 115.841 169.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -154.75 151.75 29.07 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 122.35 1.071 . . . . 0.0 113.375 168.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.2 m95 -80.11 86.88 5.5 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 122.121 0.962 . . . . 0.0 112.279 160.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 68.2 p -73.76 157.99 86.69 Favored Pre-proline 0 CA--C 1.577 1.994 0 C-N-CA 123.771 0.828 . . . . 0.0 113.157 172.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -73.66 58.52 3.93 Favored 'Trans proline' 0 CA--C 1.578 2.683 0 C-N-CA 122.568 2.179 . . . . 0.0 114.784 170.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -173.66 -64.29 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -159.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.01 -44.95 83.32 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 159.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 74.4 mt -59.55 -34.33 72.53 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 164.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -60.34 -46.31 90.37 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-N 121.12 1.782 . . . . 0.0 114.144 171.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -68.13 -46.76 69.96 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 170.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -64.32 -48.17 76.6 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.876 1.435 . . . . 0.0 114.876 175.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.3 mt -61.24 -24.51 66.42 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 116.179 1.918 . . . . 0.0 116.179 167.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.5 m -68.21 -38.58 82.09 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 121.382 1.901 . . . . 0.0 115.613 162.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -159.57 86.04 2.14 Favored Pre-proline 0 CA--C 1.576 1.979 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 -171.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -59.1 -43.16 44.39 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.476 2.784 . . . . 0.0 117.873 -171.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -77.64 -4.21 44.85 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 117.752 2.501 . . . . 0.0 117.752 169.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.24 -44.34 46.6 Favored 'General case' 0 CA--C 1.566 1.569 0 CA-C-N 120.551 1.523 . . . . 0.0 114.615 162.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 74.4 t -78.32 -53.76 13.4 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.855 0 CA-C-N 119.004 0.82 . . . . 0.0 111.83 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 41.5 t -107.63 86.91 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 120.352 1.433 . . . . 0.0 107.94 175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -74.29 104.75 5.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.259 -0.901 . . . . 0.0 111.225 -177.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.73 39.17 3.45 Favored Glycine 0 CA--C 1.555 2.574 0 N-CA-C 117.126 1.61 . . . . 0.0 117.126 -158.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.3 t -80.38 141.1 35.69 Favored 'General case' 0 CA--C 1.564 1.508 0 O-C-N 121.197 -1.178 . . . . 0.0 111.083 164.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 3.4 mptp? -67.7 3.24 1.49 Allowed 'General case' 0 CA--C 1.581 2.135 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 159.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -79.09 103.73 9.23 Favored 'General case' 0 CA--C 1.561 1.379 0 CA-C-N 120.484 1.493 . . . . 0.0 110.899 178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.18 71.42 4.65 Favored 'General case' 0 CA--C 1.569 1.674 0 CA-C-O 122.928 1.347 . . . . 0.0 113.061 174.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -143.6 129.19 19.17 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.82 -36.96 49.59 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 145.57 141.7 3.7 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 116.72 1.448 . . . . 0.0 116.72 -170.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 48.3 mt -86.09 122.74 72.48 Favored Pre-proline 0 CA--C 1.569 1.689 0 CA-C-O 118.119 -0.943 . . . . 0.0 111.357 166.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -82.96 -40.05 0.12 Allowed 'Trans proline' 0 CA--C 1.561 1.852 0 C-N-CA 122.508 2.138 . . . . 0.0 117.505 -164.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -89.01 145.86 25.23 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 119.938 1.244 . . . . 0.0 111.24 175.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.252 11.2 tp -55.7 -35.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 168.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -63.79 -31.65 72.9 Favored 'General case' 0 CA--C 1.564 1.484 0 N-CA-C 115.608 1.707 . . . . 0.0 115.608 167.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.9 m-20 -63.31 -55.25 26.25 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 121.379 1.9 . . . . 0.0 113.754 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.0 OUTLIER -66.14 -42.25 89.35 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 169.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.17 -41.59 88.81 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 117.926 2.565 . . . . 0.0 117.926 170.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -60.52 -48.63 80.94 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 169.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.448 HD11 ' SG ' ' A' ' 14' ' ' CYS . 5.3 tt -60.36 -46.98 88.02 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 115.038 1.495 . . . . 0.0 115.038 171.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.253 66.5 mt -55.24 -47.4 77.71 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 CA-C-N 119.544 1.066 . . . . 0.0 112.791 169.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.93 -47.11 78.12 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 117.282 2.327 . . . . 0.0 117.282 168.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -54.01 -54.39 39.75 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 115.412 1.634 . . . . 0.0 115.412 165.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.41 HD11 HG23 ' A' ' 34' ' ' VAL 0.313 0.3 OUTLIER -68.06 -32.15 72.29 Favored 'General case' 0 CA--C 1.575 1.933 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 -178.952 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.47 -47.69 75.7 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 162.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.14 14.94 12.47 Favored Glycine 0 CA--C 1.555 2.575 0 N-CA-C 119.492 2.557 . . . . 0.0 119.492 165.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -139.45 76.6 1.57 Allowed 'General case' 0 CA--C 1.565 1.554 0 CA-C-N 120.003 1.901 . . . . 0.0 109.119 177.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 . . . . . 0 C--O 1.255 1.382 0 C-N-CA 123.771 0.828 . . . . 0.0 113.02 -168.052 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.682 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 ppp? . . . . . 0 CA--C 1.563 1.475 0 CA-C-O 122.017 0.913 . . . . 0.0 113.201 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . 0.272 . . 53.39 49.2 20.21 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 118.388 2.736 . . . . 0.0 118.388 -171.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 41.9 m-20 -108.85 98.06 27.55 Favored Pre-proline 0 CA--C 1.569 1.708 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -68.48 -28.5 32.14 Favored 'Trans proline' 0 CA--C 1.563 1.951 0 C-N-CA 122.708 2.272 . . . . 0.0 117.591 -171.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.2 -44.46 95.3 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 167.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.34 -28.78 70.24 Favored 'General case' 0 CA--C 1.573 1.845 0 N-CA-C 116.768 2.136 . . . . 0.0 116.768 163.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -64.27 -22.97 67.79 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 118.975 2.35 . . . . 0.0 118.975 165.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -69.59 -40.07 76.93 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 169.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -67.08 -35.05 78.97 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 166.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.4 t -62.44 -44.92 99.75 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.166 0 CA-C-N 119.453 1.024 . . . . 0.0 113.11 163.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.7 t80 -56.25 -23.4 35.87 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 166.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.82 -31.58 54.49 Favored Glycine 0 CA--C 1.558 2.738 0 N-CA-C 119.036 2.374 . . . . 0.0 119.036 166.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -67.4 -36.01 80.45 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 163.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -74.26 -37.18 63.81 Favored 'General case' 0 CA--C 1.572 1.825 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 171.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 12.0 ptmm? -64.08 -24.37 67.67 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 119.922 3.305 . . . . 0.0 119.922 -164.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.57 75.42 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 165.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 59.3 m -90.83 -44.8 9.18 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.792 1.775 . . . . 0.0 115.792 168.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -110.55 132.85 53.83 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 120.074 1.306 . . . . 0.0 112.25 -171.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -100.35 -38.33 8.49 Favored 'General case' 0 N--CA 1.5 2.058 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -174.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.504 2.8 pp 56.61 8.41 0.45 Allowed 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 119.96 3.319 . . . . 0.0 119.96 -170.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -109.26 51.84 0.73 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.162 -0.961 . . . . 0.0 112.174 -178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.81 -59.71 3.43 Favored Glycine 0 N--CA 1.495 2.581 0 O-C-N 120.367 -1.458 . . . . 0.0 115.851 -169.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 32.9 p30 -65.6 159.54 24.5 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 116.084 1.883 . . . . 0.0 116.084 169.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -99.55 -77.01 0.53 Allowed 'General case' 0 N--CA 1.493 1.721 0 CA-C-N 114.139 -1.391 . . . . 0.0 111.811 -167.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.42 -128.4 7.82 Favored Glycine 0 N--CA 1.489 2.175 0 C-N-CA 123.781 0.705 . . . . 0.0 112.759 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 t -84.66 -49.23 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.225 0 O-C-N 122.377 -0.484 . . . . 0.0 110.63 163.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -90.03 175.48 41.56 Favored Glycine 0 CA--C 1.558 2.78 0 N-CA-C 115.747 1.059 . . . . 0.0 115.747 164.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -69.33 170.07 16.91 Favored 'Trans proline' 0 CA--C 1.564 2.011 0 C-N-CA 122.775 2.317 . . . . 0.0 115.815 174.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 12.9 p-80 -68.78 126.85 31.03 Favored 'General case' 0 CA--C 1.571 1.761 0 O-C-N 120.779 -1.2 . . . . 0.0 112.726 171.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 81.9 mt -99.67 18.78 17.22 Favored 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 -174.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -65.65 106.75 1.55 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.925 -1.109 . . . . 0.0 112.955 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.37 97.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 116.831 1.492 . . . . 0.0 116.831 -169.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.3 p -69.95 -25.49 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 115.973 1.842 . . . . 0.0 115.973 171.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.6 t -73.09 103.61 1.88 Allowed 'Isoleucine or valine' 0 CA--C 1.571 1.784 0 O-C-N 121.12 -0.987 . . . . 0.0 108.816 175.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.26 8.33 61.45 Favored Glycine 0 CA--C 1.558 2.719 0 N-CA-C 119.473 2.549 . . . . 0.0 119.473 -162.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttm-85 -93.22 150.58 20.39 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.692 1.746 . . . . 0.0 110.587 169.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.0 t -56.18 152.32 10.99 Favored 'General case' 0 N--CA 1.501 2.12 0 O-C-N 120.69 -1.256 . . . . 0.0 113.913 171.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.02 134.09 30.13 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.796 0 CA-C-O 121.49 0.662 . . . . 0.0 109.414 166.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 65.2 29.77 11.67 Favored 'General case' 0 CA--C 1.576 1.975 0 N-CA-C 117.717 2.488 . . . . 0.0 117.717 -155.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.37 48.77 2.38 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 119.413 2.525 . . . . 0.0 119.413 -170.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.94 102.02 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 166.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -71.76 105.72 3.86 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 123.181 0.592 . . . . 0.0 110.801 176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 138.29 -51.65 0.77 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-O 119.6 -0.555 . . . . 0.0 114.139 -158.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -79.5 134.58 36.52 Favored 'General case' 0 CA--C 1.57 1.722 0 CA-C-N 118.179 0.99 . . . . 0.0 111.899 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -82.94 98.54 9.27 Favored 'General case' 0 CA--C 1.567 1.604 0 O-C-N 121.651 -0.656 . . . . 0.0 111.257 174.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -84.09 163.16 20.02 Favored 'General case' 0 CA--C 1.571 1.782 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 177.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 72.3 p -71.87 161.56 30.76 Favored 'General case' 0 CA--C 1.57 1.728 0 N-CA-C 114.822 1.415 . . . . 0.0 114.822 174.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -56.7 -51.74 79.02 Favored Pre-proline 0 CA--C 1.578 2.022 0 N-CA-C 116.232 1.938 . . . . 0.0 116.232 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -68.94 -22.29 36.18 Favored 'Trans proline' 0 CA--C 1.571 2.33 0 CA-C-N 123.889 2.425 . . . . 0.0 117.031 172.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 1.4 tpt -63.38 -51.27 66.54 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 161.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -61.09 -42.8 99.18 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 115.654 1.724 . . . . 0.0 115.654 170.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.81 -15.59 63.03 Favored 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 170.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -67.21 -64.47 0.85 Allowed 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 120.495 1.498 . . . . 0.0 112.702 167.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 68.93 -127.3 21.95 Favored Glycine 0 N--CA 1.489 2.222 0 CA-C-N 119.317 0.962 . . . . 0.0 114.101 -174.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.46 -123.4 33.22 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 116.024 1.17 . . . . 0.0 116.024 168.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 m-20 -154.57 152.29 29.86 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 122.234 1.016 . . . . 0.0 113.722 169.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.5 m95 -79.6 84.94 5.39 Favored 'General case' 0 CA--C 1.561 1.394 0 CA-C-O 122.197 0.999 . . . . 0.0 112.508 161.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.1 p -73.82 158.34 86.16 Favored Pre-proline 0 CA--C 1.576 1.976 0 C-N-CA 123.774 0.83 . . . . 0.0 113.227 174.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -66.79 20.62 0.1 Allowed 'Trans proline' 0 CA--C 1.581 2.869 0 N-CA-C 119.122 2.701 . . . . 0.0 119.122 170.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -131.08 -41.19 1.13 Allowed 'General case' 0 CA--C 1.573 1.827 0 C-N-CA 126.272 1.829 . . . . 0.0 111.225 172.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.27 -46.02 83.49 Favored 'General case' 0 CA--C 1.566 1.567 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 161.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.6 mt -59.19 -36.21 74.93 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 165.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 61.8 mt-30 -67.51 -27.55 67.08 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 116.691 2.108 . . . . 0.0 116.691 172.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -79.24 -50.78 10.4 Favored 'General case' 0 CA--C 1.57 1.745 0 C-N-CA 124.303 1.041 . . . . 0.0 112.199 165.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -60.12 -47.14 87.13 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 115.344 1.609 . . . . 0.0 115.344 176.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.96 -16.15 60.87 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 117.843 2.534 . . . . 0.0 117.843 175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 55.1 m -94.93 -34.2 12.49 Favored 'General case' 0 N--CA 1.499 1.975 0 N-CA-C 115.233 1.568 . . . . 0.0 115.233 168.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.08 82.87 35.17 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.596 1.544 . . . . 0.0 107.868 171.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -57.16 -43.73 50.34 Favored 'Trans proline' 0 C--N 1.375 1.936 0 C-N-CA 123.484 2.789 . . . . 0.0 117.485 -177.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -79.93 2.59 22.88 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 170.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.71 -45.39 13.45 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 120.627 1.558 . . . . 0.0 114.024 161.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.0 t -73.23 -52.03 23.51 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.892 0 CA-C-N 119.139 0.881 . . . . 0.0 111.889 172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 54.8 t -110.05 85.17 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 CA-C-N 119.846 1.203 . . . . 0.0 107.829 172.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 111.37 3.57 Favored 'General case' 0 CA--C 1.568 1.653 0 O-C-N 121.06 -1.025 . . . . 0.0 112.375 175.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.37 36.4 7.53 Favored Glycine 0 CA--C 1.555 2.556 0 N-CA-C 117.867 1.907 . . . . 0.0 117.867 -160.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.46 133.13 37.49 Favored 'General case' 0 CA--C 1.559 1.294 0 CA-C-N 118.976 1.388 . . . . 0.0 109.857 162.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -73.25 22.1 0.07 Allowed 'General case' 0 CA--C 1.58 2.096 0 N-CA-C 116.263 1.949 . . . . 0.0 116.263 163.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -89.19 105.77 18.0 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.98 -1.075 . . . . 0.0 108.977 172.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.39 70.72 4.79 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.601 1.191 . . . . 0.0 113.252 176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -136.5 129.8 31.55 Favored 'General case' 0 CA--C 1.561 1.381 0 C-N-CA 124.037 0.935 . . . . 0.0 108.933 -175.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.61 -38.18 40.49 Favored 'General case' 0 CA--C 1.562 1.428 0 N-CA-C 116.384 1.994 . . . . 0.0 116.384 -178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 143.99 140.27 3.61 Favored Glycine 0 CA--C 1.546 1.977 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 -174.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 62.5 mt -79.84 134.35 57.08 Favored Pre-proline 0 CA--C 1.574 1.877 0 CA-C-O 118.263 -0.875 . . . . 0.0 112.762 164.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -82.25 -54.83 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 2.016 0 C-N-CA 122.441 2.094 . . . . 0.0 116.159 -172.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -84.92 149.11 25.87 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-N 119.525 1.057 . . . . 0.0 112.061 -176.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.37 -39.93 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 N-CA-C 113.95 1.092 . . . . 0.0 113.95 166.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -60.87 -32.63 72.05 Favored 'General case' 0 CA--C 1.564 1.519 0 N-CA-C 115.829 1.789 . . . . 0.0 115.829 168.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -61.68 -57.83 10.43 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.18 1.809 . . . . 0.0 113.343 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.0 OUTLIER -63.63 -43.32 97.17 Favored 'General case' 0 CA--C 1.564 1.512 0 N-CA-C 116.507 2.039 . . . . 0.0 116.507 170.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -59.14 -43.84 92.03 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 171.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -59.22 -50.26 74.68 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 168.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -54.94 -45.61 74.86 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 116.114 1.894 . . . . 0.0 116.114 167.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 53.9 mt -60.48 -43.66 94.7 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 119.685 1.13 . . . . 0.0 113.093 173.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.23 -43.62 74.72 Favored 'General case' 0 CA--C 1.573 1.83 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 164.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -49.51 75.74 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 166.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 93.3 mt -64.06 -30.09 71.19 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -63.07 -50.69 69.58 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 114.438 1.274 . . . . 0.0 114.438 165.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -66.34 -37.08 92.51 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 118.862 2.305 . . . . 0.0 118.862 174.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -89.87 91.75 8.74 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 118.016 0.908 . . . . 0.0 109.318 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 . . . . . 0 C--O 1.255 1.344 0 C-N-CA 124.152 0.981 . . . . 0.0 111.166 -171.023 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.661 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 80.3 mmm . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 121.094 0.474 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -117.33 74.54 0.93 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 121.441 0.638 . . . . 0.0 111.421 175.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -107.15 101.71 39.63 Favored Pre-proline 0 CA--C 1.568 1.642 0 O-C-N 121.452 -0.78 . . . . 0.0 109.244 -177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -70.53 -30.08 19.26 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 122.614 2.209 . . . . 0.0 117.202 -173.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.28 -42.48 99.38 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 167.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.04 -31.57 71.99 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 163.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -66.06 -21.45 69.82 Favored Glycine 0 CA--C 1.548 2.123 0 N-CA-C 119.035 2.374 . . . . 0.0 119.035 166.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.77 -45.04 76.04 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 119.574 1.687 . . . . 0.0 113.719 169.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -65.24 -34.33 78.1 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 168.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -62.5 -45.48 98.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 119.449 1.022 . . . . 0.0 113.048 162.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -57.7 -24.4 56.63 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.193 2.294 . . . . 0.0 117.193 167.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.39 -34.05 53.99 Favored Glycine 0 CA--C 1.555 2.565 0 N-CA-C 118.887 2.315 . . . . 0.0 118.887 165.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -67.96 -36.45 80.09 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 164.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.9 m -71.92 -39.59 69.37 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 116.602 2.075 . . . . 0.0 116.602 170.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.5 ptmt -74.45 -9.17 58.33 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 119.761 3.245 . . . . 0.0 119.761 -162.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.39 -33.42 73.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 115.883 1.809 . . . . 0.0 115.883 155.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 28.7 m -96.32 -44.67 7.13 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 170.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -109.73 135.7 50.25 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 120.122 1.328 . . . . 0.0 113.573 -170.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.92 -51.64 4.78 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 115.95 1.833 . . . . 0.0 115.95 -173.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.327 17.0 mt 85.9 -49.4 0.07 Allowed 'General case' 0 N--CA 1.508 2.457 0 C-N-CA 124.853 1.261 . . . . 0.0 112.92 -158.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -82.42 64.89 7.29 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 113.418 0.896 . . . . 0.0 113.418 -172.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 59.8 16.8 40.19 Favored Glycine 0 N--CA 1.494 2.557 0 N-CA-C 121.623 3.409 . . . . 0.0 121.623 172.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -134.34 158.81 42.86 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.477 1.639 . . . . 0.0 110.926 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -110.04 -80.25 0.58 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.386 -172.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.66 -93.85 1.83 Allowed Glycine 0 N--CA 1.49 2.29 0 O-C-N 120.897 -1.127 . . . . 0.0 113.767 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 54.3 t -95.69 -64.54 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 166.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -99.76 142.46 15.96 Favored Glycine 0 CA--C 1.554 2.476 0 CA-C-O 118.569 -1.128 . . . . 0.0 114.411 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -67.96 151.21 78.1 Favored 'Trans proline' 0 CA--C 1.56 1.825 0 CA-C-N 121.85 2.825 . . . . 0.0 115.894 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -56.63 125.1 20.74 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -176.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 84.4 mt -95.74 25.45 4.62 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 115.169 1.544 . . . . 0.0 115.169 -171.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 46.7 p30 -70.02 88.74 0.59 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -172.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.74 50.19 15.21 Favored Glycine 0 CA--C 1.548 2.094 0 N-CA-C 115.677 1.031 . . . . 0.0 115.677 -160.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.4 p -68.43 -28.65 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 N-CA-C 115.662 1.727 . . . . 0.0 115.662 165.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.9 t -71.97 105.78 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 C-N-CA 124.175 0.99 . . . . 0.0 109.153 176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.05 2.08 69.27 Favored Glycine 0 CA--C 1.556 2.647 0 N-CA-C 119.406 2.522 . . . . 0.0 119.406 -163.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.5 ttm-85 -86.2 152.74 22.57 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.892 . . . . 0.0 110.888 169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.4 t -53.88 152.71 5.34 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.865 -1.147 . . . . 0.0 114.023 166.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.5 t -76.56 127.04 37.75 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.725 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 162.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.272 . . 66.74 76.3 0.3 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -160.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -154.25 58.56 0.4 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 117.336 1.695 . . . . 0.0 117.336 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 59.8 t -138.23 115.18 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 105.963 -1.865 . . . . 0.0 105.963 167.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.75 107.08 3.8 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.513 -0.742 . . . . 0.0 111.511 178.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.51 -42.56 1.19 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 116.259 1.263 . . . . 0.0 116.259 -165.302 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -91.79 143.61 26.34 Favored 'General case' 0 CA--C 1.57 1.721 0 CA-C-N 118.816 1.308 . . . . 0.0 113.898 -174.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -82.66 96.29 8.08 Favored 'General case' 0 CA--C 1.57 1.714 0 CA-C-O 121.542 0.687 . . . . 0.0 111.495 172.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -79.33 152.82 30.24 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 29.8 p -74.88 156.72 36.11 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -58.63 -47.39 98.83 Favored Pre-proline 0 CA--C 1.576 1.957 0 CA-C-O 115.741 -2.076 . . . . 0.0 116.532 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -67.43 -26.55 40.77 Favored 'Trans proline' 0 CA--C 1.571 2.362 0 CA-C-N 125.09 2.853 . . . . 0.0 116.793 169.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 2.0 tpt -63.63 -48.81 75.76 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 114.861 1.43 . . . . 0.0 114.861 165.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -61.64 -41.65 97.8 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 168.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.56 -21.11 66.6 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 169.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.6 t-80 -64.7 -64.76 0.79 Allowed 'General case' 0 CA--C 1.571 1.761 0 CA-C-N 120.37 1.441 . . . . 0.0 112.656 167.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.36 -125.62 24.13 Favored Glycine 0 N--CA 1.489 2.187 0 CA-C-N 119.366 0.984 . . . . 0.0 114.168 -175.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.64 -117.89 11.3 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 116.317 1.287 . . . . 0.0 116.317 166.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.7 m-20 -153.82 151.35 29.43 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 170.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.2 m95 -80.35 84.29 6.02 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-O 122.238 1.018 . . . . 0.0 112.167 156.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.4 p -75.75 158.44 82.82 Favored Pre-proline 0 CA--C 1.576 1.965 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 176.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -70.43 39.71 0.32 Allowed 'Trans proline' 0 CA--C 1.58 2.811 0 C-N-CA 122.673 2.249 . . . . 0.0 117.799 168.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -143.15 -39.65 0.32 Allowed 'General case' 0 CA--C 1.573 1.861 0 C-N-CA 125.995 1.718 . . . . 0.0 111.107 159.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.02 -42.96 77.26 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 116.2 1.926 . . . . 0.0 116.2 165.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -61.29 -30.3 70.39 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.9 mp0 -60.79 -42.82 98.31 Favored 'General case' 0 N--CA 1.502 2.142 0 CA-C-N 121.497 1.953 . . . . 0.0 115.646 173.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -78.88 -43.48 24.86 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 168.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -60.13 -39.11 85.14 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.745 1.757 . . . . 0.0 115.745 173.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 66.6 mt -70.89 -4.09 22.59 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 118.023 2.601 . . . . 0.0 118.023 168.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 45.3 m -111.76 -40.01 4.41 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.489 1.495 . . . . 0.0 114.165 168.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -128.54 81.15 71.22 Favored Pre-proline 0 CA--C 1.578 2.056 0 CA-C-N 120.236 1.38 . . . . 0.0 107.952 170.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -53.29 -44.45 48.83 Favored 'Trans proline' 0 C--N 1.376 1.974 0 C-N-CA 123.92 3.08 . . . . 0.0 117.857 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.0 ptpt -75.23 -19.82 59.56 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.908 2.188 . . . . 0.0 116.908 173.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -66.39 -40.01 89.42 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 121.456 1.934 . . . . 0.0 115.666 168.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.0 t -75.91 -46.94 33.96 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.958 0 CA-C-O 118.683 -0.675 . . . . 0.0 112.491 170.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.0 t -116.37 96.94 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 CA-C-N 120.142 1.337 . . . . 0.0 107.709 175.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -71.09 90.4 0.86 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.874 1.321 . . . . 0.0 112.544 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 107.23 45.69 1.14 Allowed Glycine 0 CA--C 1.551 2.308 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.642 -165.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.7 t -79.64 139.38 37.44 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 118.674 1.237 . . . . 0.0 109.857 163.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 27.2 mmtt -69.25 14.66 0.08 Allowed 'General case' 0 CA--C 1.585 2.325 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 171.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.481 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.1 ttt -94.14 110.96 22.65 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.667 -1.271 . . . . 0.0 111.003 -175.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 67.66 6.99 Favored 'General case' 0 CA--C 1.569 1.696 0 CA-C-O 122.134 0.968 . . . . 0.0 113.579 174.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -127.21 129.29 47.53 Favored 'General case' 0 CA--C 1.561 1.387 0 C-N-CA 123.918 0.887 . . . . 0.0 110.185 -176.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.63 -16.12 57.72 Favored 'General case' 0 CA--C 1.567 1.597 0 N-CA-C 117.786 2.513 . . . . 0.0 117.786 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 111.09 151.33 12.18 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 117.344 1.698 . . . . 0.0 117.344 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 87.6 mt -88.01 136.98 31.63 Favored Pre-proline 0 CA--C 1.572 1.793 0 C-N-CA 123.98 0.912 . . . . 0.0 112.667 172.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -81.63 -53.66 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.403 2.069 . . . . 0.0 116.039 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -84.67 148.87 26.19 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.544 1.066 . . . . 0.0 111.771 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.261 0.3 OUTLIER -60.49 -36.47 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 O-C-N 121.008 -1.058 . . . . 0.0 113.758 168.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -61.18 -29.36 69.75 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 117.049 2.24 . . . . 0.0 117.049 166.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -61.31 -56.2 23.16 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 121.221 1.828 . . . . 0.0 113.351 172.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.262 0.0 OUTLIER -64.51 -44.45 90.86 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.523 2.046 . . . . 0.0 116.523 169.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.91 -42.86 90.65 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.236 2.31 . . . . 0.0 117.236 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -61.64 -46.2 90.79 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 168.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.56 -49.61 69.92 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 166.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.27 67.1 mt -62.05 -45.38 98.86 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 C-N-CA 124.36 1.064 . . . . 0.0 112.635 177.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.73 -41.34 73.77 Favored 'General case' 0 CA--C 1.573 1.829 0 N-CA-C 117.64 2.459 . . . . 0.0 117.64 163.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -54.75 -66.38 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 114.504 1.298 . . . . 0.0 114.504 168.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.333 0.7 OUTLIER -84.84 6.97 22.48 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 118.234 2.679 . . . . 0.0 118.234 -175.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -62.0 -54.07 46.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.401 -1.437 . . . . 0.0 113.888 142.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.82 -48.6 6.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 117.996 1.958 . . . . 0.0 117.996 176.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.87 100.92 13.64 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-N 118.385 1.092 . . . . 0.0 110.927 -177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 . . . . . 0 C--O 1.254 1.309 0 CA-C-O 118.018 -0.992 . . . . 0.0 110.887 -167.802 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.714 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 98.7 mmm . . . . . 0 N--CA 1.484 1.255 0 CA-C-O 121.213 0.53 . . . . 0.0 109.727 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -84.88 68.21 10.42 Favored 'General case' 0 CA--C 1.566 1.584 0 N-CA-C 114.552 1.315 . . . . 0.0 114.552 -175.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -126.33 89.5 52.11 Favored Pre-proline 0 N--CA 1.495 1.814 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.59 -27.76 7.26 Favored 'Trans proline' 0 CA--C 1.565 2.055 0 C-N-CA 122.435 2.09 . . . . 0.0 117.001 -172.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.83 -39.82 91.18 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.777 1.769 . . . . 0.0 115.777 167.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.94 -39.8 93.31 Favored 'General case' 0 CA--C 1.569 1.698 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 164.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.34 -27.99 71.6 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 118.844 2.298 . . . . 0.0 118.844 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -68.1 -37.49 81.22 Favored 'General case' 0 CA--C 1.57 1.712 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -45.36 94.24 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 113.818 1.044 . . . . 0.0 113.818 166.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.6 t -58.47 -43.32 86.55 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 166.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.2 t80 -57.54 -22.95 47.7 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 116.857 2.169 . . . . 0.0 116.857 166.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -55.99 -27.51 51.24 Favored Glycine 0 CA--C 1.558 2.726 0 N-CA-C 119.293 2.477 . . . . 0.0 119.293 164.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.56 -41.4 84.29 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 161.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.23 -37.6 69.12 Favored 'General case' 0 CA--C 1.571 1.766 0 N-CA-C 116.542 2.052 . . . . 0.0 116.542 175.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.7 pttt -60.58 -28.67 68.66 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 119.89 3.293 . . . . 0.0 119.89 -163.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.97 -36.15 82.54 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 167.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.9 m -87.19 -44.61 11.35 Favored 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.776 1.769 . . . . 0.0 115.776 169.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -113.47 131.7 55.94 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 119.831 1.196 . . . . 0.0 111.793 -172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -93.79 -39.95 10.46 Favored 'General case' 0 N--CA 1.499 1.981 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.577 3.4 pp 61.71 -17.17 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.217 0 N-CA-C 119.442 3.127 . . . . 0.0 119.442 -162.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -85.76 61.17 6.69 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.663 -1.273 . . . . 0.0 112.046 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.06 -60.01 2.67 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 116.867 1.507 . . . . 0.0 116.867 -175.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -75.24 164.18 26.73 Favored 'General case' 0 CA--C 1.569 1.7 0 CA-C-O 122.812 1.291 . . . . 0.0 113.714 -179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -89.76 -79.43 0.34 Allowed 'General case' 0 CA--C 1.567 1.619 0 CA-C-N 115.248 -0.887 . . . . 0.0 112.798 -169.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.0 -129.65 8.74 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 123.667 0.651 . . . . 0.0 112.805 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 23.6 t -84.14 -48.41 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.294 0 CA-C-O 119.009 -0.52 . . . . 0.0 110.84 163.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -89.07 -179.96 45.51 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 115.647 1.019 . . . . 0.0 115.647 163.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -67.06 176.2 4.81 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 C-N-CA 122.816 2.344 . . . . 0.0 115.941 171.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.72 139.43 55.37 Favored 'General case' 0 CA--C 1.576 1.968 0 O-C-N 120.567 -1.333 . . . . 0.0 112.415 163.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 83.4 mt -109.72 27.89 9.12 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.2 p30 -69.66 98.65 1.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.94 42.27 38.11 Favored Glycine 0 N--CA 1.485 1.938 0 N-CA-C 117.108 1.603 . . . . 0.0 117.108 -170.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.302 9.8 p -66.89 -24.82 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 52.8 t -71.14 108.11 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 119.374 0.988 . . . . 0.0 109.818 174.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.15 33.56 23.08 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 117.911 1.925 . . . . 0.0 117.911 -165.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.3 ttp85 -131.18 143.99 51.02 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 118.952 1.376 . . . . 0.0 110.41 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.303 0.6 OUTLIER -59.31 147.58 35.36 Favored 'General case' 0 N--CA 1.498 1.939 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 -171.049 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 40.9 t -80.03 122.38 35.13 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.602 0 CA-C-O 121.621 0.724 . . . . 0.0 109.445 176.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.327 . . 72.14 15.65 5.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 120.252 3.427 . . . . 0.0 120.252 -177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -102.37 82.78 0.44 Allowed Glycine 0 N--CA 1.489 2.198 0 O-C-N 120.84 -1.162 . . . . 0.0 114.237 176.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 96.7 t -135.13 114.19 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 N-CA-C 106.546 -1.65 . . . . 0.0 106.546 168.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -74.41 96.73 2.93 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 121.487 0.661 . . . . 0.0 110.355 173.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.61 -50.6 0.62 Allowed Glycine 0 N--CA 1.489 2.171 0 CA-C-O 119.356 -0.691 . . . . 0.0 114.59 -158.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -104.22 125.88 50.86 Favored 'General case' 0 CA--C 1.566 1.587 0 CA-C-N 118.239 1.02 . . . . 0.0 110.881 176.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 34.0 t30 -85.78 124.31 32.13 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 121.514 0.673 . . . . 0.0 111.255 170.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -100.59 177.82 4.9 Favored 'General case' 0 CA--C 1.573 1.839 0 C-N-CA 123.641 0.776 . . . . 0.0 112.749 -177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -74.96 163.12 27.96 Favored 'General case' 0 CA--C 1.571 1.752 0 O-C-N 120.309 -1.494 . . . . 0.0 114.188 170.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -60.24 -49.19 91.81 Favored Pre-proline 0 CA--C 1.578 2.027 0 CA-C-O 116.031 -1.937 . . . . 0.0 115.915 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -67.62 -22.21 44.54 Favored 'Trans proline' 0 CA--C 1.57 2.31 0 CA-C-N 124.909 2.789 . . . . 0.0 117.128 170.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -57.82 10.53 Favored 'General case' 0 CA--C 1.569 1.681 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 158.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.96 -37.65 88.34 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 178.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.01 -17.84 63.72 Favored 'General case' 0 CA--C 1.571 1.773 0 N-CA-C 118.518 2.785 . . . . 0.0 118.518 166.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -69.32 -66.88 0.53 Allowed 'General case' 0 CA--C 1.57 1.723 0 CA-C-N 120.714 1.597 . . . . 0.0 112.401 168.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.69 -130.26 30.96 Favored Glycine 0 N--CA 1.49 2.266 0 CA-C-N 119.556 1.071 . . . . 0.0 114.263 -174.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 61.08 -125.21 37.42 Favored Glycine 0 N--CA 1.494 2.509 0 O-C-N 121.164 -1.198 . . . . 0.0 115.046 168.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -151.16 151.82 32.47 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 168.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.4 m95 -77.51 89.53 3.86 Favored 'General case' 0 CA--C 1.561 1.384 0 CA-C-O 121.975 0.893 . . . . 0.0 112.658 165.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.8 p -74.58 156.03 87.07 Favored Pre-proline 0 CA--C 1.577 1.989 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_endo -65.08 12.22 0.11 Allowed 'Trans proline' 0 CA--C 1.581 2.864 0 N-CA-C 119.722 2.932 . . . . 0.0 119.722 171.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -116.97 -50.86 2.58 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 125.871 1.669 . . . . 0.0 110.165 169.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.37 -42.16 73.58 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 116.228 1.936 . . . . 0.0 116.228 169.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.1 mt -57.93 -36.02 71.92 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.398 1.999 . . . . 0.0 116.398 162.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 36.7 mt-30 -70.43 -24.77 62.96 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 117.149 2.277 . . . . 0.0 117.149 173.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -78.7 -51.89 9.19 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 161.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -60.07 -41.91 93.41 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 116.155 1.909 . . . . 0.0 116.155 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 87.7 mt -68.82 -3.49 12.64 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.1 m -110.63 -35.05 6.11 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 120.394 1.452 . . . . 0.0 114.488 167.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.86 82.15 56.28 Favored Pre-proline 0 CA--C 1.577 2.004 0 CA-C-N 120.552 1.523 . . . . 0.0 107.837 169.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.06 -46.65 31.98 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.781 2.988 . . . . 0.0 117.177 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -80.57 7.08 10.78 Favored 'General case' 0 CA--C 1.577 2.015 0 N-CA-C 117.804 2.52 . . . . 0.0 117.804 171.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -87.29 -42.29 13.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.272 -1.518 . . . . 0.0 114.207 159.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 70.7 t -75.58 -55.74 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 CA-C-N 118.962 0.801 . . . . 0.0 111.326 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 49.1 t -105.32 86.02 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 170.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.441 ' H ' ' HD2' ' A' ' 74' ' ' LYS . 0.0 OUTLIER -68.99 110.6 4.52 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.43 1.109 . . . . 0.0 111.991 177.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 93.05 35.2 6.43 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.69 1.836 . . . . 0.0 117.69 -160.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.3 t -78.86 138.4 38.13 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 119.685 1.742 . . . . 0.0 110.274 163.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -74.94 20.53 0.13 Allowed 'General case' 0 CA--C 1.581 2.141 0 N-CA-C 115.444 1.646 . . . . 0.0 115.444 165.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.475 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.2 ttt -89.41 107.08 18.86 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.447 -1.408 . . . . 0.0 109.54 177.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.36 67.16 5.02 Favored 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.328 1.061 . . . . 0.0 113.649 177.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -128.44 125.17 37.99 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 123.869 0.867 . . . . 0.0 109.57 -174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.83 -14.38 60.29 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 117.669 2.47 . . . . 0.0 117.669 178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 107.26 151.51 17.57 Favored Glycine 0 CA--C 1.546 1.984 0 N-CA-C 117.158 1.623 . . . . 0.0 117.158 176.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 91.0 mt -86.78 138.28 33.34 Favored Pre-proline 0 CA--C 1.571 1.773 0 C-N-CA 123.854 0.862 . . . . 0.0 112.945 174.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.79 -53.3 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.024 0 C-N-CA 122.366 2.044 . . . . 0.0 115.963 -175.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -83.08 147.11 28.31 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 119.628 1.104 . . . . 0.0 112.014 -176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.73 -39.03 53.43 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.257 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 163.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -56.65 -34.65 67.53 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 116.354 1.983 . . . . 0.0 116.354 167.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -63.62 -57.76 9.07 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 120.38 1.445 . . . . 0.0 113.67 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -42.94 96.87 Favored 'General case' 0 CA--C 1.565 1.537 0 N-CA-C 116.626 2.084 . . . . 0.0 116.626 171.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -56.06 -46.93 78.8 Favored 'General case' 0 CA--C 1.569 1.689 0 N-CA-C 117.196 2.295 . . . . 0.0 117.196 168.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -62.73 -42.85 99.86 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 169.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -53.12 -48.65 67.69 Favored 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 165.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . 0.255 40.8 mt -55.73 -48.8 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.916 0 C-N-CA 124.562 1.145 . . . . 0.0 113.162 170.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.52 -42.92 83.79 Favored 'General case' 0 CA--C 1.571 1.787 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 168.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 61.9 t80 -49.57 -66.0 0.47 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 114.642 1.349 . . . . 0.0 114.642 165.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . 0.35 0.6 OUTLIER -88.72 7.06 35.71 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 118.384 2.735 . . . . 0.0 118.384 -174.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -64.35 -47.94 77.42 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.359 -1.463 . . . . 0.0 114.192 142.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -80.61 -58.65 2.65 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 116.689 1.435 . . . . 0.0 116.689 174.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.0 tt0 -82.32 93.87 7.24 Favored 'General case' 0 N--CA 1.488 1.443 0 CA-C-N 117.834 0.817 . . . . 0.0 111.239 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 . . . . . 0 N--CA 1.483 1.216 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.926 -173.318 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.689 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.7 mmt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.167 0.508 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -115.6 82.37 1.75 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.445 -0.785 . . . . 0.0 112.405 -172.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -114.82 100.22 53.1 Favored Pre-proline 0 CA--C 1.57 1.733 0 CA-C-O 118.345 -0.836 . . . . 0.0 109.206 -175.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.58 -29.84 12.74 Favored 'Trans proline' 0 CA--C 1.565 2.057 0 C-N-CA 122.654 2.236 . . . . 0.0 117.529 -174.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.61 94.25 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.47 1.655 . . . . 0.0 115.47 168.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.36 -39.0 91.71 Favored 'General case' 0 CA--C 1.568 1.65 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 164.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -60.35 -23.92 60.74 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 119.243 2.457 . . . . 0.0 119.243 168.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.71 -41.21 88.35 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 168.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.38 -33.4 69.48 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 115.767 1.765 . . . . 0.0 115.767 168.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -65.36 -42.16 92.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.211 0 CA-C-N 120.024 1.284 . . . . 0.0 113.165 165.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -56.73 -24.05 46.88 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 117.052 2.241 . . . . 0.0 117.052 165.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.58 -32.49 46.39 Favored Glycine 0 CA--C 1.557 2.701 0 N-CA-C 119.256 2.462 . . . . 0.0 119.256 168.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.8 mppt? -64.0 -36.25 83.36 Favored 'General case' 0 CA--C 1.576 1.971 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 163.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 m -72.35 -34.87 68.32 Favored 'General case' 0 CA--C 1.575 1.909 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 168.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -53.54 -29.83 38.77 Favored 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 119.239 3.051 . . . . 0.0 119.239 -173.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.02 -32.23 70.69 Favored 'General case' 0 CA--C 1.57 1.733 0 N-CA-C 116.607 2.077 . . . . 0.0 116.607 167.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.7 m -101.19 -39.79 7.48 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 116.189 1.922 . . . . 0.0 116.189 171.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 92.0 m-70 -113.09 133.96 54.76 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 120.278 1.399 . . . . 0.0 112.104 -171.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.7 mmmm -96.08 -51.22 4.52 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 116.062 1.875 . . . . 0.0 116.062 -173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.315 22.2 mt 87.2 -46.11 0.04 OUTLIER 'General case' 0 N--CA 1.507 2.393 0 C-N-CA 125.148 1.379 . . . . 0.0 113.944 -161.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -86.8 62.23 7.27 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -162.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.22 -45.63 2.84 Favored Glycine 0 N--CA 1.496 2.684 0 N-CA-C 118.726 2.25 . . . . 0.0 118.726 172.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -86.12 160.33 19.28 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 123.077 1.418 . . . . 0.0 113.637 165.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -85.1 -74.12 0.41 Allowed 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.611 -167.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.9 -129.45 8.13 Favored Glycine 0 N--CA 1.488 2.151 0 C-N-CA 123.92 0.771 . . . . 0.0 112.451 -175.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.5 t -88.02 -53.73 9.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 O-C-N 122.321 -0.517 . . . . 0.0 109.778 163.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -83.08 -179.04 52.51 Favored Glycine 0 CA--C 1.555 2.584 0 N-CA-C 115.652 1.021 . . . . 0.0 115.652 161.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.35 168.92 18.13 Favored 'Trans proline' 0 CA--C 1.563 1.94 0 CA-C-N 120.584 2.192 . . . . 0.0 116.099 171.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -69.59 125.1 25.68 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.807 -1.183 . . . . 0.0 111.378 161.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 77.1 mt -92.54 26.26 2.72 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -176.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 35.8 p30 -66.55 95.66 0.34 Allowed 'General case' 0 CA--C 1.565 1.554 0 C-N-CA 124.492 1.117 . . . . 0.0 113.867 -174.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.44 42.49 33.73 Favored Glycine 0 N--CA 1.486 1.996 0 N-CA-C 117.223 1.649 . . . . 0.0 117.223 -167.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.272 9.1 p -69.9 -24.97 27.16 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.181 0 N-CA-C 116.923 2.194 . . . . 0.0 116.923 176.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.6 t -72.22 107.64 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 119.39 0.996 . . . . 0.0 109.514 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.18 30.97 26.79 Favored Glycine 0 CA--C 1.554 2.513 0 N-CA-C 118.083 1.993 . . . . 0.0 118.083 -163.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 20.7 ttp85 -132.24 150.34 52.18 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.118 1.459 . . . . 0.0 110.998 -176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.32 0.6 OUTLIER -61.41 151.14 33.31 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 117.153 2.279 . . . . 0.0 117.153 -167.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -86.82 106.1 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.233 174.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.268 . . 77.75 98.45 0.06 Allowed 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 124.606 1.162 . . . . 0.0 113.75 -169.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 157.43 83.12 0.04 OUTLIER Glycine 0 N--CA 1.486 2.006 0 CA-C-O 119.311 -0.716 . . . . 0.0 112.97 172.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.58 141.04 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 118.191 0.996 . . . . 0.0 109.873 175.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . 0.332 2.4 t70 60.88 -150.84 0.4 Allowed 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 114.53 1.308 . . . . 0.0 114.53 167.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -94.24 41.37 2.6 Favored Glycine 0 N--CA 1.488 2.143 0 O-C-N 121.197 -0.939 . . . . 0.0 114.875 151.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -86.73 121.5 29.33 Favored 'General case' 0 CA--C 1.565 1.544 0 CA-C-N 118.833 1.316 . . . . 0.0 111.433 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -76.67 111.92 12.67 Favored 'General case' 0 CA--C 1.566 1.582 0 O-C-N 121.856 -0.527 . . . . 0.0 111.086 171.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -92.98 161.62 14.38 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.067 0.937 . . . . 0.0 112.286 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 51.4 p -69.29 156.69 38.36 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 177.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -54.93 -47.69 97.76 Favored Pre-proline 0 CA--C 1.577 2.017 0 CA-C-O 115.719 -2.086 . . . . 0.0 116.412 173.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -66.82 -27.57 43.87 Favored 'Trans proline' 0 CA--C 1.568 2.202 0 CA-C-N 125.217 2.899 . . . . 0.0 117.088 171.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 27.6 tpp -64.16 -49.96 70.04 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-N 119.426 1.012 . . . . 0.0 113.643 165.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.2 mttt -60.46 -43.08 97.26 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 115.586 1.699 . . . . 0.0 115.586 169.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.79 -26.02 68.17 Favored 'General case' 0 CA--C 1.568 1.669 0 N-CA-C 117.92 2.563 . . . . 0.0 117.92 168.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.31 -68.96 0.33 Allowed 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 119.924 1.238 . . . . 0.0 112.182 165.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.87 -158.92 46.87 Favored Glycine 0 CA--C 1.552 2.36 0 CA-C-N 119.84 1.2 . . . . 0.0 115.973 -174.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 79.35 -116.73 4.37 Favored Glycine 0 N--CA 1.49 2.237 0 O-C-N 120.847 -1.384 . . . . 0.0 113.261 173.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -154.58 149.95 27.21 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 118.547 1.174 . . . . 0.0 113.819 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.2 m95 -83.24 88.58 6.93 Favored 'General case' 0 CA--C 1.562 1.416 0 CA-C-O 121.717 0.77 . . . . 0.0 112.742 171.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -75.35 156.52 85.42 Favored Pre-proline 0 CA--C 1.583 2.239 0 CA-C-O 118.322 -0.847 . . . . 0.0 113.192 178.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.2 13.9 0.12 Allowed 'Trans proline' 0 CA--C 1.579 2.763 0 N-CA-C 120.038 3.053 . . . . 0.0 120.038 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -122.74 -43.04 2.28 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.766 1.626 . . . . 0.0 111.336 168.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.21 -44.01 71.29 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 115.955 1.835 . . . . 0.0 115.955 163.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 71.6 mt -59.29 -33.21 70.81 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 116.389 1.996 . . . . 0.0 116.389 162.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -66.29 -44.76 82.6 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 121.656 2.026 . . . . 0.0 115.019 171.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mm-40 -65.92 -44.61 84.66 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 168.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -62.71 -49.38 75.31 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.9 mt -63.51 -26.47 68.73 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 121.498 1.954 . . . . 0.0 116.219 169.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.3 m -68.94 -44.23 73.44 Favored 'General case' 0 N--CA 1.502 2.133 0 CA-C-N 121.271 1.85 . . . . 0.0 115.198 165.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -148.03 85.45 6.45 Favored Pre-proline 0 CA--C 1.576 1.977 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 -174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_exo -56.56 -42.67 62.85 Favored 'Trans proline' 0 C--N 1.371 1.763 0 C-N-CA 123.641 2.894 . . . . 0.0 117.776 -175.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -78.53 -5.25 52.15 Favored 'General case' 0 CA--C 1.574 1.881 0 N-CA-C 117.694 2.479 . . . . 0.0 117.694 169.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.35 -40.6 62.04 Favored 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 121.119 1.781 . . . . 0.0 114.813 161.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.8 t -81.97 -55.88 7.06 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.899 0 CA-C-N 119.122 0.874 . . . . 0.0 111.61 172.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 65.2 t -103.94 87.18 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 CA-C-N 120.42 1.463 . . . . 0.0 108.02 175.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.0 tptt -69.04 108.21 3.46 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.956 -1.09 . . . . 0.0 112.669 -175.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 91.26 37.27 6.3 Favored Glycine 0 CA--C 1.55 2.262 0 N-CA-C 117.518 1.767 . . . . 0.0 117.518 -166.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.2 t -72.47 144.15 48.18 Favored 'General case' 0 CA--C 1.562 1.413 0 CA-C-N 119.357 1.579 . . . . 0.0 112.503 172.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -68.91 2.44 2.63 Favored 'General case' 0 CA--C 1.578 2.045 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 161.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -80.31 101.69 9.08 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 120.273 1.397 . . . . 0.0 109.796 174.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.99 72.4 4.52 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.85 1.31 . . . . 0.0 112.892 176.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.97 132.56 32.49 Favored 'General case' 0 CA--C 1.562 1.41 0 C-N-CA 124.336 1.055 . . . . 0.0 108.494 -175.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.76 -41.21 27.08 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 116.209 1.929 . . . . 0.0 116.209 -178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 149.2 139.93 3.19 Favored Glycine 0 N--CA 1.485 1.913 0 N-CA-C 117.0 1.56 . . . . 0.0 117.0 -171.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 37.2 mt -85.44 123.84 72.37 Favored Pre-proline 0 CA--C 1.569 1.677 0 CA-C-O 117.985 -1.007 . . . . 0.0 111.796 166.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -83.28 -41.41 0.1 OUTLIER 'Trans proline' 0 CA--C 1.563 1.943 0 C-N-CA 122.536 2.157 . . . . 0.0 117.372 -166.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -88.55 148.16 24.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.091 1.314 . . . . 0.0 111.786 177.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -53.45 -40.92 42.88 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 164.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -57.06 -36.64 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 116.095 1.887 . . . . 0.0 116.095 166.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -62.3 -56.24 20.39 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 121.048 1.749 . . . . 0.0 113.875 179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.43 78.1 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 116.181 1.919 . . . . 0.0 116.181 171.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.61 -42.59 88.53 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.487 2.403 . . . . 0.0 117.487 171.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -62.24 -46.07 90.49 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 169.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.3 tt -59.33 -43.42 92.73 Favored 'General case' 0 CA--C 1.576 1.955 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 169.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 55.6 mt -58.8 -45.47 91.38 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.603 -1.311 . . . . 0.0 113.501 169.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.21 -43.9 83.2 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.964 2.209 . . . . 0.0 116.964 167.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -51.02 -53.79 30.35 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 160.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.7 mt -65.05 -27.27 68.68 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -65.55 -51.51 59.29 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 163.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -76.04 -58.57 3.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 117.212 1.645 . . . . 0.0 117.212 176.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -86.46 115.74 24.16 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.408 0.683 . . . . 0.0 110.717 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 . . . . . 0 C--O 1.253 1.252 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -173.532 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.662 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.5 mtp . . . . . 0 N--CA 1.489 1.49 0 CA-C-O 118.91 -0.567 . . . . 0.0 111.21 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -126.3 76.07 1.58 Allowed 'General case' 0 N--CA 1.49 1.574 0 CA-C-N 119.027 0.83 . . . . 0.0 111.638 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -106.94 103.61 48.25 Favored Pre-proline 0 CA--C 1.57 1.728 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.252 -177.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -69.92 -29.75 22.61 Favored 'Trans proline' 0 CA--C 1.568 2.191 0 C-N-CA 122.679 2.253 . . . . 0.0 117.534 -175.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.82 -36.26 83.31 Favored 'General case' 0 CA--C 1.569 1.687 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 166.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.82 -27.04 65.5 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 160.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.49 -34.36 88.96 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 118.502 2.161 . . . . 0.0 118.502 173.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . 0.26 0.6 OUTLIER -64.31 -28.38 69.68 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.614 2.079 . . . . 0.0 116.614 163.672 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -67.03 -49.18 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.887 0.875 . . . . 0.0 113.179 166.147 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.7 t -58.08 -37.72 63.39 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 114.371 1.249 . . . . 0.0 114.371 170.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -53.28 -23.68 9.64 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 117.444 2.386 . . . . 0.0 117.444 164.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.33 -30.39 40.3 Favored Glycine 0 CA--C 1.558 2.736 0 N-CA-C 119.58 2.592 . . . . 0.0 119.58 166.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.3 mtmm -69.98 -33.3 71.89 Favored 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 164.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -79.03 -34.92 43.44 Favored 'General case' 0 CA--C 1.571 1.774 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 172.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 59.3 pttt -59.19 -30.54 68.28 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 119.745 3.239 . . . . 0.0 119.745 -165.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.1 -34.9 77.18 Favored 'General case' 0 CA--C 1.568 1.639 0 N-CA-C 116.199 1.925 . . . . 0.0 116.199 169.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.4 m -90.3 -40.45 12.12 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 116.202 1.927 . . . . 0.0 116.202 168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -117.95 149.13 41.42 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 120.06 1.3 . . . . 0.0 113.177 -170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -121.26 146.26 47.0 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.065 0.936 . . . . 0.0 111.956 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 22.2 mt -95.55 17.21 15.22 Favored 'General case' 0 N--CA 1.501 2.101 0 N-CA-C 116.493 2.035 . . . . 0.0 116.493 172.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 -129.65 58.4 1.64 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.35 -1.469 . . . . 0.0 111.781 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.84 -42.62 1.83 Allowed Glycine 0 N--CA 1.497 2.711 0 N-CA-C 118.253 2.061 . . . . 0.0 118.253 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -70.73 160.6 32.37 Favored 'General case' 0 CA--C 1.569 1.698 0 C-N-CA 124.37 1.068 . . . . 0.0 113.804 -174.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -102.33 -87.46 0.41 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 0.0 110.187 -173.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.07 -113.36 2.93 Favored Glycine 0 N--CA 1.49 2.259 0 CA-C-N 118.986 0.812 . . . . 0.0 112.393 -178.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.2 t -95.08 -49.14 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-O 118.93 -0.557 . . . . 0.0 110.403 166.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.37 -179.23 46.77 Favored Glycine 0 CA--C 1.555 2.589 0 N-CA-C 115.707 1.043 . . . . 0.0 115.707 163.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -68.33 179.51 2.91 Favored 'Trans proline' 0 CA--C 1.568 2.183 0 CA-C-N 120.786 2.293 . . . . 0.0 115.145 172.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -66.23 143.15 57.41 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.4 -1.437 . . . . 0.0 113.136 166.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 80.9 mt -105.59 4.95 30.86 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 116.696 2.109 . . . . 0.0 116.696 174.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 10.3 p-10 -74.89 119.33 18.92 Favored 'General case' 0 CA--C 1.566 1.596 0 CA-C-N 120.335 1.425 . . . . 0.0 110.987 169.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.27 49.48 8.34 Favored Glycine 0 CA--C 1.542 1.751 0 CA-C-O 118.649 -1.084 . . . . 0.0 115.644 -166.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 p -103.6 -35.47 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 N-CA-C 115.914 1.82 . . . . 0.0 115.914 177.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 49.1 t -74.41 110.06 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 CA-C-N 121.001 1.728 . . . . 0.0 108.898 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.9 68.56 Favored Glycine 0 CA--C 1.556 2.63 0 N-CA-C 118.911 2.324 . . . . 0.0 118.911 -161.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.4 ttm180 -91.02 148.23 22.54 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 119.615 1.708 . . . . 0.0 110.569 167.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.4 t -52.27 153.2 2.95 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 166.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' CE2' ' A' ' 57' ' ' TRP . 39.0 t -81.61 117.29 27.35 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . 70.64 90.43 0.09 Allowed 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 124.539 1.136 . . . . 0.0 113.922 -164.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.65 70.81 0.1 OUTLIER Glycine 0 N--CA 1.488 2.129 0 N-CA-C 115.237 0.855 . . . . 0.0 115.237 177.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 85.8 t -142.81 115.44 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 174.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -70.21 101.59 1.91 Allowed 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 123.145 0.578 . . . . 0.0 111.533 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.18 -51.15 0.8 Allowed Glycine 0 N--CA 1.489 2.192 0 CA-C-O 119.157 -0.802 . . . . 0.0 114.893 -162.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -88.05 129.78 35.18 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 118.601 1.2 . . . . 0.0 112.472 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -86.96 111.94 21.33 Favored 'General case' 0 CA--C 1.568 1.651 0 O-C-N 121.76 -0.588 . . . . 0.0 110.91 172.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.1 163.21 14.04 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 121.496 0.665 . . . . 0.0 112.698 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 52.3 p -70.53 158.85 35.38 Favored 'General case' 0 CA--C 1.567 1.606 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 176.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.5 -50.87 84.39 Favored Pre-proline 0 CA--C 1.578 2.035 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.34 -22.62 29.19 Favored 'Trans proline' 0 CA--C 1.571 2.345 0 CA-C-N 123.761 2.379 . . . . 0.0 116.989 172.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -62.47 -49.96 73.35 Favored 'General case' 0 CA--C 1.571 1.768 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 161.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 63.2 mttt -62.15 -40.13 94.96 Favored 'General case' 0 N--CA 1.494 1.746 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 169.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.2 -21.07 66.43 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 118.177 2.658 . . . . 0.0 118.177 168.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -65.75 -65.86 0.62 Allowed 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.275 1.398 . . . . 0.0 112.792 168.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.01 -124.2 16.52 Favored Glycine 0 N--CA 1.489 2.19 0 CA-C-N 119.486 1.039 . . . . 0.0 113.765 -173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.22 -124.47 36.7 Favored Glycine 0 N--CA 1.493 2.451 0 N-CA-C 115.944 1.138 . . . . 0.0 115.944 167.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -155.78 152.9 29.04 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 113.795 1.035 . . . . 0.0 113.795 169.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.426 ' CE2' HG22 ' A' ' 38' ' ' VAL . 27.7 m95 -80.57 85.13 6.03 Favored 'General case' 0 CA--C 1.563 1.457 0 CA-C-O 122.239 1.018 . . . . 0.0 112.563 161.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.3 p -74.66 159.25 83.71 Favored Pre-proline 0 CA--C 1.578 2.038 0 N-CA-C 113.49 0.922 . . . . 0.0 113.49 175.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.94 58.27 3.35 Favored 'Trans proline' 0 CA--C 1.578 2.704 0 C-N-CA 122.769 2.313 . . . . 0.0 115.392 172.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -176.12 -62.06 0.01 OUTLIER 'General case' 0 CA--C 1.569 1.695 0 C-N-CA 125.89 1.676 . . . . 0.0 107.155 -162.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -56.57 -43.52 80.06 Favored 'General case' 0 CA--C 1.568 1.673 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 163.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -56.9 -33.5 66.98 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 162.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 -68.56 -30.68 69.51 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 116.891 2.182 . . . . 0.0 116.891 176.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -81.16 -46.39 14.96 Favored 'General case' 0 CA--C 1.57 1.728 0 CA-C-N 119.593 1.088 . . . . 0.0 113.459 162.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -59.23 -41.33 88.45 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.336 1.976 . . . . 0.0 116.336 175.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.7 mt -66.99 -8.62 31.22 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.788 2.514 . . . . 0.0 117.788 168.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 52.4 m -105.29 -42.84 5.15 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 120.706 1.594 . . . . 0.0 113.926 169.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -128.12 83.18 66.85 Favored Pre-proline 0 CA--C 1.576 1.949 0 CA-C-N 120.251 1.387 . . . . 0.0 108.094 170.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.18 -45.27 40.31 Favored 'Trans proline' 0 C--N 1.375 1.967 0 C-N-CA 123.866 3.044 . . . . 0.0 117.601 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 9.9 ptpp? -79.97 -3.77 49.7 Favored 'General case' 0 CA--C 1.574 1.895 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.76 -40.3 41.35 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-N 120.711 1.596 . . . . 0.0 114.856 161.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.24 -54.74 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.839 0 CA-C-N 119.103 0.865 . . . . 0.0 111.662 171.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.49 87.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 175.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.61 109.2 3.18 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.998 -1.064 . . . . 0.0 112.294 177.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.87 39.29 6.21 Favored Glycine 0 CA--C 1.554 2.486 0 N-CA-C 117.667 1.827 . . . . 0.0 117.667 -160.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.8 t -78.01 138.46 38.82 Favored 'General case' 0 CA--C 1.56 1.363 0 CA-C-N 118.676 1.238 . . . . 0.0 110.423 163.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 39.2 mttp -66.64 4.37 0.8 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 163.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.9 ttt -83.28 101.07 11.03 Favored 'General case' 0 CA--C 1.559 1.307 0 O-C-N 120.821 -1.174 . . . . 0.0 110.245 178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.47 71.8 7.32 Favored 'General case' 0 CA--C 1.566 1.565 0 CA-C-O 122.189 0.995 . . . . 0.0 112.709 176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -127.26 130.25 49.25 Favored 'General case' 0 CA--C 1.562 1.427 0 CA-C-O 121.706 0.765 . . . . 0.0 110.241 -173.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.56 -15.03 59.5 Favored 'General case' 0 CA--C 1.566 1.571 0 N-CA-C 117.833 2.531 . . . . 0.0 117.833 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 109.14 145.24 11.06 Favored Glycine 0 CA--C 1.546 2.016 0 N-CA-C 117.179 1.632 . . . . 0.0 117.179 176.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 73.1 mt -84.12 132.51 47.75 Favored Pre-proline 0 CA--C 1.574 1.867 0 C-N-CA 123.78 0.832 . . . . 0.0 112.483 170.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -82.87 -53.36 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.977 0 C-N-CA 122.368 2.046 . . . . 0.0 116.255 -170.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.6 mtpt -83.1 150.29 26.37 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 119.586 1.085 . . . . 0.0 111.829 -179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -39.67 68.94 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 168.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 20.2 pt-20 -63.95 -26.65 68.68 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 117.114 2.265 . . . . 0.0 117.114 167.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -62.15 -55.31 30.0 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 121.938 2.154 . . . . 0.0 113.467 174.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -64.21 -45.4 88.41 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 166.704 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -63.09 -32.34 73.7 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 118.2 2.667 . . . . 0.0 118.2 173.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -63.32 -50.6 69.4 Favored 'General case' 0 N--CA 1.499 1.976 0 CA-C-N 120.746 1.612 . . . . 0.0 113.656 165.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.439 HD21 HMB1 ' A' ' 101' ' ' HEC . 38.3 tp -59.53 -46.52 88.63 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.864 1.802 . . . . 0.0 115.864 169.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 58.1 mt -63.0 -41.34 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.85 0 CA-C-O 117.709 -1.139 . . . . 0.0 112.821 172.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.33 -44.45 80.0 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 116.606 2.076 . . . . 0.0 116.606 164.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -55.2 -50.5 69.21 Favored 'General case' 0 CA--C 1.571 1.755 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 164.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 46.8 mt -64.37 -28.43 69.69 Favored 'General case' 0 CA--C 1.576 1.978 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 171.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.73 -39.66 66.72 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.246 -1.534 . . . . 0.0 115.07 169.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -73.99 -61.9 3.13 Favored Glycine 0 N--CA 1.49 2.291 0 CA-C-N 119.857 1.208 . . . . 0.0 115.909 168.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.5 mp0 -90.5 96.13 10.5 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 173.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 85.5 mt-30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 -164.194 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.655 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mpt? . . . . . 0 N--CA 1.487 1.395 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -103.0 83.38 2.21 Favored 'General case' 0 CA--C 1.563 1.47 0 N-CA-C 113.568 0.951 . . . . 0.0 113.568 -170.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -121.15 99.01 46.67 Favored Pre-proline 0 CA--C 1.573 1.853 0 O-C-N 121.439 -0.788 . . . . 0.0 110.187 -175.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -72.68 -14.86 27.26 Favored 'Trans proline' 0 CA--C 1.575 2.571 0 N-CA-C 118.11 2.312 . . . . 0.0 118.11 179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.92 89.25 Favored 'General case' 0 CA--C 1.567 1.633 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 162.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.76 -35.5 57.68 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.84 1.793 . . . . 0.0 115.84 162.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.95 -29.84 76.0 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 119.261 2.465 . . . . 0.0 119.261 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -64.77 -43.65 92.56 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 170.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -70.95 -32.72 69.67 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 115.903 1.816 . . . . 0.0 115.903 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 43.0 t -63.14 -39.89 86.95 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 119.853 1.206 . . . . 0.0 113.431 161.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -58.42 -28.09 64.91 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 116.928 2.195 . . . . 0.0 116.928 167.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.3 -31.56 35.11 Favored Glycine 0 N--CA 1.495 2.621 0 N-CA-C 119.342 2.497 . . . . 0.0 119.342 169.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 1.2 mptp? -65.54 -35.69 81.59 Favored 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 115.502 1.667 . . . . 0.0 115.502 164.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.38 -35.04 70.95 Favored 'General case' 0 CA--C 1.574 1.891 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 167.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -55.37 -27.3 46.56 Favored 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 -170.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -62.24 -40.35 95.87 Favored 'General case' 0 CA--C 1.569 1.682 0 N-CA-C 115.571 1.693 . . . . 0.0 115.571 167.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.1 m -90.35 -43.16 10.51 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 172.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 -119.47 139.9 51.32 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-N 120.289 1.404 . . . . 0.0 111.982 -170.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.84 143.84 50.62 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 122.529 1.156 . . . . 0.0 110.317 173.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.2 mt -71.06 -33.41 70.24 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.712 1.745 . . . . 0.0 115.712 171.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -83.8 53.47 2.57 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 120.467 1.485 . . . . 0.0 114.18 -169.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 58.01 30.99 64.29 Favored Glycine 0 CA--C 1.553 2.462 0 N-CA-C 119.43 2.532 . . . . 0.0 119.43 -172.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -127.13 141.3 51.79 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 119.152 1.476 . . . . 0.0 109.965 -174.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -119.02 -92.3 0.54 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -161.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.08 -93.31 1.86 Allowed Glycine 0 N--CA 1.489 2.197 0 CA-C-N 119.603 1.092 . . . . 0.0 113.84 175.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.4 t -92.76 -57.52 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 CA-C-O 118.466 -0.778 . . . . 0.0 110.12 169.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -103.84 151.54 17.68 Favored Glycine 0 CA--C 1.559 2.793 0 CA-C-N 119.748 1.158 . . . . 0.0 114.958 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -71.87 149.59 53.98 Favored 'Trans proline' 0 CA--C 1.564 1.986 0 CA-C-N 121.411 2.605 . . . . 0.0 115.999 -177.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.7 p-80 -57.54 129.0 39.89 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -171.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 92.7 mt -95.77 20.38 9.92 Favored 'General case' 0 N--CA 1.5 2.071 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 -167.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.6 p30 -58.34 104.52 0.22 Allowed 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.9 37.9 88.53 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 117.693 1.837 . . . . 0.0 117.693 -173.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.291 9.3 p -65.4 -26.66 39.91 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.138 0 N-CA-C 117.18 2.289 . . . . 0.0 117.18 -177.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 45.0 t -71.26 108.32 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 CA-C-N 119.203 0.911 . . . . 0.0 109.517 174.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.87 23.6 45.12 Favored Glycine 0 CA--C 1.554 2.523 0 N-CA-C 118.626 2.21 . . . . 0.0 118.626 -165.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 40.9 ttp180 -122.74 146.06 47.85 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 119.492 1.646 . . . . 0.0 110.847 -178.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.265 52.6 m -57.56 140.37 51.06 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 116.184 1.92 . . . . 0.0 116.184 -171.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.2 t -72.84 120.51 21.61 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.74 0 CA-C-N 114.61 -1.177 . . . . 0.0 109.033 172.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.292 . . 67.21 33.14 5.65 Favored 'General case' 0 CA--C 1.579 2.084 0 N-CA-C 117.13 2.27 . . . . 0.0 117.13 -156.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -81.4 -35.88 21.98 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 119.818 2.687 . . . . 0.0 119.818 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 45.9 t -80.08 97.07 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 CA-C-N 119.426 1.613 . . . . 0.0 108.996 177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -73.62 129.13 37.32 Favored 'General case' 0 CA--C 1.568 1.664 0 CA-C-O 121.576 0.703 . . . . 0.0 112.113 -179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.82 -54.15 0.76 Allowed Glycine 0 N--CA 1.491 2.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 113.087 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.1 t80 -70.46 141.9 52.0 Favored 'General case' 0 CA--C 1.574 1.886 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 168.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -86.63 102.8 14.52 Favored 'General case' 0 CA--C 1.567 1.624 0 O-C-N 121.719 -0.613 . . . . 0.0 110.956 175.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -83.56 170.5 14.3 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 113.464 0.913 . . . . 0.0 113.464 -176.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.2 p -76.18 154.18 35.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.484 -1.385 . . . . 0.0 113.256 170.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -54.43 -48.15 95.66 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-O 116.047 -1.93 . . . . 0.0 115.955 175.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -70.07 -20.65 33.12 Favored 'Trans proline' 0 CA--C 1.569 2.27 0 CA-C-N 124.515 2.648 . . . . 0.0 117.041 169.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 33.2 ttm -67.45 -48.88 65.93 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 120.698 1.59 . . . . 0.0 113.968 164.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -60.73 -44.04 97.13 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.02 1.489 . . . . 0.0 115.02 170.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.02 -21.74 65.92 Favored 'General case' 0 CA--C 1.569 1.711 0 N-CA-C 118.225 2.676 . . . . 0.0 118.225 170.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -66.18 -68.65 0.35 Allowed 'General case' 0 CA--C 1.57 1.727 0 CA-C-N 120.388 1.449 . . . . 0.0 112.221 167.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.31 -158.74 48.29 Favored Glycine 0 CA--C 1.553 2.411 0 N-CA-C 116.184 1.233 . . . . 0.0 116.184 -176.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.11 -107.99 2.69 Favored Glycine 0 N--CA 1.489 2.187 0 O-C-N 121.087 -1.243 . . . . 0.0 113.568 170.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -156.12 149.35 24.46 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -82.76 89.87 6.83 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-O 121.83 0.824 . . . . 0.0 112.456 165.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.0 p -74.48 156.92 86.8 Favored Pre-proline 0 CA--C 1.578 2.052 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -66.56 17.75 0.1 Allowed 'Trans proline' 0 CA--C 1.582 2.899 0 N-CA-C 119.599 2.884 . . . . 0.0 119.599 172.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -129.23 -40.02 1.49 Allowed 'General case' 0 CA--C 1.571 1.774 0 C-N-CA 126.197 1.799 . . . . 0.0 111.39 172.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -57.38 -46.72 83.11 Favored 'General case' 0 CA--C 1.565 1.538 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 160.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.1 mt -59.85 -36.03 76.0 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 165.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -69.98 -24.21 63.29 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 172.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -79.5 -52.57 7.86 Favored 'General case' 0 CA--C 1.572 1.796 0 C-N-CA 124.086 0.954 . . . . 0.0 112.204 163.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.6 t80 -61.1 -42.97 99.5 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 177.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 92.0 mt -68.29 -5.62 19.59 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 117.85 2.537 . . . . 0.0 117.85 172.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 40.5 m -107.53 -35.63 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-N 120.198 1.363 . . . . 0.0 114.484 166.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -132.56 82.25 57.38 Favored Pre-proline 0 CA--C 1.577 2.007 0 CA-C-N 120.453 1.479 . . . . 0.0 107.906 171.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.83 -43.57 58.02 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.521 2.814 . . . . 0.0 117.27 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.2 ptpt -80.67 6.07 13.81 Favored 'General case' 0 CA--C 1.576 1.965 0 N-CA-C 118.013 2.597 . . . . 0.0 118.013 170.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.47 -43.98 13.11 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 120.445 1.475 . . . . 0.0 113.956 158.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.7 t -77.78 -54.43 12.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 CA-C-N 119.157 0.89 . . . . 0.0 111.808 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 77.2 t -103.35 87.76 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -72.25 100.87 2.7 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.181 -0.95 . . . . 0.0 111.245 -178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.62 46.62 1.77 Allowed Glycine 0 CA--C 1.553 2.408 0 N-CA-C 116.307 1.283 . . . . 0.0 116.307 -158.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.6 t -85.43 137.25 33.05 Favored 'General case' 0 CA--C 1.559 1.32 0 CA-C-N 118.796 1.298 . . . . 0.0 110.525 165.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -72.04 14.85 0.19 Allowed 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 165.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.44 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.3 ttt -90.57 110.06 21.2 Favored 'General case' 0 CA--C 1.559 1.305 0 O-C-N 120.745 -1.222 . . . . 0.0 110.007 178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.53 69.61 5.84 Favored 'General case' 0 CA--C 1.569 1.678 0 CA-C-O 122.357 1.075 . . . . 0.0 113.279 175.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.406 ' CZ ' HBB2 ' A' ' 101' ' ' HEC . 58.4 t80 -131.45 128.56 39.72 Favored 'General case' 0 CA--C 1.561 1.375 0 C-N-CA 124.029 0.931 . . . . 0.0 109.58 -175.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -77.84 -23.96 48.77 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 -179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 116.0 148.38 9.15 Favored Glycine 0 CA--C 1.547 2.092 0 N-CA-C 116.91 1.524 . . . . 0.0 116.91 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 83.4 mt -84.4 139.11 38.59 Favored Pre-proline 0 CA--C 1.573 1.828 0 C-N-CA 123.978 0.911 . . . . 0.0 113.013 171.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -81.43 -54.23 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.006 0 C-N-CA 122.368 2.045 . . . . 0.0 116.173 -174.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -84.08 149.37 26.27 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-N 119.462 1.028 . . . . 0.0 111.937 -175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -55.46 -40.28 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.343 0 N-CA-C 113.875 1.065 . . . . 0.0 113.875 164.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 58.3 mp0 -54.78 -38.9 67.82 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -60.88 -57.2 13.65 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 120.301 1.41 . . . . 0.0 113.932 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.259 0.0 OUTLIER -65.87 -42.53 90.24 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 170.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.06 -46.86 82.13 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 117.419 2.378 . . . . 0.0 117.419 169.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.3 m-20 -60.6 -46.55 89.82 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 114.579 1.325 . . . . 0.0 114.579 170.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.417 HD21 HMB1 ' A' ' 101' ' ' HEC . 61.4 tp -55.63 -45.07 77.62 Favored 'General case' 0 CA--C 1.571 1.769 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 165.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 42.9 mt -61.09 -35.76 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.096 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 171.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.74 -49.35 76.77 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 164.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -50.97 -52.52 41.75 Favored 'General case' 0 CA--C 1.573 1.839 0 N-CA-C 115.889 1.811 . . . . 0.0 115.889 164.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.21 -27.85 68.96 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -67.4 -50.64 58.68 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.598 1.333 . . . . 0.0 114.598 163.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -71.84 -55.29 7.43 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -89.63 112.34 23.55 Favored 'General case' 0 CA--C 1.561 1.377 0 CA-C-N 117.718 0.759 . . . . 0.0 110.591 178.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 68.9 mt-30 . . . . . 0 N--CA 1.484 1.27 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -172.613 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.621 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 118.768 -0.634 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.55 75.16 0.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.184 0.902 . . . . 0.0 111.985 175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -107.75 105.63 56.6 Favored Pre-proline 0 CA--C 1.57 1.718 0 CA-C-O 118.377 -0.821 . . . . 0.0 109.364 -176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -66.23 -29.24 47.22 Favored 'Trans proline' 0 CA--C 1.568 2.195 0 C-N-CA 122.735 2.29 . . . . 0.0 117.496 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.92 -23.14 66.56 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 164.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.25 -33.96 32.42 Favored 'General case' 0 CA--C 1.57 1.742 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 158.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -62.16 -22.63 63.14 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 173.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -62.93 -45.99 89.87 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 115.812 1.782 . . . . 0.0 115.812 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 20.2 pttm -73.36 -32.92 64.8 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 169.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 54.5 t -59.15 -43.3 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.16 0 CA-C-N 120.23 1.377 . . . . 0.0 113.765 162.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -53.14 -22.51 6.46 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 117.47 2.396 . . . . 0.0 117.47 170.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.21 -29.37 36.8 Favored Glycine 0 CA--C 1.559 2.827 0 N-CA-C 119.592 2.597 . . . . 0.0 119.592 166.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -68.67 -30.7 69.44 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 116.045 1.869 . . . . 0.0 116.045 164.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' SG ' HD11 ' A' ' 92' ' ' LEU . 4.7 m -84.37 -32.39 24.24 Favored 'General case' 0 CA--C 1.575 1.912 0 N-CA-C 116.445 2.017 . . . . 0.0 116.445 171.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.8 ptmt -62.11 -26.81 68.51 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 119.967 3.321 . . . . 0.0 119.967 -166.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.85 -32.97 72.37 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 116.224 1.935 . . . . 0.0 116.224 169.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 61.6 m -92.97 -43.6 8.85 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 116.019 1.859 . . . . 0.0 116.019 167.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -112.45 139.75 47.76 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.931 1.241 . . . . 0.0 113.298 -169.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.6 mmpt? -108.5 152.81 24.22 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-O 122.742 1.258 . . . . 0.0 112.142 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 43.6 mt -104.66 25.77 9.9 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 115.1 1.518 . . . . 0.0 115.1 174.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -136.02 62.07 1.63 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.564 -1.335 . . . . 0.0 111.55 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 72.6 -42.42 0.86 Allowed Glycine 0 N--CA 1.496 2.65 0 N-CA-C 119.454 2.542 . . . . 0.0 119.454 174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -74.65 161.34 29.77 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 118.457 1.128 . . . . 0.0 112.331 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -103.25 -84.21 0.47 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.537 -0.727 . . . . 0.0 111.391 -165.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.36 -118.27 3.98 Favored Glycine 0 N--CA 1.489 2.229 0 CA-C-N 118.617 0.644 . . . . 0.0 112.218 -177.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 41.1 t -88.74 -50.74 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.255 0 CA-C-O 118.974 -0.536 . . . . 0.0 110.252 164.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.36 172.07 35.84 Favored Glycine 0 CA--C 1.558 2.774 0 N-CA-C 115.969 1.148 . . . . 0.0 115.969 167.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -67.66 170.28 14.2 Favored 'Trans proline' 0 CA--C 1.563 1.953 0 C-N-CA 123.035 2.49 . . . . 0.0 115.616 175.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 23.9 p-80 -68.51 124.32 23.24 Favored 'General case' 0 CA--C 1.563 1.472 0 O-C-N 120.653 -1.28 . . . . 0.0 112.781 174.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -92.97 5.48 51.29 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 -178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.6 p-10 -69.65 110.11 4.68 Favored 'General case' 0 CA--C 1.564 1.496 0 CA-C-N 119.597 1.09 . . . . 0.0 111.018 175.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.55 35.03 26.87 Favored Glycine 0 CA--C 1.544 1.898 0 N-CA-C 117.098 1.599 . . . . 0.0 117.098 -168.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.276 9.9 p -79.5 -33.91 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 115.867 1.803 . . . . 0.0 115.867 175.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.4 t -72.6 110.16 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 CA-C-N 120.104 1.32 . . . . 0.0 109.617 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.72 -35.75 4.85 Favored Glycine 0 CA--C 1.55 2.242 0 N-CA-C 117.041 1.576 . . . . 0.0 117.041 -162.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.9 ttp180 -72.02 155.25 40.53 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.759 1.779 . . . . 0.0 113.156 -171.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.7 t -54.22 150.38 8.52 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-O 122.463 1.125 . . . . 0.0 113.969 174.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 30.2 t -72.66 129.43 35.85 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.671 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.166 166.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.324 . . 70.09 29.58 3.77 Favored 'General case' 0 CA--C 1.575 1.905 0 N-CA-C 117.867 2.543 . . . . 0.0 117.867 -159.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.22 58.42 2.37 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 118.049 1.98 . . . . 0.0 118.049 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 75.8 t -140.47 100.96 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 164.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 80.2 m-20 -74.04 103.04 4.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.715 -0.616 . . . . 0.0 110.921 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.78 -47.92 0.85 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 114.743 0.657 . . . . 0.0 114.743 -158.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -77.72 139.87 39.45 Favored 'General case' 0 CA--C 1.572 1.825 0 CA-C-N 118.402 1.101 . . . . 0.0 112.716 176.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -79.3 92.88 5.2 Favored 'General case' 0 CA--C 1.569 1.676 0 CA-C-O 121.593 0.711 . . . . 0.0 111.739 173.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -83.99 153.5 23.84 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 122.276 1.036 . . . . 0.0 113.602 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 59.5 p -65.04 153.59 40.29 Favored 'General case' 0 CA--C 1.565 1.541 0 N-CA-C 114.422 1.267 . . . . 0.0 114.422 173.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -54.42 -47.73 96.82 Favored Pre-proline 0 CA--C 1.578 2.051 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -66.94 -25.89 44.44 Favored 'Trans proline' 0 CA--C 1.569 2.264 0 CA-C-N 124.834 2.762 . . . . 0.0 117.074 172.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 36.0 tpp -67.1 -50.17 62.5 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 113.985 1.105 . . . . 0.0 113.985 169.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 66.3 mmtt -61.76 -41.02 97.14 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 168.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.94 -23.63 67.48 Favored 'General case' 0 CA--C 1.571 1.777 0 N-CA-C 118.221 2.674 . . . . 0.0 118.221 169.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.2 t-80 -66.3 -62.64 1.36 Allowed 'General case' 0 CA--C 1.57 1.739 0 CA-C-N 119.885 1.22 . . . . 0.0 113.176 169.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.93 -124.91 15.2 Favored Glycine 0 N--CA 1.489 2.232 0 CA-C-N 119.454 1.025 . . . . 0.0 113.813 -174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.84 -126.87 43.57 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 116.252 1.261 . . . . 0.0 116.252 167.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -153.38 149.22 27.59 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 118.002 0.901 . . . . 0.0 113.244 174.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -83.22 82.72 8.14 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.024 0.916 . . . . 0.0 113.033 163.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.9 p -70.81 157.46 90.19 Favored Pre-proline 0 CA--C 1.577 1.996 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 173.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -68.9 28.14 0.15 Allowed 'Trans proline' 0 CA--C 1.583 2.953 0 N-CA-C 118.224 2.355 . . . . 0.0 118.224 167.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -129.38 -48.3 1.18 Allowed 'General case' 0 CA--C 1.572 1.801 0 C-N-CA 126.426 1.891 . . . . 0.0 109.969 167.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.84 -45.87 74.56 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 165.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.0 mt -58.75 -33.75 70.63 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 116.444 2.016 . . . . 0.0 116.444 164.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -64.39 -36.8 85.32 Favored 'General case' 0 N--CA 1.498 1.936 0 N-CA-C 115.532 1.678 . . . . 0.0 115.532 173.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -78.81 -44.66 22.62 Favored 'General case' 0 CA--C 1.565 1.555 0 CA-C-N 119.369 0.986 . . . . 0.0 112.83 166.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -60.95 -43.82 98.16 Favored 'General case' 0 N--CA 1.495 1.818 0 N-CA-C 116.326 1.972 . . . . 0.0 116.326 175.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 49.2 mt -61.88 -23.22 66.16 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 117.319 2.34 . . . . 0.0 117.319 170.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 64.8 m -88.4 -27.03 21.84 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 116.133 1.901 . . . . 0.0 116.133 164.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.525 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.4 m-80 -136.64 69.2 59.89 Favored Pre-proline 0 CA--C 1.584 2.288 0 C-N-CA 125.592 1.557 . . . . 0.0 109.612 -176.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -62.55 -52.43 2.47 Favored 'Trans proline' 0 C--N 1.378 2.08 0 C-N-CA 123.242 2.628 . . . . 0.0 116.222 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -85.33 33.82 0.56 Allowed 'General case' 0 CA--C 1.575 1.917 0 N-CA-C 115.71 1.744 . . . . 0.0 115.71 168.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.525 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -136.13 -40.9 0.66 Allowed 'General case' 0 CA--C 1.569 1.704 0 C-N-CA 125.443 1.497 . . . . 0.0 112.06 173.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.0 t -65.71 -54.14 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 CA-C-N 121.063 1.756 . . . . 0.0 111.39 156.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 40.8 t -104.73 78.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 171.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.86 115.06 4.95 Favored 'General case' 0 CA--C 1.569 1.701 0 O-C-N 120.939 -1.1 . . . . 0.0 113.595 -175.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 88.69 29.16 19.5 Favored Glycine 0 CA--C 1.551 2.322 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -165.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 11.3 t -70.69 148.23 48.24 Favored 'General case' 0 CA--C 1.562 1.414 0 CA-C-N 120.276 2.038 . . . . 0.0 112.817 168.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 17.5 mtpt -73.13 9.95 1.09 Allowed 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 116.129 1.899 . . . . 0.0 116.129 161.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.27 103.81 11.3 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 120.664 1.575 . . . . 0.0 109.798 170.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.01 70.96 5.43 Favored 'General case' 0 CA--C 1.568 1.668 0 CA-C-O 122.957 1.361 . . . . 0.0 113.253 176.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -140.28 132.04 27.42 Favored 'General case' 0 CA--C 1.562 1.439 0 C-N-CA 124.605 1.162 . . . . 0.0 108.133 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.64 -45.47 21.44 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.14 135.46 2.6 Favored Glycine 0 N--CA 1.484 1.846 0 N-CA-C 115.893 1.117 . . . . 0.0 115.893 -175.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.9 mt -78.59 133.94 62.32 Favored Pre-proline 0 CA--C 1.574 1.902 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 168.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -82.1 -53.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 1.994 0 C-N-CA 122.544 2.163 . . . . 0.0 116.374 -174.054 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -86.75 142.49 28.11 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 119.575 1.079 . . . . 0.0 111.427 -173.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . 0.254 0.2 OUTLIER -60.1 -36.75 69.69 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 173.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.75 -28.64 70.02 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 169.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.4 -57.49 6.49 Favored 'General case' 0 CA--C 1.568 1.659 0 CA-C-N 120.092 1.315 . . . . 0.0 112.132 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -64.13 -37.16 86.47 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 168.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.04 -42.17 97.97 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.599 2.444 . . . . 0.0 117.599 168.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -55.87 -51.5 67.33 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 165.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.4 HD11 ' SG ' ' A' ' 14' ' ' CYS . 0.7 OUTLIER -54.82 -50.7 67.93 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 115.974 1.842 . . . . 0.0 115.974 168.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 62.2 mt -59.94 -43.24 91.87 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 C-N-CA 124.598 1.159 . . . . 0.0 113.309 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -54.07 -44.46 71.14 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 165.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -60.86 -46.7 89.57 Favored 'General case' 0 CA--C 1.57 1.749 0 N-CA-C 115.238 1.569 . . . . 0.0 115.238 166.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 91.8 mt -60.09 -26.9 66.57 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 170.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.68 -50.62 66.28 Favored 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 164.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -69.88 -26.89 73.83 Favored Glycine 0 N--CA 1.496 2.641 0 N-CA-C 119.461 2.545 . . . . 0.0 119.461 173.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 45.1 mm-40 -89.23 104.98 17.48 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 118.584 1.192 . . . . 0.0 109.622 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 . . . . . 0 C--O 1.253 1.249 0 C-N-CA 123.427 0.691 . . . . 0.0 110.787 -166.217 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.659 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -94.93 95.85 8.91 Favored 'General case' 0 CA--C 1.558 1.274 0 CA-C-N 119.546 1.066 . . . . 0.0 111.759 177.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -128.53 106.56 19.04 Favored Pre-proline 0 CA--C 1.572 1.805 0 O-C-N 120.442 -1.411 . . . . 0.0 109.113 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -69.18 -30.83 24.3 Favored 'Trans proline' 0 CA--C 1.568 2.224 0 C-N-CA 122.794 2.329 . . . . 0.0 117.543 -178.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.1 -25.12 67.64 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 117.21 2.3 . . . . 0.0 117.21 165.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.06 -36.43 55.93 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 157.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.06 -25.55 68.19 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 119.245 2.458 . . . . 0.0 119.245 176.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -61.97 -43.79 98.09 Favored 'General case' 0 N--CA 1.498 1.944 0 N-CA-C 116.231 1.938 . . . . 0.0 116.231 169.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -74.4 -34.52 63.3 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.272 1.582 . . . . 0.0 115.272 168.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 50.3 t -58.45 -43.24 86.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.256 0 CA-C-N 120.413 1.461 . . . . 0.0 114.015 164.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -52.24 -18.85 1.7 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 117.714 2.487 . . . . 0.0 117.714 166.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -54.12 -28.84 42.93 Favored Glycine 0 CA--C 1.558 2.757 0 N-CA-C 119.728 2.651 . . . . 0.0 119.728 163.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.85 -34.9 77.58 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 163.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.7 m -82.85 -33.81 26.97 Favored 'General case' 0 CA--C 1.574 1.889 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 175.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -63.45 -24.86 68.01 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 120.029 3.344 . . . . 0.0 120.029 -166.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.61 -39.3 87.64 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 167.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 63.9 m -85.84 -45.54 11.47 Favored 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 115.785 1.772 . . . . 0.0 115.785 168.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -111.26 138.23 47.99 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 120.072 1.305 . . . . 0.0 113.641 -169.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -107.28 142.69 36.64 Favored 'General case' 0 N--CA 1.497 1.877 0 CA-C-O 122.476 1.131 . . . . 0.0 111.462 171.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 21.4 mt -83.04 -28.81 29.34 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 114.672 1.36 . . . . 0.0 114.672 163.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -92.18 63.51 4.33 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.484 -1.385 . . . . 0.0 111.196 -171.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.12 42.06 Favored Glycine 0 CA--C 1.544 1.877 0 O-C-N 121.586 -0.696 . . . . 0.0 113.049 -165.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 59.6 m-80 50.88 -164.96 0.04 OUTLIER 'General case' 0 CA--C 1.58 2.128 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -176.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -137.52 -81.33 0.36 Allowed 'General case' 0 CA--C 1.566 1.568 0 O-C-N 119.868 -1.77 . . . . 0.0 106.671 157.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 121.88 -107.66 1.21 Allowed Glycine 0 N--CA 1.487 2.09 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -98.96 -50.53 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.151 0 CA-C-O 118.889 -0.577 . . . . 0.0 109.623 157.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.59 169.34 32.69 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 116.493 1.357 . . . . 0.0 116.493 169.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -70.59 169.21 20.51 Favored 'Trans proline' 0 CA--C 1.564 2.009 0 C-N-CA 122.957 2.438 . . . . 0.0 116.475 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -66.93 126.77 30.15 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 114.842 1.423 . . . . 0.0 114.842 176.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 72.5 mt -99.1 19.61 14.9 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 116.157 1.91 . . . . 0.0 116.157 -172.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -66.79 90.91 0.18 Allowed 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 -175.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 47.18 23.66 Favored Glycine 0 N--CA 1.487 2.045 0 N-CA-C 116.411 1.324 . . . . 0.0 116.411 -163.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.5 p -63.58 -30.28 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 N-CA-C 115.985 1.846 . . . . 0.0 115.985 166.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.49 104.41 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.82 0 CA-C-N 119.295 0.952 . . . . 0.0 109.04 173.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.22 -3.76 60.15 Favored Glycine 0 N--CA 1.496 2.691 0 N-CA-C 119.339 2.496 . . . . 0.0 119.339 -163.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 53.4 ttm-85 -83.77 151.9 24.95 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-N 120.006 1.903 . . . . 0.0 111.336 172.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.56 153.21 13.44 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.687 -1.258 . . . . 0.0 113.391 167.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 57' ' ' TRP . 24.2 t -72.87 133.04 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.752 0 CA-C-O 121.46 0.647 . . . . 0.0 109.506 164.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.306 . . 66.47 30.84 8.46 Favored 'General case' 0 CA--C 1.575 1.93 0 N-CA-C 117.905 2.557 . . . . 0.0 117.905 -158.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.81 52.81 1.7 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 119.067 2.387 . . . . 0.0 119.067 -171.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.9 t -137.17 102.81 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.953 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 166.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -72.25 108.94 5.66 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 123.182 0.593 . . . . 0.0 110.922 176.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.83 -49.07 0.91 Allowed Glycine 0 N--CA 1.49 2.296 0 CA-C-O 119.509 -0.606 . . . . 0.0 114.592 -159.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -80.69 135.84 36.09 Favored 'General case' 0 CA--C 1.57 1.732 0 CA-C-N 118.224 1.012 . . . . 0.0 112.249 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -81.45 99.75 8.92 Favored 'General case' 0 CA--C 1.567 1.621 0 O-C-N 121.534 -0.729 . . . . 0.0 111.296 173.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -84.3 167.44 16.58 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 45.6 p -75.89 163.61 27.03 Favored 'General case' 0 CA--C 1.571 1.77 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -59.51 -49.6 91.4 Favored Pre-proline 0 CA--C 1.577 2.008 0 CA-C-O 115.982 -1.961 . . . . 0.0 115.676 175.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -67.93 -22.56 42.05 Favored 'Trans proline' 0 CA--C 1.569 2.238 0 CA-C-N 124.883 2.78 . . . . 0.0 117.064 170.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -56.59 -56.86 16.06 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 159.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -64.3 -42.92 96.14 Favored 'General case' 0 CA--C 1.568 1.653 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.18 -20.59 66.52 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 118.358 2.725 . . . . 0.0 118.358 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.4 t-80 -65.68 -64.04 0.95 Allowed 'General case' 0 CA--C 1.572 1.793 0 CA-C-N 120.378 1.444 . . . . 0.0 112.595 165.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.8 -127.0 24.85 Favored Glycine 0 N--CA 1.489 2.23 0 CA-C-N 119.349 0.977 . . . . 0.0 114.273 -176.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.74 -117.94 11.54 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 116.405 1.322 . . . . 0.0 116.405 167.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -153.84 151.57 29.66 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 171.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.404 ' CE2' HG22 ' A' ' 38' ' ' VAL . 15.2 m95 -82.35 85.94 6.79 Favored 'General case' 0 CA--C 1.562 1.415 0 CA-C-N 114.822 -1.081 . . . . 0.0 112.112 156.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 78.6 p -74.41 160.54 81.05 Favored Pre-proline 0 CA--C 1.578 2.024 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -67.3 24.33 0.11 Allowed 'Trans proline' 0 CA--C 1.582 2.885 0 N-CA-C 118.846 2.595 . . . . 0.0 118.846 168.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -132.82 -44.55 0.88 Allowed 'General case' 0 CA--C 1.57 1.747 0 C-N-CA 126.015 1.726 . . . . 0.0 110.968 169.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.23 -44.72 71.97 Favored 'General case' 0 CA--C 1.567 1.632 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 163.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.4 mt -61.1 -32.93 72.59 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.383 1.994 . . . . 0.0 116.383 164.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 45.4 mm-40 -63.73 -36.62 84.46 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 115.688 1.736 . . . . 0.0 115.688 173.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.58 -44.76 18.45 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.953 166.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -60.55 -41.03 93.72 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 121.548 1.976 . . . . 0.0 116.227 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.9 mt -64.55 -21.22 66.63 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 117.593 2.442 . . . . 0.0 117.593 170.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 56.2 m -93.21 -25.7 17.7 Favored 'General case' 0 N--CA 1.504 2.245 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 164.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.505 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 6.6 m-80 -137.23 69.49 55.55 Favored Pre-proline 0 CA--C 1.583 2.222 0 C-N-CA 125.662 1.585 . . . . 0.0 109.244 -177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.91 -55.12 1.81 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 123.321 2.681 . . . . 0.0 115.474 -179.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -74.58 8.7 2.16 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 117.533 2.419 . . . . 0.0 117.533 171.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -113.01 -38.69 4.42 Favored 'General case' 0 CA--C 1.567 1.62 0 C-N-CA 124.971 1.309 . . . . 0.0 113.968 171.383 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 77.5 t -70.71 -51.1 39.36 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.149 0 CA-C-N 121.06 1.754 . . . . 0.0 111.875 164.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 57.2 t -108.07 96.43 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 167.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -74.19 110.6 8.61 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.151 -0.968 . . . . 0.0 110.863 177.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.12 37.76 6.62 Favored Glycine 0 CA--C 1.553 2.454 0 N-CA-C 117.495 1.758 . . . . 0.0 117.495 -161.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.2 t -78.69 133.3 37.2 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-N 118.865 1.333 . . . . 0.0 109.302 160.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -72.56 22.33 0.06 Allowed 'General case' 0 CA--C 1.58 2.129 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 168.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . 0.45 ' SD ' ' C1A' ' A' ' 101' ' ' HEC . 2.6 ttt -87.24 108.86 19.13 Favored 'General case' 0 CA--C 1.559 1.317 0 O-C-N 120.576 -1.328 . . . . 0.0 109.437 176.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.31 68.04 3.36 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-O 123.077 1.418 . . . . 0.0 113.715 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -142.09 128.53 20.09 Favored 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 124.765 1.226 . . . . 0.0 107.739 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -76.77 -41.56 44.22 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -177.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 144.17 137.2 3.18 Favored Glycine 0 CA--C 1.544 1.867 0 N-CA-C 115.576 0.991 . . . . 0.0 115.576 -173.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 56.3 mt -79.41 135.44 57.21 Favored Pre-proline 0 CA--C 1.571 1.788 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 171.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.73 -53.27 0.04 OUTLIER 'Trans proline' 0 CA--C 1.566 2.108 0 C-N-CA 122.548 2.165 . . . . 0.0 116.06 -176.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -78.91 142.46 36.74 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-N 119.578 1.081 . . . . 0.0 111.713 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -59.37 -37.22 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.226 0 N-CA-C 113.639 0.977 . . . . 0.0 113.639 166.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 43.3 mp0 -62.1 -32.01 72.52 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 171.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -64.64 -57.33 9.37 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.696 1.589 . . . . 0.0 112.455 176.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.264 0.1 OUTLIER -63.82 -38.39 90.92 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 117.213 2.301 . . . . 0.0 117.213 169.717 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.78 81.66 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.932 2.568 . . . . 0.0 117.932 168.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -61.46 -52.06 66.12 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 119.702 1.137 . . . . 0.0 113.545 167.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 5.5 mt -47.37 -53.49 13.68 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 117.154 2.279 . . . . 0.0 117.154 162.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.9 mt -64.67 -36.61 77.95 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 CA-C-N 119.951 1.25 . . . . 0.0 113.901 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -58.78 -50.83 72.49 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 115.769 1.766 . . . . 0.0 115.769 162.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -54.41 -54.67 37.55 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 168.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 48.1 mt -61.08 -24.09 65.97 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 117.071 2.249 . . . . 0.0 117.071 177.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -70.53 -52.96 18.14 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 114.575 1.324 . . . . 0.0 114.575 164.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -77.53 -52.53 5.48 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 117.584 1.793 . . . . 0.0 117.584 178.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 9.9 mp0 -90.1 104.39 16.97 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.089 0.955 . . . . 0.0 109.194 177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 . . . . . 0 C--O 1.253 1.284 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 -174.698 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.689 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.91 72.55 0.89 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -178.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -103.51 107.8 57.24 Favored Pre-proline 0 CA--C 1.574 1.895 0 O-C-N 121.18 -0.95 . . . . 0.0 110.094 174.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.41 -27.1 19.64 Favored 'Trans proline' 0 CA--C 1.568 2.189 0 C-N-CA 122.58 2.186 . . . . 0.0 117.432 178.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -46.74 77.71 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 171.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.41 74.96 Favored 'General case' 0 CA--C 1.568 1.652 0 N-CA-C 116.203 1.927 . . . . 0.0 116.203 164.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.15 -24.56 63.33 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 119.247 2.459 . . . . 0.0 119.247 167.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -69.04 -42.77 75.86 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 170.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -66.51 -35.83 81.23 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.799 1.777 . . . . 0.0 115.799 166.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.0 t -61.78 -45.05 99.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 CA-C-N 119.626 1.103 . . . . 0.0 113.185 165.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.7 t80 -56.91 -26.69 59.72 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 168.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.42 -32.33 37.64 Favored Glycine 0 CA--C 1.557 2.697 0 N-CA-C 119.143 2.417 . . . . 0.0 119.143 167.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.4 mtmt -64.15 -34.07 77.23 Favored 'General case' 0 CA--C 1.576 1.967 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 163.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.8 m -75.88 -34.46 60.0 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 168.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -51.9 -33.27 36.24 Favored 'General case' 0 N--CA 1.503 2.215 0 N-CA-C 119.067 2.988 . . . . 0.0 119.067 -173.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.17 -32.83 71.43 Favored 'General case' 0 CA--C 1.568 1.656 0 N-CA-C 116.574 2.065 . . . . 0.0 116.574 170.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 69.9 m -96.64 -41.72 8.38 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 169.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.1 m-70 -116.26 141.42 48.17 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 120.426 1.466 . . . . 0.0 112.667 -169.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 30.5 mmtp -117.77 147.5 42.94 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 122.369 1.08 . . . . 0.0 111.14 168.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.6 mt -78.38 -34.66 48.09 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 115.289 1.588 . . . . 0.0 115.289 166.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -86.15 65.39 9.06 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-N 119.973 1.26 . . . . 0.0 112.826 -170.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.47 -49.0 3.53 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 117.956 1.942 . . . . 0.0 117.956 176.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.7 m-80 -68.27 154.13 42.37 Favored 'General case' 0 CA--C 1.567 1.603 0 CA-C-O 122.875 1.321 . . . . 0.0 113.164 -179.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -97.04 -86.3 0.33 Allowed 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 115.077 -0.965 . . . . 0.0 108.968 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 118.72 -109.31 1.72 Allowed Glycine 0 N--CA 1.489 2.226 0 CA-C-N 118.792 0.723 . . . . 0.0 111.736 178.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.4 t -94.27 -47.64 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.174 0 CA-C-O 118.693 -0.67 . . . . 0.0 110.439 162.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.37 172.15 31.5 Favored Glycine 0 CA--C 1.557 2.699 0 N-CA-C 116.256 1.262 . . . . 0.0 116.256 168.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.09 170.31 13.36 Favored 'Trans proline' 0 CA--C 1.565 2.047 0 C-N-CA 123.129 2.553 . . . . 0.0 116.495 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -69.48 129.12 38.84 Favored 'General case' 0 CA--C 1.571 1.757 0 O-C-N 120.714 -1.241 . . . . 0.0 113.367 172.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 86.2 mt -99.98 20.95 13.44 Favored 'General case' 0 N--CA 1.501 2.121 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -173.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -66.06 92.5 0.17 Allowed 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.01 45.75 31.15 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 116.312 1.285 . . . . 0.0 116.312 -164.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.557 HG21 HMA3 ' A' ' 101' ' ' HEC . 9.0 p -63.68 -29.62 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 N-CA-C 116.022 1.86 . . . . 0.0 116.022 167.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -72.06 102.21 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.573 1.852 0 C-N-CA 123.943 0.897 . . . . 0.0 108.917 173.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 98.02 5.25 57.43 Favored Glycine 0 CA--C 1.557 2.719 0 N-CA-C 119.466 2.547 . . . . 0.0 119.466 -163.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 51.6 ttm-85 -93.36 151.23 19.9 Favored 'General case' 0 N--CA 1.494 1.76 0 CA-C-N 119.853 1.827 . . . . 0.0 111.175 173.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 6.5 t -57.26 152.74 13.35 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 120.507 -1.371 . . . . 0.0 113.651 168.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 HG22 ' CE2' ' A' ' 57' ' ' TRP . 20.5 t -74.29 134.97 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.809 0 CA-C-O 121.474 0.655 . . . . 0.0 109.503 164.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.291 . . 64.28 33.09 11.82 Favored 'General case' 0 CA--C 1.577 1.984 0 N-CA-C 117.44 2.385 . . . . 0.0 117.44 -156.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -97.55 51.59 1.37 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 119.13 2.412 . . . . 0.0 119.13 -170.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 44.1 t -138.28 106.6 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 165.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -72.94 108.19 5.72 Favored 'General case' 0 CA--C 1.568 1.671 0 O-C-N 121.736 -0.602 . . . . 0.0 110.644 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.92 -53.05 0.75 Allowed Glycine 0 N--CA 1.49 2.269 0 CA-C-O 119.665 -0.519 . . . . 0.0 113.895 -159.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 39.0 t80 -82.63 129.78 35.01 Favored 'General case' 0 CA--C 1.567 1.622 0 CA-C-N 117.887 0.843 . . . . 0.0 111.42 174.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -84.06 103.62 13.44 Favored 'General case' 0 CA--C 1.566 1.584 0 O-C-N 121.513 -0.742 . . . . 0.0 111.172 173.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -82.25 166.03 19.92 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 113.448 0.907 . . . . 0.0 113.448 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 77.7 p -70.6 162.24 29.26 Favored 'General case' 0 CA--C 1.571 1.76 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 173.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -57.39 -51.76 79.27 Favored Pre-proline 0 CA--C 1.577 2.01 0 N-CA-C 116.411 2.004 . . . . 0.0 116.411 178.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.25 -21.42 35.9 Favored 'Trans proline' 0 CA--C 1.57 2.276 0 CA-C-N 123.928 2.439 . . . . 0.0 116.874 172.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -64.48 -51.69 61.7 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 162.181 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 78.0 mttt -60.79 -41.79 96.28 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 170.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.58 -17.1 64.32 Favored 'General case' 0 CA--C 1.572 1.804 0 N-CA-C 118.386 2.736 . . . . 0.0 118.386 169.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -68.3 -64.42 0.87 Allowed 'General case' 0 CA--C 1.571 1.778 0 CA-C-N 120.43 1.468 . . . . 0.0 112.826 169.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 69.51 -127.16 19.78 Favored Glycine 0 N--CA 1.491 2.303 0 CA-C-N 119.384 0.993 . . . . 0.0 114.17 -174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 59.51 -124.38 36.23 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 116.071 1.188 . . . . 0.0 116.071 167.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -154.81 151.93 29.22 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 114.286 1.217 . . . . 0.0 114.286 170.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.406 ' CE2' HG22 ' A' ' 38' ' ' VAL . 12.8 m95 -81.44 84.58 6.65 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 122.366 1.079 . . . . 0.0 112.553 160.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 71.4 p -75.73 161.42 76.12 Favored Pre-proline 0 CA--C 1.578 2.053 0 C-N-CA 124.133 0.973 . . . . 0.0 113.614 174.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.01 58.75 2.84 Favored 'Trans proline' 0 CA--C 1.578 2.71 0 C-N-CA 122.822 2.348 . . . . 0.0 115.229 169.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -176.69 -59.87 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 125.914 1.685 . . . . 0.0 107.274 -160.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.95 -47.27 86.5 Favored 'General case' 0 CA--C 1.567 1.614 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 159.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 63.3 mt -61.12 -34.91 75.73 Favored 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 166.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.9 mm-40 -62.07 -33.4 74.35 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 171.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -79.15 -50.7 10.59 Favored 'General case' 0 CA--C 1.569 1.711 0 C-N-CA 124.346 1.058 . . . . 0.0 111.81 167.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -62.95 -39.58 95.07 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 116.561 2.06 . . . . 0.0 116.561 179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 72.2 mt -64.69 -23.34 67.22 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 117.163 2.283 . . . . 0.0 117.163 172.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.6 m -88.98 -29.36 19.57 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 115.841 1.793 . . . . 0.0 115.841 162.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.511 ' HB3' ' HB3' ' A' ' 71' ' ' ALA . 10.7 m-80 -131.73 69.84 81.21 Favored Pre-proline 0 CA--C 1.582 2.184 0 C-N-CA 125.108 1.363 . . . . 0.0 110.22 -178.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_exo -62.2 -53.96 1.69 Allowed 'Trans proline' 0 C--N 1.378 2.106 0 C-N-CA 123.116 2.544 . . . . 0.0 115.901 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -84.1 31.83 0.49 Allowed 'General case' 0 CA--C 1.576 1.946 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 169.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.511 ' HB3' ' HB3' ' A' ' 68' ' ' ASN . . . -134.84 -40.63 0.77 Allowed 'General case' 0 CA--C 1.569 1.707 0 C-N-CA 125.51 1.524 . . . . 0.0 112.137 173.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.1 t -67.43 -53.28 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.982 1.719 . . . . 0.0 111.59 159.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.7 t -105.71 85.8 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 166.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -71.54 106.93 4.18 Favored 'General case' 0 CA--C 1.57 1.712 0 O-C-N 120.788 -1.195 . . . . 0.0 110.83 179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 98.69 33.57 5.54 Favored Glycine 0 CA--C 1.555 2.568 0 N-CA-C 117.731 1.853 . . . . 0.0 117.731 -159.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.3 t -76.06 143.21 41.5 Favored 'General case' 0 CA--C 1.564 1.485 0 CA-C-N 119.309 1.555 . . . . 0.0 110.911 162.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 5.2 tppt? -63.99 -0.89 1.25 Allowed 'General case' 0 CA--C 1.584 2.251 0 N-CA-C 117.074 2.249 . . . . 0.0 117.074 163.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.2 ttt -81.96 105.17 12.86 Favored 'General case' 0 CA--C 1.559 1.298 0 O-C-N 120.886 -1.134 . . . . 0.0 110.624 -177.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.8 71.52 5.26 Favored 'General case' 0 CA--C 1.567 1.632 0 CA-C-O 122.938 1.351 . . . . 0.0 112.824 174.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -138.74 130.11 27.2 Favored 'General case' 0 CA--C 1.561 1.374 0 C-N-CA 124.649 1.179 . . . . 0.0 107.86 -177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -75.89 -44.47 40.33 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 115.875 1.806 . . . . 0.0 115.875 -178.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.81 138.43 3.15 Favored Glycine 0 CA--C 1.543 1.828 0 N-CA-C 115.49 0.956 . . . . 0.0 115.49 -176.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.4 mt -76.03 135.57 70.26 Favored Pre-proline 0 CA--C 1.574 1.875 0 CA-C-O 118.266 -0.873 . . . . 0.0 113.064 166.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -82.1 -57.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.564 1.996 0 C-N-CA 122.315 2.01 . . . . 0.0 115.838 -173.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.62 144.92 29.12 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 119.125 0.875 . . . . 0.0 111.97 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -58.84 -36.23 60.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 171.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.81 -29.24 70.46 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 116.795 2.146 . . . . 0.0 116.795 169.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -72.81 -50.19 25.74 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 120.138 1.335 . . . . 0.0 112.744 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.27 0.3 OUTLIER -66.6 -38.36 86.83 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 117.224 2.305 . . . . 0.0 117.224 165.595 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.73 -44.36 90.46 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 117.5 2.407 . . . . 0.0 117.5 168.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -57.76 -48.56 79.29 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.466 HD21 HMB1 ' A' ' 101' ' ' HEC . 68.2 tp -54.68 -45.21 73.88 Favored 'General case' 0 CA--C 1.572 1.81 0 N-CA-C 116.689 2.107 . . . . 0.0 116.689 165.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.5 mt -62.67 -43.86 98.95 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 CA-C-N 120.2 1.364 . . . . 0.0 113.286 173.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.83 -45.76 78.28 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 116.674 2.101 . . . . 0.0 116.674 165.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -52.4 -54.35 33.1 Favored 'General case' 0 CA--C 1.57 1.715 0 N-CA-C 115.205 1.558 . . . . 0.0 115.205 162.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 61.4 mt -64.29 -26.59 68.56 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.41 -52.89 41.82 Favored 'General case' 0 CA--C 1.57 1.729 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 161.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -75.16 -54.02 5.88 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 117.735 1.854 . . . . 0.0 117.735 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -90.26 94.03 9.59 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 122.045 0.926 . . . . 0.0 109.564 174.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 . . . . . 0 C--O 1.254 1.291 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.729 -169.378 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.601 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.5 tpt . . . . . 0 CA--C 1.562 1.412 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.31 80.62 1.51 Allowed 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 123.743 0.817 . . . . 0.0 111.763 177.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -112.19 103.55 55.41 Favored Pre-proline 0 CA--C 1.571 1.76 0 CA-C-O 118.204 -0.903 . . . . 0.0 109.58 -172.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -67.92 -32.87 27.91 Favored 'Trans proline' 0 CA--C 1.569 2.247 0 C-N-CA 122.625 2.217 . . . . 0.0 117.346 -179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -64.92 -25.5 67.91 Favored 'General case' 0 CA--C 1.571 1.763 0 N-CA-C 117.385 2.365 . . . . 0.0 117.385 167.38 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.55 -35.42 34.42 Favored 'General case' 0 CA--C 1.568 1.671 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 159.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -61.65 -26.52 66.85 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 119.096 2.398 . . . . 0.0 119.096 175.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -59.81 -41.26 90.86 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 164.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . 0.27 51.4 pttt -79.71 -30.76 41.05 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 171.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.0 t -61.8 -43.51 97.42 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.521 0 CA-C-N 121.396 1.907 . . . . 0.0 112.984 160.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 50.7 t80 -54.91 -17.07 3.19 Favored 'General case' 0 CA--C 1.572 1.802 0 N-CA-C 117.778 2.51 . . . . 0.0 117.778 163.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.36 -33.45 39.42 Favored Glycine 0 CA--C 1.558 2.724 0 N-CA-C 119.088 2.395 . . . . 0.0 119.088 163.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 50.2 mtmt -69.04 -32.28 71.67 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 165.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.2 m -78.58 -37.31 42.9 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 116.403 2.001 . . . . 0.0 116.403 172.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -66.04 -18.76 65.55 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 120.026 3.343 . . . . 0.0 120.026 -162.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.44 -33.98 74.64 Favored 'General case' 0 CA--C 1.569 1.707 0 N-CA-C 116.165 1.913 . . . . 0.0 116.165 162.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 58.9 m -91.85 -44.82 8.72 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 115.832 1.79 . . . . 0.0 115.832 168.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -110.05 132.06 54.5 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 120.127 1.33 . . . . 0.0 112.254 -171.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 mtmm -95.56 -40.06 9.63 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.565 3.2 pp 60.77 -10.65 0.05 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 120.213 3.412 . . . . 0.0 120.213 -165.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.1 m-20 -88.66 61.46 6.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.103 -0.998 . . . . 0.0 112.053 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.17 -51.15 2.43 Favored Glycine 0 N--CA 1.493 2.494 0 N-CA-C 118.16 2.024 . . . . 0.0 118.16 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -94.53 164.64 12.9 Favored 'General case' 0 CA--C 1.569 1.702 0 CA-C-O 122.967 1.365 . . . . 0.0 112.239 177.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -86.93 -80.17 0.25 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.352 -0.842 . . . . 0.0 112.929 -159.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.27 -134.16 10.25 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 123.882 0.753 . . . . 0.0 112.413 -172.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 t -81.76 -51.76 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.263 0 O-C-N 122.143 -0.622 . . . . 0.0 110.35 162.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -88.19 175.98 45.01 Favored Glycine 0 CA--C 1.559 2.802 0 N-CA-C 115.698 1.039 . . . . 0.0 115.698 165.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -68.21 166.08 26.4 Favored 'Trans proline' 0 CA--C 1.563 1.946 0 C-N-CA 122.924 2.416 . . . . 0.0 116.457 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p-80 -70.84 121.47 18.12 Favored 'General case' 0 CA--C 1.568 1.658 0 O-C-N 120.862 -1.149 . . . . 0.0 112.02 170.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 66.6 mt -93.84 16.91 13.06 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 -172.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 36.9 p-10 -61.54 103.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.97 37.11 64.72 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.034 1.574 . . . . 0.0 117.034 -171.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.265 8.8 p -68.91 -24.41 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 116.522 2.045 . . . . 0.0 116.522 176.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.6 t -70.91 108.9 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.802 0 C-N-CA 124.299 1.04 . . . . 0.0 109.461 175.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 82.97 27.46 41.03 Favored Glycine 0 CA--C 1.554 2.53 0 N-CA-C 118.395 2.118 . . . . 0.0 118.395 -163.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.0 ttp180 -126.3 147.62 49.68 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 119.133 1.466 . . . . 0.0 110.298 179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.269 52.6 m -58.34 140.54 53.32 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.887 1.81 . . . . 0.0 115.887 -172.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.3 t -71.84 121.1 21.34 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.641 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.347 173.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.322 . . 68.24 18.18 9.26 Favored 'General case' 0 CA--C 1.575 1.925 0 N-CA-C 118.364 2.727 . . . . 0.0 118.364 -158.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.14 66.72 1.81 Allowed Glycine 0 N--CA 1.488 2.109 0 O-C-N 120.234 -1.541 . . . . 0.0 116.312 -177.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 62.7 t -140.31 107.39 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 N-CA-C 105.935 -1.876 . . . . 0.0 105.935 168.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -73.67 104.55 4.64 Favored 'General case' 0 CA--C 1.567 1.619 0 O-C-N 121.746 -0.596 . . . . 0.0 111.106 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.82 -50.57 0.77 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 114.72 0.648 . . . . 0.0 114.72 -162.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 42.3 t80 -87.24 128.14 35.16 Favored 'General case' 0 CA--C 1.566 1.59 0 CA-C-N 118.106 0.953 . . . . 0.0 111.671 178.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -82.12 109.23 16.24 Favored 'General case' 0 CA--C 1.567 1.606 0 CA-C-O 121.63 0.729 . . . . 0.0 111.225 172.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -87.51 166.61 14.63 Favored 'General case' 0 CA--C 1.569 1.683 0 CA-C-O 122.641 1.21 . . . . 0.0 113.822 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 95.1 p -66.68 153.59 42.79 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 168.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -56.05 -47.01 99.69 Favored Pre-proline 0 CA--C 1.576 1.956 0 N-CA-C 116.698 2.11 . . . . 0.0 116.698 176.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -65.79 -27.13 52.07 Favored 'Trans proline' 0 CA--C 1.569 2.265 0 CA-C-N 125.179 2.885 . . . . 0.0 116.883 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 35.7 tpp -65.69 -49.92 66.76 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 113.809 1.04 . . . . 0.0 113.809 166.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 77.2 mttt -59.05 -46.01 89.33 Favored 'General case' 0 CA--C 1.569 1.694 0 N-CA-C 115.362 1.615 . . . . 0.0 115.362 168.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.03 -23.95 66.65 Favored 'General case' 0 CA--C 1.568 1.666 0 N-CA-C 118.157 2.651 . . . . 0.0 118.157 171.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -65.31 -68.08 0.39 Allowed 'General case' 0 CA--C 1.569 1.708 0 CA-C-N 120.019 1.281 . . . . 0.0 112.212 165.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.2 -159.42 44.3 Favored Glycine 0 CA--C 1.552 2.391 0 N-CA-C 116.314 1.286 . . . . 0.0 116.314 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.75 -108.28 2.79 Favored Glycine 0 N--CA 1.488 2.125 0 O-C-N 120.99 -1.3 . . . . 0.0 113.534 171.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -157.37 150.01 23.12 Favored 'General case' 0 N--CA 1.49 1.54 0 CA-C-O 122.271 1.034 . . . . 0.0 113.757 176.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 12.6 m95 -84.17 90.38 7.49 Favored 'General case' 0 CA--C 1.563 1.449 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.611 168.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 81.5 p -72.62 156.75 89.85 Favored Pre-proline 0 CA--C 1.579 2.059 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.9 55.87 2.34 Favored 'Trans proline' 0 CA--C 1.578 2.723 0 C-N-CA 122.964 2.442 . . . . 0.0 116.047 171.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -173.19 -59.98 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.66 0 C-N-CA 126.08 1.752 . . . . 0.0 107.162 -166.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.21 -45.01 75.89 Favored 'General case' 0 CA--C 1.566 1.587 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 160.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 73.9 mt -59.76 -35.44 74.6 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 116.066 1.876 . . . . 0.0 116.066 162.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -62.99 -45.41 92.55 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 121.255 1.843 . . . . 0.0 114.511 172.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -64.92 -47.91 76.03 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 168.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -63.5 -48.33 78.06 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 174.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.2 mt -63.29 -25.45 68.32 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 116.027 1.862 . . . . 0.0 116.027 169.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 3.0 m -69.6 -43.55 72.54 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 121.193 1.815 . . . . 0.0 115.203 164.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 -149.75 86.31 5.41 Favored Pre-proline 0 CA--C 1.576 1.966 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 -173.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -57.11 -43.94 48.69 Favored 'Trans proline' 0 C--N 1.372 1.765 0 C-N-CA 123.455 2.77 . . . . 0.0 117.21 -176.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 77.9 mttt -68.41 -17.78 64.29 Favored 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 117.576 2.436 . . . . 0.0 117.576 169.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.96 -42.51 69.66 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.479 1.659 . . . . 0.0 115.479 167.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 75.9 t -81.09 -54.9 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-N 119.172 0.896 . . . . 0.0 111.792 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 86.8 t -104.16 92.89 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 CA-C-N 120.044 1.293 . . . . 0.0 107.576 177.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.47 105.64 2.69 Favored 'General case' 0 CA--C 1.567 1.621 0 N-CA-C 113.947 1.092 . . . . 0.0 113.947 -174.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 84.68 45.71 5.98 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 117.122 1.609 . . . . 0.0 117.122 -166.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 14.6 t -73.43 144.79 46.2 Favored 'General case' 0 CA--C 1.562 1.417 0 CA-C-N 118.684 1.242 . . . . 0.0 112.761 171.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.58 7.15 1.54 Allowed 'General case' 0 CA--C 1.576 1.962 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 159.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.1 ttt -81.26 101.96 10.07 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.336 1.425 . . . . 0.0 109.6 169.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.91 72.44 5.43 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-O 122.734 1.254 . . . . 0.0 112.861 176.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -137.13 131.96 33.36 Favored 'General case' 0 CA--C 1.562 1.411 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.56 -175.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -79.39 -38.03 35.89 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 116.298 1.962 . . . . 0.0 116.298 -178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 146.32 140.71 3.5 Favored Glycine 0 N--CA 1.485 1.948 0 N-CA-C 117.132 1.613 . . . . 0.0 117.132 -172.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.8 mt -84.1 125.87 71.43 Favored Pre-proline 0 CA--C 1.57 1.73 0 CA-C-O 117.931 -1.033 . . . . 0.0 111.578 164.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -83.36 -44.33 0.07 OUTLIER 'Trans proline' 0 CA--C 1.564 1.98 0 C-N-CA 122.447 2.098 . . . . 0.0 117.24 -167.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -88.76 147.94 24.21 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-N 119.592 1.087 . . . . 0.0 111.852 177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.5 tp -57.05 -36.48 51.17 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 168.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.96 -28.96 70.44 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 167.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.9 -58.87 6.28 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 121.163 1.801 . . . . 0.0 113.624 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.273 0.0 OUTLIER -63.76 -43.17 97.21 Favored 'General case' 0 CA--C 1.568 1.643 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 171.11 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.37 -41.25 93.35 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 117.674 2.472 . . . . 0.0 117.674 171.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -61.17 -47.8 84.51 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 114.267 1.21 . . . . 0.0 114.267 167.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -44.93 95.53 Favored 'General case' 0 CA--C 1.575 1.939 0 N-CA-C 115.506 1.669 . . . . 0.0 115.506 171.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 61.9 mt -59.77 -37.38 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.225 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -59.99 -48.54 81.3 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 164.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -52.85 -52.59 56.65 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 166.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 79.8 mt -61.46 -29.24 69.84 Favored 'General case' 0 N--CA 1.499 2.009 0 N-CA-C 116.98 2.215 . . . . 0.0 116.98 176.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -65.46 -49.71 68.09 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.83 1.419 . . . . 0.0 114.83 163.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -79.11 -47.11 7.77 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 118.963 2.345 . . . . 0.0 118.963 178.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -96.48 94.48 7.42 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.066 0.946 . . . . 0.0 110.017 -170.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 C--O 1.255 1.353 0 CA-C-O 118.138 -0.934 . . . . 0.0 112.579 -169.38 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.642 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.9 mtt . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 115.186 1.551 . . . . 0.0 115.186 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.74 73.54 0.91 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 120.199 1.363 . . . . 0.0 112.092 172.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -108.72 103.64 52.17 Favored Pre-proline 0 CA--C 1.57 1.728 0 O-C-N 121.394 -0.816 . . . . 0.0 109.71 -175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -67.81 -30.33 33.86 Favored 'Trans proline' 0 CA--C 1.568 2.222 0 C-N-CA 122.792 2.328 . . . . 0.0 117.466 -179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.99 -23.52 66.6 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 117.358 2.355 . . . . 0.0 117.358 165.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -80.02 -36.5 35.72 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 158.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -63.02 -23.13 65.57 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 119.263 2.465 . . . . 0.0 119.263 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -61.41 -43.08 99.49 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 167.033 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 51.2 pttt -76.5 -30.74 57.34 Favored 'General case' 0 CA--C 1.568 1.659 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 170.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 t -63.94 -44.16 97.88 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.38 0 CA-C-N 120.971 1.714 . . . . 0.0 112.83 162.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.5 t80 -57.24 -21.78 36.46 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.241 2.312 . . . . 0.0 117.241 163.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -52.93 -34.78 46.44 Favored Glycine 0 CA--C 1.557 2.666 0 N-CA-C 118.859 2.304 . . . . 0.0 118.859 164.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -68.14 -37.76 81.41 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 115.42 1.637 . . . . 0.0 115.42 165.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 m -68.34 -38.71 81.74 Favored 'General case' 0 CA--C 1.569 1.699 0 N-CA-C 116.64 2.089 . . . . 0.0 116.64 170.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . 0.255 0.1 OUTLIER -73.07 -6.69 47.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 119.817 3.266 . . . . 0.0 119.817 -166.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.42 -33.53 72.64 Favored 'General case' 0 CA--C 1.571 1.785 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 155.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 57.0 m -95.78 -47.45 6.16 Favored 'General case' 0 CA--C 1.572 1.816 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 168.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -103.4 135.66 44.61 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 120.249 1.386 . . . . 0.0 113.804 -169.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -100.24 -42.42 6.68 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.317 23.5 mt 84.74 -45.97 0.08 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.028 1.331 . . . . 0.0 114.181 -166.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -83.86 58.72 4.82 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 113.859 1.059 . . . . 0.0 113.859 -165.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.6 8.62 14.92 Favored Glycine 0 N--CA 1.497 2.731 0 N-CA-C 120.923 3.129 . . . . 0.0 120.923 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -131.0 165.56 22.91 Favored 'General case' 0 CA--C 1.567 1.608 0 CA-C-N 118.85 1.325 . . . . 0.0 110.091 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -113.25 -82.37 0.6 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.202 -0.936 . . . . 0.0 111.154 -168.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 95.6 -95.5 1.84 Allowed Glycine 0 N--CA 1.489 2.226 0 O-C-N 121.41 -0.806 . . . . 0.0 112.563 -176.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.0 t -102.07 -62.39 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 164.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -91.82 142.1 15.92 Favored Glycine 0 CA--C 1.554 2.487 0 CA-C-O 118.836 -0.98 . . . . 0.0 114.312 176.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.81 152.04 63.59 Favored 'Trans proline' 0 CA--C 1.558 1.716 0 CA-C-N 121.494 2.647 . . . . 0.0 115.885 -179.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.6 p-80 -50.93 121.66 6.34 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 -179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 61.1 mt -91.47 22.05 4.21 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -61.27 99.98 0.11 Allowed 'General case' 0 CA--C 1.567 1.607 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -178.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.31 38.39 81.29 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 117.559 1.784 . . . . 0.0 117.559 -169.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.275 7.4 p -66.69 -27.92 41.57 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 N-CA-C 116.494 2.035 . . . . 0.0 116.494 177.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 40.7 t -69.99 104.97 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.572 1.813 0 C-N-CA 124.068 0.947 . . . . 0.0 109.447 174.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.0 8.47 63.27 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.427 2.531 . . . . 0.0 119.427 -164.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.6 ttp180 -104.74 153.0 21.85 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 120.134 1.967 . . . . 0.0 110.642 175.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.4 t -54.38 151.58 7.43 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.403 HG22 ' CE2' ' A' ' 57' ' ' TRP . 30.6 t -76.34 133.66 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.735 0 CA-C-N 115.225 -0.898 . . . . 0.0 109.066 165.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.309 . . 68.18 30.18 5.83 Favored 'General case' 0 CA--C 1.576 1.973 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 -154.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -94.21 58.59 2.02 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 118.353 2.101 . . . . 0.0 118.353 -171.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 50.1 t -141.66 109.53 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 106.217 -1.772 . . . . 0.0 106.217 162.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -70.53 94.54 0.99 Allowed 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 176.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.02 -46.89 0.71 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 115.108 0.803 . . . . 0.0 115.108 -163.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -80.33 138.0 36.66 Favored 'General case' 0 CA--C 1.568 1.673 0 CA-C-N 118.441 1.12 . . . . 0.0 112.806 178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -75.88 89.05 2.9 Favored 'General case' 0 CA--C 1.567 1.627 0 C-N-CA 124.433 1.093 . . . . 0.0 113.664 171.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -79.86 158.96 26.61 Favored 'General case' 0 CA--C 1.57 1.724 0 O-C-N 121.387 -0.821 . . . . 0.0 112.792 176.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 73.0 p -70.18 159.4 34.03 Favored 'General case' 0 CA--C 1.569 1.703 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 175.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -57.59 -48.72 96.75 Favored Pre-proline 0 CA--C 1.578 2.034 0 CA-C-O 115.999 -1.953 . . . . 0.0 116.224 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -67.65 -24.35 41.54 Favored 'Trans proline' 0 CA--C 1.571 2.342 0 CA-C-N 124.84 2.764 . . . . 0.0 117.02 170.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -62.7 -51.38 67.4 Favored 'General case' 0 CA--C 1.569 1.68 0 N-CA-C 114.748 1.388 . . . . 0.0 114.748 163.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -60.15 -41.01 91.85 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 169.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.64 -21.08 66.64 Favored 'General case' 0 CA--C 1.571 1.771 0 N-CA-C 118.413 2.746 . . . . 0.0 118.413 169.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -66.05 -63.98 0.96 Allowed 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 120.377 1.444 . . . . 0.0 112.701 167.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 67.75 -126.41 24.12 Favored Glycine 0 N--CA 1.49 2.233 0 CA-C-N 119.371 0.987 . . . . 0.0 114.294 -176.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 57.75 -119.04 14.65 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 116.447 1.339 . . . . 0.0 116.447 167.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 35.9 m-20 -154.17 151.99 29.86 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 113.656 0.984 . . . . 0.0 113.656 170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.403 ' CE2' HG22 ' A' ' 38' ' ' VAL . 23.4 m95 -80.25 86.81 5.6 Favored 'General case' 0 CA--C 1.561 1.373 0 CA-C-O 121.908 0.861 . . . . 0.0 112.349 159.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.1 p -71.63 156.47 91.26 Favored Pre-proline 0 CA--C 1.577 1.999 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 174.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -65.64 17.38 0.09 OUTLIER 'Trans proline' 0 CA--C 1.579 2.745 0 N-CA-C 119.376 2.798 . . . . 0.0 119.376 172.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -129.63 -40.28 1.41 Allowed 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 125.545 1.538 . . . . 0.0 111.712 169.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.61 -42.49 71.23 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 161.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.0 mt -59.21 -33.24 70.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 116.319 1.97 . . . . 0.0 116.319 162.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -68.08 -30.84 70.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 116.372 1.99 . . . . 0.0 116.372 172.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -76.64 -51.19 12.03 Favored 'General case' 0 CA--C 1.57 1.725 0 CA-C-N 118.78 0.718 . . . . 0.0 112.666 164.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -60.39 -43.41 96.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.978 1.844 . . . . 0.0 115.978 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.7 mt -66.4 -9.66 35.95 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 117.751 2.5 . . . . 0.0 117.751 171.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 47.2 m -104.3 -34.88 8.17 Favored 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 120.71 1.596 . . . . 0.0 114.919 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -133.69 81.75 52.54 Favored Pre-proline 0 CA--C 1.578 2.047 0 CA-C-N 120.806 1.639 . . . . 0.0 107.993 170.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.47 -46.68 30.5 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.714 2.943 . . . . 0.0 117.242 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -83.0 12.52 4.87 Favored 'General case' 0 CA--C 1.574 1.885 0 N-CA-C 117.454 2.39 . . . . 0.0 117.454 171.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -92.47 -44.27 8.75 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 120.189 1.359 . . . . 0.0 113.73 159.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.8 t -71.35 -50.64 39.46 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 119.031 0.832 . . . . 0.0 112.2 173.023 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 99.0 t -110.05 90.28 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.915 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 170.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.31 107.89 3.0 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.948 . . . . 0.0 111.199 178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 89.74 40.81 5.84 Favored Glycine 0 CA--C 1.554 2.494 0 N-CA-C 117.857 1.903 . . . . 0.0 117.857 -161.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 15.2 t -76.03 137.8 40.46 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 118.851 1.325 . . . . 0.0 110.379 163.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 14.2 ttmm -65.78 6.45 0.35 Allowed 'General case' 0 CA--C 1.584 2.264 0 N-CA-C 116.86 2.17 . . . . 0.0 116.86 166.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 3.0 ttt -87.33 105.75 17.46 Favored 'General case' 0 CA--C 1.559 1.302 0 O-C-N 120.81 -1.182 . . . . 0.0 109.915 -178.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.97 71.71 5.44 Favored 'General case' 0 CA--C 1.568 1.637 0 CA-C-O 122.504 1.145 . . . . 0.0 113.011 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.6 t80 -135.5 130.85 35.3 Favored 'General case' 0 CA--C 1.562 1.429 0 C-N-CA 123.971 0.908 . . . . 0.0 109.319 -174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.42 -33.9 48.34 Favored 'General case' 0 CA--C 1.563 1.478 0 N-CA-C 116.724 2.12 . . . . 0.0 116.724 -179.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 134.8 144.88 5.1 Favored Glycine 0 N--CA 1.486 1.997 0 N-CA-C 117.225 1.65 . . . . 0.0 117.225 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 81.4 mt -82.01 137.19 46.63 Favored Pre-proline 0 CA--C 1.573 1.852 0 C-N-CA 123.899 0.88 . . . . 0.0 112.753 166.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.17 -55.41 0.03 OUTLIER 'Trans proline' 0 CA--C 1.563 1.968 0 C-N-CA 122.413 2.076 . . . . 0.0 115.964 -174.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 11.8 mmpt? -83.51 149.14 26.81 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 119.574 1.079 . . . . 0.0 111.877 -176.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 10.9 tp -60.41 -34.83 59.26 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.765 1.394 . . . . 0.0 114.765 169.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -63.02 -30.73 71.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 165.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -59.52 -54.92 40.95 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 121.38 1.9 . . . . 0.0 113.771 174.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.38 -44.49 82.96 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 168.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -58.42 -39.35 79.54 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 117.652 2.464 . . . . 0.0 117.652 171.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -60.52 -49.39 77.76 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 166.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.13 -42.99 99.54 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 172.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 65.1 mt -59.45 -45.41 93.66 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 120.683 -1.261 . . . . 0.0 113.154 169.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -56.14 -46.04 79.38 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 116.499 2.037 . . . . 0.0 116.499 166.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -51.16 -53.4 35.0 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.204 1.557 . . . . 0.0 115.204 162.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 66.0 mt -65.04 -27.85 69.08 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 117.003 2.223 . . . . 0.0 117.003 177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -65.7 -50.75 63.73 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 163.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.88 -58.57 4.02 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 117.194 1.637 . . . . 0.0 117.194 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 -86.48 116.95 24.96 Favored 'General case' 0 N--CA 1.487 1.393 0 CA-C-N 117.614 0.707 . . . . 0.0 110.855 176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 . . . . . 0 C--O 1.253 1.271 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -173.339 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.635 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.491 1.624 0 N-CA-C 115.979 1.844 . . . . 0.0 115.979 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.75 72.52 0.86 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.773 1.624 . . . . 0.0 113.146 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.4 t0 -104.65 107.79 59.09 Favored Pre-proline 0 CA--C 1.574 1.903 0 O-C-N 121.269 -0.894 . . . . 0.0 110.205 177.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.1 -27.67 24.55 Favored 'Trans proline' 0 CA--C 1.569 2.274 0 C-N-CA 122.765 2.31 . . . . 0.0 117.472 175.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -65.75 -34.07 77.33 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 167.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -71.1 -34.63 71.3 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 115.987 1.847 . . . . 0.0 115.987 159.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -65.58 -29.69 75.74 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 119.089 2.396 . . . . 0.0 119.089 176.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -62.09 -36.26 81.18 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 162.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.3 mmmp? -67.12 -46.76 73.19 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 124.019 0.928 . . . . 0.0 113.315 171.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 t -62.52 -39.04 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 169.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -57.1 -22.65 41.17 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 117.209 2.3 . . . . 0.0 117.209 163.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -50.84 -31.79 24.77 Favored Glycine 0 CA--C 1.56 2.905 0 N-CA-C 119.195 2.438 . . . . 0.0 119.195 161.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -66.92 -39.82 87.49 Favored 'General case' 0 CA--C 1.576 1.966 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 165.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.4 m -75.99 -36.22 59.29 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 116.528 2.047 . . . . 0.0 116.528 177.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.3 ptpt -66.9 -8.04 26.4 Favored 'General case' 0 N--CA 1.499 2.012 0 N-CA-C 119.873 3.286 . . . . 0.0 119.873 -171.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.29 -37.53 80.79 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 115.503 1.668 . . . . 0.0 115.503 157.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 32.2 m -99.89 -45.66 5.64 Favored 'General case' 0 CA--C 1.572 1.808 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 172.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 -100.92 133.39 45.48 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 120.1 1.318 . . . . 0.0 113.537 -170.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -102.69 -30.71 10.74 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 117.426 2.38 . . . . 0.0 117.426 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.2 mt 75.09 -41.31 0.46 Allowed 'General case' 0 N--CA 1.51 2.548 0 N-CA-C 115.859 1.8 . . . . 0.0 115.859 -172.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -90.72 58.3 3.84 Favored 'General case' 0 CA--C 1.566 1.573 0 C-N-CA 123.73 0.812 . . . . 0.0 112.111 -163.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 61.9 6.66 9.91 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 120.94 3.136 . . . . 0.0 120.94 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -126.55 165.07 19.83 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 119.276 1.538 . . . . 0.0 110.904 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 44.9 m-20 -119.88 -80.54 0.62 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.475 -0.766 . . . . 0.0 110.535 -167.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.58 -93.08 1.85 Allowed Glycine 0 N--CA 1.49 2.237 0 O-C-N 121.262 -0.899 . . . . 0.0 113.295 179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.6 t -98.5 -64.97 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 165.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.54 138.53 14.06 Favored Glycine 0 CA--C 1.553 2.46 0 CA-C-O 118.442 -1.199 . . . . 0.0 114.265 179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.29 149.21 75.47 Favored 'Trans proline' 0 CA--C 1.56 1.796 0 CA-C-N 121.904 2.852 . . . . 0.0 115.35 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 -52.13 123.21 10.03 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.728 1.751 . . . . 0.0 115.728 -177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 64.7 mt -93.35 18.72 9.22 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 -172.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -59.18 105.64 0.35 Allowed 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 177.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 37.11 92.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 117.633 1.813 . . . . 0.0 117.633 -171.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 8.0 p -68.14 -26.24 33.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 38.4 t -71.65 106.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-N 119.202 0.91 . . . . 0.0 109.094 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.0 26.83 33.11 Favored Glycine 0 CA--C 1.554 2.528 0 N-CA-C 118.61 2.204 . . . . 0.0 118.61 -163.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.9 ttp180 -122.66 150.1 43.15 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 119.081 1.441 . . . . 0.0 110.066 174.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . 0.315 0.6 OUTLIER -59.89 150.6 28.12 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.405 1.631 . . . . 0.0 115.405 -174.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.0 t -79.11 115.85 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.683 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 173.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.321 . . 73.51 62.87 0.09 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -150.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -122.59 52.57 0.76 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 117.051 1.58 . . . . 0.0 117.051 -177.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 48.7 t -142.48 108.44 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 N-CA-C 105.848 -1.908 . . . . 0.0 105.848 168.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -73.84 100.87 3.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.496 -0.752 . . . . 0.0 110.953 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.17 -48.35 0.74 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 115.268 0.867 . . . . 0.0 115.268 -163.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -79.76 141.84 35.94 Favored 'General case' 0 CA--C 1.57 1.734 0 CA-C-N 118.422 1.111 . . . . 0.0 113.254 -179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -78.64 91.02 4.59 Favored 'General case' 0 CA--C 1.57 1.724 0 CA-C-O 121.702 0.763 . . . . 0.0 111.881 173.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -75.83 158.28 32.34 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 177.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 26.6 p -74.08 159.12 33.08 Favored 'General case' 0 CA--C 1.568 1.638 0 O-C-N 121.08 -1.012 . . . . 0.0 113.653 172.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.25 -51.19 81.83 Favored Pre-proline 0 CA--C 1.577 2.014 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -71.47 -14.21 30.67 Favored 'Trans proline' 0 CA--C 1.569 2.257 0 CA-C-N 123.729 2.367 . . . . 0.0 117.48 171.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -60.74 -60.99 2.92 Favored 'General case' 0 CA--C 1.569 1.699 0 CA-C-N 120.359 1.436 . . . . 0.0 113.872 159.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.8 ptpt -68.86 -33.02 73.12 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.09 2.256 . . . . 0.0 117.09 175.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.8 -18.02 64.11 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 117.688 2.477 . . . . 0.0 117.688 164.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 4.0 t-80 -67.58 -65.91 0.63 Allowed 'General case' 0 N--CA 1.494 1.741 0 CA-C-N 120.712 1.597 . . . . 0.0 111.771 161.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.9 -128.95 29.47 Favored Glycine 0 N--CA 1.489 2.204 0 CA-C-N 119.528 1.058 . . . . 0.0 114.039 -175.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.3 -127.87 44.64 Favored Glycine 0 N--CA 1.493 2.466 0 O-C-N 121.194 -1.18 . . . . 0.0 114.807 171.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -149.43 152.36 35.57 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 166.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 8.5 m95 -77.64 89.83 3.95 Favored 'General case' 0 CA--C 1.565 1.53 0 CA-C-O 121.947 0.879 . . . . 0.0 112.874 167.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 73.9 p -77.36 158.54 79.11 Favored Pre-proline 0 CA--C 1.581 2.135 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 177.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -72.4 46.18 0.93 Allowed 'Trans proline' 0 CA--C 1.58 2.794 0 C-N-CA 123.158 2.572 . . . . 0.0 117.952 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -167.22 -58.48 0.03 OUTLIER 'General case' 0 CA--C 1.566 1.583 0 C-N-CA 126.079 1.752 . . . . 0.0 108.484 -161.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.51 -44.76 73.0 Favored 'General case' 0 CA--C 1.568 1.649 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 155.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 79.2 mt -60.04 -34.76 73.84 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.163 1.912 . . . . 0.0 116.163 162.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -64.7 -44.58 89.82 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 121.737 2.062 . . . . 0.0 114.812 171.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -64.63 -45.74 85.55 Favored 'General case' 0 CA--C 1.571 1.765 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 168.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -64.48 -50.09 68.8 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 173.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.73 -24.12 66.59 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 116.331 1.974 . . . . 0.0 116.331 169.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 2.8 m -72.51 -35.68 68.19 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 121.452 1.933 . . . . 0.0 115.617 164.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -157.54 85.55 2.74 Favored Pre-proline 0 CA--C 1.574 1.899 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 -175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -58.82 -44.62 34.46 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 123.377 2.718 . . . . 0.0 117.308 -172.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 81.7 mttt -66.93 -18.0 65.17 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 117.378 2.362 . . . . 0.0 117.378 170.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.76 -44.96 63.15 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 168.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 71.0 t -77.75 -51.95 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-N 118.984 0.811 . . . . 0.0 112.052 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.82 94.23 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 173.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 106.68 4.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.315 -0.865 . . . . 0.0 111.917 176.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.89 41.1 4.75 Favored Glycine 0 CA--C 1.553 2.406 0 N-CA-C 117.221 1.648 . . . . 0.0 117.221 -160.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 12.0 t -80.05 137.14 36.72 Favored 'General case' 0 CA--C 1.563 1.458 0 CA-C-N 118.739 1.269 . . . . 0.0 109.966 161.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 44.8 mttm -67.95 6.88 0.62 Allowed 'General case' 0 CA--C 1.582 2.21 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 164.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.7 ttt -82.79 106.21 14.44 Favored 'General case' 0 CA--C 1.56 1.341 0 O-C-N 120.609 -1.307 . . . . 0.0 110.582 179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.15 69.75 4.41 Favored 'General case' 0 CA--C 1.569 1.708 0 CA-C-O 122.812 1.292 . . . . 0.0 113.385 174.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -139.62 131.78 28.09 Favored 'General case' 0 CA--C 1.562 1.406 0 C-N-CA 124.438 1.095 . . . . 0.0 108.405 -177.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -81.84 -36.29 28.45 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 -178.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 148.26 139.7 3.22 Favored Glycine 0 CA--C 1.546 2.002 0 N-CA-C 117.482 1.753 . . . . 0.0 117.482 -170.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.7 mt -84.74 126.47 68.43 Favored Pre-proline 0 CA--C 1.569 1.71 0 CA-C-O 118.036 -0.983 . . . . 0.0 111.892 165.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -82.85 -41.34 0.11 Allowed 'Trans proline' 0 CA--C 1.563 1.942 0 C-N-CA 122.427 2.085 . . . . 0.0 117.487 -167.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -88.53 146.33 25.22 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.068 1.304 . . . . 0.0 111.742 177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -41.83 38.0 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.238 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 165.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -61.86 -32.33 72.67 Favored 'General case' 0 CA--C 1.563 1.477 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 169.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -63.61 -53.79 46.12 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 121.279 1.854 . . . . 0.0 113.886 178.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.256 0.0 OUTLIER -66.46 -45.5 79.51 Favored 'General case' 0 CA--C 1.567 1.618 0 N-CA-C 116.151 1.908 . . . . 0.0 116.151 169.576 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -57.45 -41.42 80.47 Favored 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 117.897 2.554 . . . . 0.0 117.897 171.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -62.31 -48.49 79.64 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 169.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.22 -42.89 87.25 Favored 'General case' 0 CA--C 1.574 1.901 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 169.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.02 -45.1 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 120.959 -1.088 . . . . 0.0 113.621 168.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.3 -44.42 75.72 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 116.803 2.149 . . . . 0.0 116.803 167.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -53.98 -55.79 23.86 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.875 1.435 . . . . 0.0 114.875 161.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 83.4 mt -62.78 -24.21 67.61 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 178.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -63.56 -53.9 44.52 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 163.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -72.11 -30.13 65.75 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 119.186 2.434 . . . . 0.0 119.186 172.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tp-100 -86.2 87.75 7.48 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 118.544 1.172 . . . . 0.0 111.204 -176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 C--O 1.254 1.325 0 C-N-CA 123.911 0.884 . . . . 0.0 111.25 -169.385 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.682 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 CA--C 1.562 1.437 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.85 69.47 1.28 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.188 -0.945 . . . . 0.0 113.286 -179.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -107.25 105.04 54.69 Favored Pre-proline 0 CA--C 1.573 1.848 0 CA-C-O 118.239 -0.886 . . . . 0.0 109.921 175.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.81 -25.49 23.68 Favored 'Trans proline' 0 CA--C 1.571 2.331 0 C-N-CA 122.661 2.241 . . . . 0.0 117.365 176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -66.77 -31.37 71.96 Favored 'General case' 0 CA--C 1.571 1.754 0 N-CA-C 116.507 2.04 . . . . 0.0 116.507 165.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -72.93 -32.29 65.18 Favored 'General case' 0 CA--C 1.57 1.745 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 159.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.15 -25.55 75.47 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 119.134 2.414 . . . . 0.0 119.134 175.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.84 -41.23 95.88 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 173.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -72.87 -33.75 66.28 Favored 'General case' 0 CA--C 1.567 1.627 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 48.8 t -61.09 -40.99 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 CA-C-N 119.963 1.256 . . . . 0.0 113.515 162.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -57.41 -24.39 55.22 Favored 'General case' 0 CA--C 1.569 1.692 0 N-CA-C 116.905 2.187 . . . . 0.0 116.905 165.229 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -53.89 -33.23 49.74 Favored Glycine 0 CA--C 1.556 2.606 0 N-CA-C 119.266 2.466 . . . . 0.0 119.266 170.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.94 -35.9 77.92 Favored 'General case' 0 N--CA 1.499 1.979 0 N-CA-C 115.685 1.735 . . . . 0.0 115.685 162.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -76.14 -33.81 59.4 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -52.25 -34.28 45.47 Favored 'General case' 0 N--CA 1.502 2.146 0 N-CA-C 119.375 3.102 . . . . 0.0 119.375 -167.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.13 -38.6 83.57 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 169.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 35.1 m -87.1 -50.9 6.31 Favored 'General case' 0 CA--C 1.569 1.679 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 169.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 -108.7 138.9 44.28 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 120.383 1.447 . . . . 0.0 112.11 -170.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.1 mptt -111.94 -36.46 5.39 Favored 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . 0.545 3.2 pp 60.2 -5.34 0.09 Allowed 'General case' 0 N--CA 1.503 2.218 0 N-CA-C 120.165 3.394 . . . . 0.0 120.165 -170.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 52.3 p30 -98.0 53.25 1.08 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.266 -0.896 . . . . 0.0 113.164 173.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.29 -39.56 1.22 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 118.32 2.088 . . . . 0.0 118.32 -168.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.81 152.82 40.18 Favored 'General case' 0 CA--C 1.567 1.628 0 CA-C-O 123.102 1.43 . . . . 0.0 113.58 -175.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -112.71 -81.47 0.59 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.409 -1.269 . . . . 0.0 109.181 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.49 -96.79 2.25 Favored Glycine 0 N--CA 1.49 2.238 0 CA-C-N 119.245 0.93 . . . . 0.0 113.391 179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 42.3 t -97.81 -60.95 2.44 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 167.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.03 142.29 15.95 Favored Glycine 0 CA--C 1.555 2.532 0 CA-C-O 118.838 -0.979 . . . . 0.0 114.224 176.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.51 157.87 59.32 Favored 'Trans proline' 0 CA--C 1.558 1.681 0 CA-C-N 121.563 2.681 . . . . 0.0 116.048 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.6 p-80 -56.07 124.73 18.78 Favored 'General case' 0 CA--C 1.572 1.826 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 60.0 mt -94.97 17.89 13.03 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -61.79 108.52 1.02 Allowed 'General case' 0 CA--C 1.568 1.657 0 CA-C-O 122.029 0.919 . . . . 0.0 112.987 174.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.5 24.16 73.55 Favored Glycine 0 CA--C 1.546 2.011 0 N-CA-C 118.246 2.058 . . . . 0.0 118.246 -172.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . 0.281 7.9 p -64.72 -32.75 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 116.604 2.075 . . . . 0.0 116.604 -179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.2 t -70.01 104.8 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 119.125 0.875 . . . . 0.0 108.901 172.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 102.37 -10.69 56.59 Favored Glycine 0 CA--C 1.555 2.588 0 N-CA-C 119.125 2.41 . . . . 0.0 119.125 -164.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 46.5 ttp180 -91.19 160.34 15.6 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 120.582 2.191 . . . . 0.0 112.438 178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 10.9 t -56.4 153.68 9.46 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 120.632 -1.292 . . . . 0.0 113.968 172.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.417 HG22 ' CE2' ' A' ' 57' ' ' TRP . 18.6 t -72.06 137.51 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.751 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.273 158.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . 0.276 . . 63.49 37.69 10.38 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 117.404 2.372 . . . . 0.0 117.404 -158.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.68 53.6 1.71 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 118.88 2.312 . . . . 0.0 118.88 -171.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 73.7 t -141.46 104.77 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 N-CA-C 106.005 -1.85 . . . . 0.0 106.005 162.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -73.24 100.48 3.13 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.626 -0.671 . . . . 0.0 110.675 177.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.63 -50.79 0.67 Allowed Glycine 0 N--CA 1.49 2.24 0 CA-C-O 119.52 -0.6 . . . . 0.0 114.452 -158.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -78.76 136.27 37.34 Favored 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.314 1.057 . . . . 0.0 112.127 174.011 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -80.31 94.86 6.19 Favored 'General case' 0 CA--C 1.567 1.621 0 CA-C-O 121.257 0.551 . . . . 0.0 111.321 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -80.0 160.78 25.76 Favored 'General case' 0 CA--C 1.57 1.75 0 CA-C-O 121.341 0.591 . . . . 0.0 112.582 174.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 61.2 p -68.4 159.63 31.2 Favored 'General case' 0 CA--C 1.571 1.757 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 174.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.89 -51.18 81.45 Favored Pre-proline 0 CA--C 1.577 2.013 0 N-CA-C 116.287 1.958 . . . . 0.0 116.287 176.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -68.92 -22.9 35.38 Favored 'Trans proline' 0 CA--C 1.57 2.314 0 CA-C-N 123.688 2.353 . . . . 0.0 117.019 171.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -63.72 -50.22 69.98 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 114.733 1.383 . . . . 0.0 114.733 162.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 68.4 mmtt -60.6 -43.88 96.92 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.39 1.626 . . . . 0.0 115.39 168.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.42 -19.62 66.02 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 118.365 2.728 . . . . 0.0 118.365 171.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 5.8 t-80 -64.01 -63.05 1.26 Allowed 'General case' 0 CA--C 1.571 1.767 0 CA-C-N 120.464 1.484 . . . . 0.0 112.49 164.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.21 -120.97 19.89 Favored Glycine 0 N--CA 1.49 2.269 0 CA-C-N 119.342 0.974 . . . . 0.0 113.777 -176.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 60.15 -114.39 6.37 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 116.174 1.229 . . . . 0.0 116.174 161.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -163.41 153.8 15.87 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 115.245 1.572 . . . . 0.0 115.245 173.012 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.417 ' CE2' HG22 ' A' ' 38' ' ' VAL . 9.9 m95 -90.96 86.69 6.35 Favored 'General case' 0 CA--C 1.559 1.323 0 CA-C-N 114.808 -1.087 . . . . 0.0 112.167 164.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 74.1 p -72.75 158.58 87.07 Favored Pre-proline 0 CA--C 1.577 2.004 0 N-CA-C 113.647 0.981 . . . . 0.0 113.647 173.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -70.25 50.67 0.97 Allowed 'Trans proline' 0 CA--C 1.58 2.813 0 C-N-CA 122.927 2.418 . . . . 0.0 116.612 169.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -167.89 -58.68 0.02 OUTLIER 'General case' 0 CA--C 1.568 1.654 0 C-N-CA 126.061 1.744 . . . . 0.0 107.616 -166.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -54.54 -44.42 72.83 Favored 'General case' 0 CA--C 1.567 1.629 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 160.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 78.8 mt -59.18 -35.08 72.92 Favored 'General case' 0 N--CA 1.496 1.844 0 N-CA-C 116.211 1.93 . . . . 0.0 116.211 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -67.69 -27.77 67.12 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 175.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -83.39 -47.56 11.3 Favored 'General case' 0 CA--C 1.567 1.634 0 CA-C-N 119.271 0.941 . . . . 0.0 113.416 162.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -57.21 -41.21 78.99 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 116.063 1.875 . . . . 0.0 116.063 174.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.2 mt -69.28 -8.36 45.35 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 117.764 2.505 . . . . 0.0 117.764 170.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' THR . . . . . . . . . . . . . 54.1 m -104.31 -37.59 7.18 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 120.547 1.521 . . . . 0.0 114.131 167.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -132.67 82.84 55.25 Favored Pre-proline 0 CA--C 1.578 2.052 0 CA-C-N 120.249 1.386 . . . . 0.0 107.754 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.23 -46.8 30.85 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 123.762 2.975 . . . . 0.0 117.008 178.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 85.1 mttt -69.63 -17.51 63.52 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 173.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -43.69 63.56 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 115.389 1.625 . . . . 0.0 115.389 167.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 84.9 t -76.9 -49.91 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 CA-C-N 118.902 0.774 . . . . 0.0 112.235 174.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 92.3 t -110.32 96.4 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -72.95 106.88 5.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.346 -0.846 . . . . 0.0 111.425 178.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 90.24 40.83 5.68 Favored Glycine 0 CA--C 1.552 2.4 0 N-CA-C 117.356 1.703 . . . . 0.0 117.356 -162.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 13.1 t -77.82 130.47 36.71 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 118.683 1.242 . . . . 0.0 109.444 162.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LYS . . . . . . . . . . . . . 19.7 ptpt -72.55 23.28 0.06 Allowed 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 116.29 1.959 . . . . 0.0 116.29 164.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' MET . . . . . . . . . . . . . 2.8 ttt -90.18 104.74 17.28 Favored 'General case' 0 CA--C 1.559 1.296 0 O-C-N 121.069 -1.019 . . . . 0.0 108.833 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.58 73.37 6.27 Favored 'General case' 0 CA--C 1.566 1.58 0 CA-C-O 122.25 1.024 . . . . 0.0 112.77 177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.7 t80 -132.05 127.81 36.92 Favored 'General case' 0 CA--C 1.561 1.369 0 C-N-CA 123.67 0.788 . . . . 0.0 109.984 -173.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -78.38 -19.06 54.13 Favored 'General case' 0 CA--C 1.565 1.553 0 N-CA-C 117.653 2.464 . . . . 0.0 117.653 -179.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLY . . . . . . . . . . . . . . . 115.49 146.37 8.82 Favored Glycine 0 N--CA 1.486 1.978 0 N-CA-C 117.306 1.683 . . . . 0.0 117.306 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 72.3 mt -83.6 134.89 44.06 Favored Pre-proline 0 CA--C 1.574 1.871 0 C-N-CA 123.964 0.906 . . . . 0.0 112.774 169.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -82.41 -50.8 0.04 OUTLIER 'Trans proline' 0 CA--C 1.564 2.001 0 C-N-CA 122.447 2.098 . . . . 0.0 116.456 -173.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.5 147.56 25.91 Favored 'General case' 0 N--CA 1.487 1.387 0 CA-C-N 119.624 1.102 . . . . 0.0 111.767 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -55.76 -40.02 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.27 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 166.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.0 mp0 -55.59 -37.37 68.0 Favored 'General case' 0 CA--C 1.562 1.408 0 N-CA-C 115.74 1.756 . . . . 0.0 115.74 168.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 63.7 m-20 -64.84 -58.09 7.12 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 119.985 1.266 . . . . 0.0 113.143 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . 0.258 0.0 OUTLIER -62.61 -42.78 99.78 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.622 2.082 . . . . 0.0 116.622 170.947 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -61.54 -45.24 94.99 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 117.23 2.308 . . . . 0.0 117.23 172.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -60.7 -45.37 94.46 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 167.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -54.6 -44.88 73.45 Favored 'General case' 0 CA--C 1.573 1.848 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 164.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.1 -34.89 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 O-C-N 120.797 -1.189 . . . . 0.0 114.184 171.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -61.06 -46.82 89.11 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 162.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -53.49 -52.99 57.77 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 165.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 97.5 mt -62.41 -27.78 69.33 Favored 'General case' 0 N--CA 1.5 2.061 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 176.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -66.58 -50.45 63.07 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 163.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -74.66 -46.47 18.48 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 118.573 2.189 . . . . 0.0 118.573 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -88.32 89.08 7.85 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-N 118.128 0.964 . . . . 0.0 111.391 -173.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 C--O 1.254 1.33 0 CA-C-O 117.896 -1.05 . . . . 0.0 112.568 -172.953 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HEC . . . . . 0.648 HBC3 HMC1 ' A' ' 101' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_